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This thesis explores the use of susceptibility-weighted imaging (SWI) and quantitative 
susceptibility mapping (QSM), to characterize carotid artery plaques with and without 
the use of ultrasmall superparamagnetic iron oxide (USPIO) nanoparticle contrast 
agents. The overall hypothesis is that QSM can serve to differentiate carotid artery 
plaque features of different susceptibility and provide a positive contrast mechanism 
for imaging the uptake of USPIOs. 
Chapter 1 describes the pathophysiology of carotid atherosclerosis. Vulnerable 
plaques, i.e. those at risk of rupture, can be characterized by the presence of a lipid 
rich necrotic core (LRNC), intraplaque haemorrhage (IPH), and inflammation. In 
addition, plaques may develop calcifications that may be protective of rupture. The 
chapter describes the established multi-contrast imaging protocols used for 
characterizing plaques. Furthermore, the use of USPIO-contrast agents to image 
inflammation is described. 
Chapter 2 describes the physical principles of MR image generation including the 
sensitivity to magnetic susceptibility. The principles of T2*w imaging, and susceptibility 
weighted imaging (SWI) are explained. 
Chapter 3 reviews the principles and post-processing steps involved in commonly 
used algorithms for QSM in terms of the underlying physical and mathematical 
principles which are then demonstrated in the form of numerical simulations. 
Chapter 4 presents the application of SWI to a group of patients who underwent 
USPIO enhanced MRI on a 1.5T MRI system. Images were acquired prior to infusion 
and 48 hours post infusion. SWI and gradient echo phase images were used to depict 
the field inhomogeneities generated by diamagnetic and paramagnetic materials 
within the plaques, calcification and USPIO-uptake. These results were then 
compared to a conventional carotid multi-contrast protocol, which includes R2*-
mapping and T2*w imaging, and, where available, CT and histology. 
In chapter 5 QSM is performed in the carotid artery wall of a cohort of normal 
volunteers on a 1.5T MRI system. Unlike the brain, the neck contains fat which can 
cause severe errors in the field estimate, which propagate into the susceptibility map. 
 
 
Therefore, QSM was combined with water-fat separation for application in the neck to 
correct for these artifacts. This correctly estimated a high fat-fraction in fatty tissue in 
the neck and allowed for a detailed depiction of the anatomy of healthy volunteers. 
The susceptibility value measured in fatty tissue agreed with literature values. 
Chapter 6 applies QSM with water-fat separation to a subset of the patient group on a 
1.5T MRI system. On pre-contrast scans QSM successfully identified calcification as 
diamagnetic tissue and the water-fat separation identified a lipid core. On the post-
contrast susceptibility maps, USPIO-uptake was identified as hyperintense signal. 
This allows QSM to provide quantitative contrast in carotid imaging that can identify 
multiple features simultaneously and to simplify the imaging of USPIO-contrast. The 
results were confirmed using the multi-contrast carotid MRI protocol and, where 
available, histology and CT. 
Chapter 7 discusses the limitations of the current studies and the potential future 
improvements of the current methodology in terms of MR acquisition, post-processing 
algorithms and MR protocols. 
Future studies could serve to further evaluate the potential of QSM in carotid imaging 
and use it as a novel tool to quantify USPIO uptake in atherosclerotic carotid arteries. 
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Chapter 1 Stroke and Atherosclerotic 
Disease 
1.1 Carotid Artery Disease 
Cardiovascular disease is the leading cause of death worldwide (1) and stroke in 
particular, which affects the vasculature of the brain, has a very high mortality rate and 
is a leading cause of long-term disability, which causes a significant amount of social 
expenditure (1,2). This explains the high interest in continually improving 
understanding of the disease for better diagnosis and medical treatments, which 
includes life-style changes, medication and surgical intervention. 
The improvements in medical treatment and risk factor control has had the effect of 
reducing the incidence of stroke and associated deaths over the recent decades (1–
6), which may be due to improved understanding of the disease. In particular, 
controlling certain risk factors, for example, through lipid lowering therapy, blood 
pressure control or smoking cessation have decreased stroke incidence and mortality 
rates over the past decades (4–6).  While this shows the importance of medical 
research in this field, the incidence rates are nonetheless high and the long-term 
effects severe (1,2,6). 
 
Figure 1-1: Atherosclerotic plaque in the carotid bifurcation 
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The most prevalent type of stroke is ischemic (~85%), while the remaining types of 
stroke are haemorrhagic (7). During an ischaemic stroke a thrombus (blood clot) or 
occlusion blocks the blood and nutrient supply to the brain. Of those a large part are 
caused by atherosclerotic carotid plaques, which are illustrated in Figure 1-1 (7). 
Atherosclerotic plaques typically grow more and more complex during the life of the 
patient, so that they may eventually rupture, which leads to the formation of a blood 
clot, which can cause the ischemic stroke. In spite of the decrease in incidence and 
mortality rates associated with stroke, there remain large areas for improvement in 
patient diagnosis: Currently, luminal narrowing (luminal stenosis) as diagnosed on 
Doppler Ultrasound is used clinically as a marker to identify patients at risk and decide 
on their treatment approach (8). Severe levels of stenosis have shown to be an 
important indicator of the risk of future events in patients who have shown stroke 
symptoms: Both the North American Symptomatic Carotid Endarterectomy Trial 
(NASCET) and European Carotid Surgery Trial (ECST) found that symptomatic 
patients with severe levels of stenosis had a great benefit in reduction of future events 
after carotid endarterectomy surgery (9,10). During this surgery, the carotid artery is 
opened so that the inner artery lining can be removed along with the plaque (8). As 
there is a perioperative risk associated with this procedure, it is important to carefully 
select the patients eligible for surgery to maximize the benefit to risk ratio of the 
surgery. However, the benefit of considering carotid stenosis as a sole risk factor in 
asymptomatic patients and those with mild to moderate levels of carotid stenosis 
remains questionable (9,11). Plaques may, for example, progress without occluding 
the lumen and expand outward, which is called positive remodelling (12,13). In vivo 
imaging of different patient groups and ex vivo analysis of excised carotid plaques 
have suggested that the presence of certain morphological features may render 
certain plaques more prone or vulnerable to rupture. These include plaques that 
contain intra plaque haemorrhage (IPH), a thin and/or ruptured fibrous cap (FC), a 
larger lipid rich necrotic core (LRNC), large amounts of inflammation, and to a lesser 
degree calcification (14,15).  
1.2 Pathology 
Atherosclerosis originates with the formation of fatty streaks, often early in the life of 
the patient. Over a long period of time, the fatty streaks may progress into more 
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complex atherosclerotic plaques, which may become increasingly unstable and 
eventually rupture. As the plaque ruptures, its thrombogenic core is exposed so that a 
thrombus may be formed in the vasculature. In the carotid arteries, this may lead to a 
blockage of the blood supply to the brain, which results in an ischaemic stroke (16).  
 
Figure 1-2: The formation of carotid plaques involves the infiltration of lipids and macrophages (17) 
A particular risk factor of atherosclerosis is heightened low density lipoprotein (LDL) 
levels in the circulation (12). In areas with increased endothelial cell permeability LDLs 
may enter the subendothelial space (12,18). Increased endothelial cell permeability is 
an effect of endothelial dysfunction (19), which may be caused by other risk factors, 
such as smoking, diabetes mellitus, hypertension, or hypercholesterolemia (12,20). 
As LDLs enter the vessel wall, they undergo modification and become oxidized LDLs 
(oxLDLs) (12,20–22) which are cytotoxic, which means that they cause cell damage 
(20). OxLDLs cause further endothelial dysfunction (23,24), allowing for a heightened 
influx of LDL particles and also lead to an inflammatory response. This involves the 
expression of vascular cell adhesion molecules (VCAMs), which may bind monocytes 
and lymphocytes, which are then recruited into the plaque by chemokines (20,25–28).  
Inside the plaque, the monocytes can differentiate into macrophages (20,25,29) which 
take up oxLDLs until they become lipid laden macrophages or foam cells (20,25). The 
macrophages secrete cytokines, which are pro-inflammatory and lead to the 
upregulation of VCAMs and also the recruitment of further macrophages (12,30,31). 
Therefore, through the recruitment of macrophages, the inflammatory response is 
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further enhanced and can be seen as a marker for plaque progression. As 
macrophages and foam cells die, they form a lipid rich necrotic core, which was 
previously mentioned as a marker of unstable plaques (16).  
In addition, growth factors and cytokines released by foam cells also attract vascular 
smooth muscle cells from the media into the intima (12,20,32,33). Within the intima, 
the VSMCs change their phenotype and release proteoglycans, which can bind and 
oxidize LDL (20,34–36) they attract and bind monocytes (20,35) and also secrete 
cytokines and chemokines (34,35), all of which enhances the accumulation of 
macrophages in the plaque. As the VSMCs can also take up lipids, they may also turn 
into foam cells (33,35,37–40). Similarly to the macrophages, these VSMCs may die 
and contribute to the lipid rich necrotic core (35,41).  
This has demonstrated that the presence of inflammation in atherosclerotic plaques 
leads to positive feedback to increase inflammation even further. This is particularly 
problematic in regions of non-laminar flow, such as the carotid bifurcation (12). The 
reduction of shear stress caused by the altered flow pattern leads to a downregulation 
of the atheroprotective nitric oxide (NO) (12,20,42). NO has several functions such as 
preventing platelet aggregation (anti-thrombotic) (12,43) and the expression of 
adhesion molecules and therefore inhibiting macrophage infiltration (anti-adhesive) 
(12,20,43). Therefore, regions of turbulent flow, such as the carotid bifurcation, are 
especially predisposed for the formation of atherosclerotic plaques. 
However, in addition to these pro-inflammatory, destabilizing effects, VSMCs also play 
a stabilizing role in atherosclerosis through the generation of a fibrous cap (12,44). 
VSMCs synthesize an extracellular matrix containing for example collagen (45,46), 
which together with the smooth muscle cells forms the fibrous cap (16,45). This 
protective structure covers the thrombogenic necrotic core and shields it from 
exposure to the lumen. However, when the fibrous cap of an atherosclerotic plaque 
ruptures, a thrombus can but does not have to be formed, which can but does not 
necessarily have to lead to symptoms (47–49). Furthermore, it is important to note that 
once a fibrous cap has ruptured it may remain thrombotically active so that multiple 
recurring events may follow (15). Therefore, fibrous cap rupture is an important feature 
of vulnerable plaques which is associated with thrombus formation (15,50) and also 
with other features of plaque instability such as a lipid rich necrotic core or intraplaque 
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haemorrhage (47). Cap rupture is caused by the thinning of the fibrous cap, which is 
enhanced by inflammation. Macrophages, which accumulate at the border of the lipid 
core and in the shoulder region of the plaque, or around neovessels, which are 
described in more detail below, release matrix metalloproteinases (MMPs) (18,50–
52), which degrade the extracellular matrix, which leads to cap thinning (18,50–52).  
A thick FC does not necessarily indicate a low risk of symptoms. Studies conducted in 
plaques in the coronary vasculature, for instance show that, a number of thrombi occur 
with an eroded and thick FC as opposed to a ruptured cap (53–56). In carotid artery 
plaques, plaque erosion is less frequent and occurs less often than plaque rupture in 
symptomatic patients (15,57,58). 
Another feature of vulnerable plaques is intraplaque haemorrhage. Erythrocytes (red 
blood cells) can leak into the fibrous cap through fissures in the fibrous cap or a 
network of microvessels, the vasa vasorum. It is thought to be formed in response to 
plaque thickening. As the intima thickens, the diffusion path of nutrients and oxygen, 
that need to be supplied to the VSMCs, growths in length. The vasa vasorum is formed 
in response to this so that across its highly permeable walls the nutrients and oxygen 
can be supplied to VSMCs (59–67). Along with nutrients, erythrocytes also leak into 
the plaque, which is associated with an increased infiltration of macrophages (62–65). 
Higher levels of apoptotic macrophages and higher phagocytosis of erythrocytes 
increases the content of free cholesterol in the plaque and produces lipids and iron. 
Therefore, the development of intraplaque haemorrhage (IPH) has been shown to 
cause progression of the LRNC and an increase in wall volume while decreasing the 
lumen volume and exhibiting a high association with a thin and/or ruptured fibrous cap 
(63–66,68–71). 
Advanced atherosclerotic plaques typically also contain calcification. While its  role in 
plaque vulnerability is ambiguous, calcification is seen as an overall marker of 
cardiovascular risk and atherosclerotic disease burden and may increase with age 
(20,23,72). Calcification originates within apoptotic bodies or necrotic debris released 
by apoptotic macrophages and VSMCs or matrix vesicles released by VSMCs and 
macrophages as an inflammatory response (73–76). This process may be aided by 
the absence of mineralization inhibitors and VSMCs that transdifferentiate into 
osteochondrogenic precursors, which can regulate mineralization (73–76). The initial 
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formation of microcalcifications, which are of a size between 0.5-15 µm (77), is 
therefore associated with inflammation. This is even further enhanced, since 
microcalcifications may induce another inflammatory response, therefore enhancing 
plaque progression and destabilizing the atherosclerotic plaques (74,78). However, 
microcalcifications may also coalesce into larger sheets of macrocalcification which 
are greater in size than 15µm (77,79,80). This may be aided by the transdifferentiation 
of VSMCs into an osteoblast-like phenotype (75). These macrocalcifications are 
thought to have a stabilizing effect on the plaque as they may shield inflammation, 
therefore slowing plaque progression and potentially stabilizing the plaque 
(74,75,78,81). 
1.3 Current Diagnosis and Treatment  
Atherosclerosis is a complex process. Luminal stenosis is used as a risk evaluation 
criterion for making a decision on medical treatment (8). As previously described, the 
large-scale NASCET and ECST trials have demonstrated that surgical intervention 
was beneficial in high risk symptomatic patients with a high degree of stenosis by 
reducing the risk of recurrent strokes through carotid endarterectomy surgery (9,10). 
It has furthermore been shown that patients who have suffered from a recent event 
are at an increased risk of a recurrent event in the 30 days following the initial event 
so that they would benefit greatly from surgery (82). Therefore, patients who have 
suffered from symptoms will undergo screening for carotid artery stenosis, which is 
typically done using carotid doppler ultrasound/duplex ultrasound, and subsequently 
often undergo surgery in the two weeks subsequent to the initial event, where benefit 
has shown to be greatest (8,83,84). The benefit of surgery in symptomatic patients 
with lower degrees of stenosis was much lower (9). In asymptomatic patients, even 
with high levels of stenosis, careful consideration before surgery is recommended and 
the uncertainty about treatment strategies is higher (11). In combination with the 
overall low prevalence of atherosclerotic plaques in the general population and the 
questionable benefit of stenosis as a marker for risk of future events in asymptomatic 
patients have led to recommendations against a screening of the general population 
(85–87). 
However, as many asymptomatic patients may suffer from stroke as well and because 
a high degree of stenosis is regarded as an increased risk of stroke (88), it would be 
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beneficial to identify subgroups of patients at risk. The common risk factors of 
atherosclerosis and increased stroke risk are known. In addition to examining 
symptomatic patients, the “ASA/ACCF/AHA/AANN/AANS/ACR/ 
ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of 
Patients With Extracranial Carotid and Vertebral Artery Disease” has therefore 
recommended the screening of asymptomatic patients with duplex ultrasonography  
with symptomatic peripheral artery disease, coronary artery disease, atherosclerotic 
aortic aneurysm, carotid bruit, or two of the following: hypertension, hyperlipidaemia, 
tobacco smoking, family history of early onset of atherosclerotic disease (89,90). 
 
Figure 1-3: Stenosis as calculated with the NASCET and ECST criteria. A) shows an X-ray angiogram 
where the narrowest diameter of the internal carotid artery, the estimated original diameter of the lumen 
at said location and the normal distal cervical internal carotid artery diameter are indicated in red, purple, 
and green respectively. B) and c) illustrate how these diameters can be measured on black blood MR 
images, also. (courtesy of Martin Graves) 
Carotid stenosis can be assessed with different methodologies. In the NASCET and 
ECST studies, two different methods of measurement and calculation have been 
proposed to measure stenosis in X-ray angiography as illustrated in Figure 1-3: In the 
NASCET study (10), the difference between the narrowest diameter of the internal 
carotid artery (ICA) and the normal distal cervical ICA diameter is measured relative 
to the normal distal cervical ICA diameter to give a percentage stenosis. In the ECST 
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study, stenosis was defined as the difference between the diameter of the lumen at 
the most stenotic part of the ICA and the estimated original diameter of the lumen at 
said location relative to this original diameter (9,91).  
Carotid ultrasound imaging, is commonly used to assess carotid artery stenosis since 
it is cost-effective and non-invasive and does not expose the patients to ionizing 
radiation (8,89,92). Doppler ultrasound uses the Doppler effect to measure the blood 
velocity, which is elevated in stenotic regions and allows for grading of stenosis (93). 
If the results from this examination are ambiguous or further information is required for 
surgical planning, additional examinations such as X-ray angiography or Magnetic 
Resonance Angiography may be performed (89,92).  
Once a patient has been diagnosed with carotid artery stenosis, several different steps 
are involved in order to provide the best medical therapy (BMT) according to disease 
severity. Initially lifestyle changes such as cessation of smoking, diet changes, and 
cardiovascular exercise are prescribed (89), which may be combined with medication. 
This can consist of antiplatelet and antithrombotic therapy to prevent further blood 
clotting (89,94), antihypertensive therapy to regulate blood pressure (89,95) and/or 
statin therapy to decrease low density lipoprotein cholesterol (LDL-C) level to a target 
level (89,96). 
In especially severe cases, patients may undergo carotid revascularization surgery: in 
particular carotid endarterectomy (CEA) or carotid artery stenting (CAS). As these 
surgeries carry great perioperative risks, which may lead to ischemic events in itself, 
it is important to weigh the benefits against the risks of the surgery. CEA involves the 
excision of the carotid artery plaque from the carotid artery. This is a well-established 
technique and from the results of several studies, in particular the previously 
mentioned NASCET and ECST trials, a risk assessment according to the patient 
status can be made. In particular, in symptomatic patients with severe and, to a lesser 
degree, moderate cases of carotid artery stenosis, the removal of the plaque has 
shown to lower the overall risk of recurrent events (97,98). In patients with less than 
50% of stenosis, however, medical management was shown to be more beneficial 
than surgery (97). Furthermore, the benefit was greatest two weeks after an ischemic 
event (83). An alternative procedure to CEA is carotid artery stenting, which involves 
the placement of a stent inside the region of the carotid artery plaque. The 
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perioperative risks and post-surgery reduction of risk of ischemic events have shown 
to be similar to CEA. It has been proposed that the advantages of CEA and CAS may 
differ on a case-by-case basis, depending on the individual patient and also the 
experience of the operating surgeon (89,99). 
While the benefits of surgical intervention are clear in symptomatic and severely 
stenotic patients, a large group of patients who have never shown any symptoms or 
have a low level of stenosis may suffer from plaque rupture and ischemic events. In 
order to identify the patients at risk it is therefore necessary to find alternative 
strategies for patient screening and identifying patients eligible for surgery. An 
example for this is the identification of vulnerable complex plaques. MRI offers 
excellent soft-tissue contrast and therefore offers an excellent methodology for 
monitoring disease progression for research and clinical purposes. 
1.4 Multi-Contrast MRI of Carotid Plaque 
In order to characterize atherosclerotic carotid artery plaques MRI is a suitable imaging 
technique since it achieves high resolution, non-invasive in vivo imaging with excellent 
soft tissue contrast. A typical imaging protocol consists of multiple contrast weightings 
(T1, T2, PD, and 3D time-of-flight (TOF)), as shown in Figure 1-4. Their specific 
appearance on the individual images allows for the individual features of vulnerable 
plaques to be identified and distinguished. (See Table 1-1).  
Table 1-1: Signal intensities of different plaque features relative to the sternocleidomastoid muscle on 
different sequences of the multi-contrast protocol (100)  
Initial studies using T1w 2D Fast Spin Echo (FSE), T2w FSE, and PDw FSE  and 3D 
TOF were able to detect IPH and a thin and/or ruptured FC with high reproducibility 
and high classification accuracy, sensitivity, and specificity when compared to the gold 
standard histology (101–107). 
 3D TOF T1-w PDw T2-w 
Recent IPH High High/Moderate Variable Variable 
Lipid Rich Necrotic Core Moderate High High Variable 
Calcification Low Low Low Low 




Figure 1-4: Multi-contrast MRI of carotid plaques can identify features of vulnerable plaques (courtesy 
of Martin Graves) 
Progress in MRI research has allowed for the increase of field strength of the magnets 
from 1.5T to 3T (108–114), and in some applications even to 7T scanners (115–118). 
This improves the SNR of the acquired images, which can improve image quality or 
can be used to acquire higher resolution images or acquire images in a shorter 
acquisition time, as parallel imaging or less signal averages can be employed to 
acquire high quality images within a smaller time period (108–113). Additionally, the 
use of 3D instead of 2D imaging sequences further improved the SNR of the image 
acquisition (119,120). In 3D imaging a 3D volume, rather than a 2D slice is excited by 
the radiofrequency excitation pulse. For a given sequence, where all other imaging 
parameters are kept constant, 3D imaging increases the SNR by a factor of √𝑁𝑃𝐸2, 
where 𝑁𝑃𝐸2 is the number of phase encode steps in the slice direction, since the 
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relationships between SNR, volume of interest and the resolution can be described as 









Here 𝐹𝑠𝑒𝑞 is a sequence dependent factor that gives the signal strength relative to 
relaxation times, flip angle and echo and repetition times, 𝐵𝑊 is the imaging 
bandwidth, NSA is the number of signal averages, Δ𝑥, Δ𝑦, and Δ𝑧 are the resolution 
in the x, y, and z-direction, NFE is the number of frequency encode steps, and NPE1 
and NPE2 are the number of phase encode steps (121). The acquired images therefore 
have a higher SNR or can be acquired at a higher resolution. This can be used to 
improve the resolution in the slice direction and image quality and partial volume 
effects (PVE) can be reduced (119,120). 
Furthermore, specialist sequences have been developed for certain applications. 
Black-blood imaging aims to suppress the signal from flowing blood. This has the 
effect of eliminating plaque mimicking artifacts caused by slow or turbulent flow. Inflow-
outflow saturation band (IOSB) and double-inversion recovery (DIR) are two 
techniques, successfully used in 2D FSE (112,122,123). IOSB places two parallel 
saturation bands on either side of the imaging slice prior to data acquisition. The spins 
that subsequently flow into the imaging slice then do not give any signal (112). DIR 
uses a train of pulses that achieves black blood preparation. The black blood 
preparation consists of two 180° radiofrequency (RF) pulses, the first of which is not 
spatially selective and therefore inverts the magnetization within the entire volume. 
The second, spatially selective RF pulse, only inverts the signal within the imaging 
slice and restores the magnetization. After an inversion time TI, the magnetization of 
the blood will have relaxed sufficiently to reach a null point and give zero signal. At this 
point, data acquisition starts. This technique requires that the blood inside the imaging 
slice will be replaced by that flowing in from the outside, which has only experienced 
the first RF pulse so that the lumen does not give any signal (112,122,123). However, 
both techniques rely on the inflow of magnetization prepared blood into the imaging 
slice, replacing any unprepared blood, which may give rise to signal within the lumen. 
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Insufficient replacement by magnetization prepared blood may occur particularly in 
thick imaging slices or in areas of slow or turbulent flow, such as the carotid bifurcation.  
Therefore, alternative blood suppression techniques which are better suited for 3D 
imaging of the carotid artery bifurcation have been proposed, such as Delay 
alternating with nutation for tailored excitation (DANTE) (124). DANTE employs a 
black blood preparation module in advance of the imaging sequence. A pulse train 
with small flip angles (3-15°), which have a fixed phase advance, are interspersed with 
gradients. Blood suppression is achieved as static spins only have a linearly increasing 
phase component. In combination with a fixed increment of the phase of the flip angle, 
this leads to phase coherence. Spins, that move along the direction of the gradient will 
accumulate a quadratic phase. This results in a spoiling mechanism similar to RF 
spoiling. This leads to a large attenuation of the longitudinal magnetization of flowing 
spins, which leads to a robust flow compensation relatively independent of flow 
velocity (124). 
In addition to that, specific properties of the individual plaque features have allowed 
for specialized pulse sequences to simplify their detection. A commonly used example 
is MR direct thrombus imaging (125). IPH contains methaemoglobin, which has a 
particularly short T1 relaxation time. Magnetization preparation is combined with a T1-
weighted sequence, in order to suppress blood flow. Overall this improves the contrast 




Figure 1-5: Appearance of intraplaque haemorrhage on T1w and T2w contrast in comparison with MR 
DTI (courtesy of Martin Graves) 
1.5 Imaging of Carotid Artery Plaque Inflammation Using 
USPIO-Contrast Agents 
1.5.1 USPIO Contrast Agents 
While the multi-contrast protocol cannot image inflammation in plaques, this can be 
achieved with a macrophage selective contrast agent. Ultrasmall Iron Oxide (USPIO) 
nanoparticles are contrast agents with a mean diameter of less than 50 nm. As they 
do not accumulate in the reticuloendothelial system (RES) as rapidly as larger iron 
oxide particles, they stay in the blood circulation for a sufficiently long time to serve as 
an attractive blood pool agent (126,127). As such USPIOs have found application in 
contrast enhanced MRA (128,129), perfusion imaging and to evaluate tumour 
vascularity (130,131). Additionally, USPIOs are taken up by the lymph node system 
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(132). Tumour metastases located in the lymph node system, can be detected as they 
do not show any change on the MR images post-contrast administration (132). 
Furthermore, USPIO-contrast agents are taken up by macrophages. In Abdominal 
Aortic Aneurysm USPIO uptake by macrophages was shown to image inflammation 
(133,134) which appeared to be a sign for more rapid expansion (133). In strokes, 
which result from a disruption in the blood supply to the brain, there are macrophages 
in the infarct zone (135). Furthermore, increased USPIO uptake within the infarcted 
and remote myocardium after acute myocardial inflammation could be detected (136).  
In addition to that, USPIO nanoparticles have also been used as a contrast agent for 
imaging carotid artery plaques. They enter the plaque through a leaky endothelium 
and are subsequently taken up by macrophages, typically within the first 24 hours after 
an intravenous bolus injection (126,137–140). Due to their paramagnetism (positive 
susceptibility), USPIO-uptake causes an increase in R2*-relaxation rate and manifests 
as signal hypointensities on T2*w gradient echo MRI when compared to a pre-contrast 
acquisition as shown in Figure 1-6 (137,138,141–143). The macrophage-specific 
property of USPIOs allows MRI to detect areas of high macrophage activity which 
could potentially help assessing pathogenesis and prognosticating disease severity. 
USPIOs also shorten T1. Especially in low concentrations they appear as 
hyperintensities on T1 weighted images (127). 
The carotid coils are typically phased array surface coils that are placed on either side 
of the neck. The carotid coil sensitivity is highly inhomogeneous so that the signal 
intensity within the plaque may vary drastically between pre- and post-contrast scans. 
Therefore, the 𝑇2
∗w signal within the plaque is typically normalized by the signal 
intensity in the sternocleidomastoid muscle to make pre- and post-contrast signal 
intensities comparable (138,141). However, this technique is nonetheless susceptible 
to inaccuracies and variability, due to the same issues concerning the scan location 
and coil positioning changes between the pre- and post-contrast acquisition. 
Therefore, T2*/R2*-mapping may offer a more reliable and quantitative assessment 
independent of the imaging variables. However, the non-local properties of the field 
inhomogeneities (field inhomogeneities extend beyond the source of the susceptibility 
variation) can cause errors on R2*-maps and lead to errors in the estimation of the 
amount of USPIO-uptake (144). Furthermore, areas of USPIO-uptake may be 
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overestimated due to non-local effects (144). A pixelwise comparison of pre- and post-
contrast images requires advanced image co-registration. Therefore, T2*w and R2*-
mapping based analyses divide the plaque area into quadrants (126,141,143) or 
octants (137) in order to compare the values for each section on pre- and post-contrast 
administration. While this allows for an operator independent analysis, the decline in 
resolution may lead to decreased detection sensitivity of small areas of USPIO uptake. 
USPIO uptake within carotid atheroma was found to be a good indicator of plaque 
inflammation (141) and USPIO uptake has also been shown to be more frequent in 
symptomatic patients (145).  
 
Figure 1-6: MR images acquired before and 36 hrs after administration of the USPIO contrast agent 
Sinerem. Hyperintensity can be observed on post-contrast T1w imaging and hypointensity on the post-
contrast T2*w image (GRE TE = 20 ms) (courtesy of Martin Graves) 
In the following chapters the USPIO contrast agent ferumoxytol will be used. 
Ferumoxytol is an iron oxide agent originally used to treat anaemia, which has been 
widely used in research and also used as an off-label clinical contrast agent (146). It 
is important to consider its safety profile. The risk assessment is based on its use as 
a therapeutic drug for anaemia treatment. In 2015 the FDA issued a boxed warning 
for ferumoxytol since in 1.2 million therapeutic doses, 79 anaphylactic reactions with 
18 fatalities occurred (146,147). However, these results were all based on therapeutic 
applications. It is important to note that the ferumoxytol doses administered for imaging 
are much lower in comparison with therapeutic doses. For imaging, the administered 
doses typically ranged from 1 to 7.5 mg/kg, while the full therapeutic dose was 1020 
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mg, which for a 70 kg adult would correspond to 14.6 mg/kg (146). During 
administration, the dose is typically diluted and a slow infusion is recommended 
(146,147). In comparison to ionic iodinated and gadolinium-based contrast agents the 
reported risks were comparable and higher respectively. However, it has been 
suggested that ferumoxytol offers a comparatively lower risk in patients with renal 
disease and could therefore be used as an alternative contrast agent (146).  
1.5.2 Positive Contrast in USPIO-Imaging 
The described techniques, that have been commonly used in imaging USPIO-contrast 
agents rely on the detection of a reduction in signal intensity on post-contrast images 
due to the increase in magnetic susceptibility caused by the uptake of USPIO particles, 
which is associated with T2*-shortening. Therefore, USPIO-uptake is imaged with 
negative contrast. The distinction from other sources of signal hypointensities, for 
example originating from bone, calcification or haemorrhages, is therefore difficult to 
impossible on a single scan. Therefore, as previously described, a comparison of pre- 
and post-contrast images is required for the detection of USPIO-uptake.  
It has been suggested that imaging USPIO-uptake as “positive” contrast, i.e. 
hyperintensities, may improve the detection of USPIO uptake, render pre-contrast 
imaging obsolete and, therefore, eliminate the associated registration errors 
(144,148). Several techniques have aimed at creating positive contrast images: 
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The IRON technique: spectrally selective pulses 
 
Figure 1-7: Pulse sequence diagram IRON (courtesy Martin Graves) 
The IRON (Inversion Recovery ON Resonance) technique (148), pictured in Figure 
1-7, uses a sequence of spectrally selective saturation preparation pulses in order to 
suppress signal from all other sources besides USPIO nanoparticles. Due to their high 
paramagnetism, the USPIO nanoparticles cause an inhomogeneity in 𝐵0. This causes 
a local change in precession frequency in the surrounding voxels. IRON saturates only 
on-frequency spins, that contain minimal changes in precession frequency. Voxels in 
proximity to the USPIO nanoparticles contain large 𝐵0 field inhomogeneities, and 
precess at a different frequency. Therefore, they remain unsuppressed and are 
highlighted and are presented as hyperintensities as shown in Figure 1-8. 
Exciting/saturating the correct frequency shifts, requires knowledge of the expected 
frequency shifts and therefore the amount of contrast agent taken up. Furthermore, 
large-scale field inhomogeneities also cause a change in precession frequency which 




Figure 1-8: The IRON sequence selectively suppresses signal from water but signal hyperintensities 
can be observed in the vial stemming from USPIO (courtesy Martin Graves, images also appear in 
(150)) 
GRASP technique 
Another, similar technique to generate positive contrast is called GRASP (151). In 
conventional imaging, the slice select gradient is followed by a re-phasing gradient in 
order to eliminate the de-phasing caused during slice selection. By estimating the 
amount of rephasing achieved by the 𝐵0 field inhomogeneities alone, the re-phasing 
gradient can be reduced by an appropriate amount so that the change in 𝐵0 leads to 
an enhanced signal recovery: The spins within voxels where the 𝐵0 field 
inhomogeneity in the direction of the slice select gradient is insufficiently large or is of 
the wrong polarity, will not be fully re-phased and only the relevant voxels where the 
USPIO contrast have caused a phase shift appear hyperintense. This technique 
requires a careful selection of the re-phasing gradient strength, based on a priori 
knowledge of the magnitude and orientation of the B0 field inhomogeneity caused by 
the contrast agent. 
SGM technique 
Alternatively, in susceptibility gradient mapping (SGM) susceptibility gradients may be 
mapped when considering the complex signal of a gradient echo acquisition. This 
delineates the region of interest by signal hyperintensities surrounding areas of USPIO 
uptake. Since there is an increase in the local field inhomogeneity (152).  
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All of these techniques simply highlight the presence of larger field inhomogeneities 
and suffer from dependence on the sequence or assumptions about the amount, 










Chapter 2 Principles of MRI 
Aspects of this work have been published in “Ruetten PPR, Gillard JH, Graves MJ. 
Introduction to Quantitative Susceptibility Mapping and Susceptibility Weighted 
Imaging. Br. J. Radiol. 2019;92:20181016 doi: 10.1259/bjr.20181016.” (153) 
2.1 MRI Physics 
2.1.1 MR Signal and Spin Relaxation 
The human body consists of atoms, whose nuclei have an associated charge and spin. 
Hydrogen atoms which are typically imaged in MRI are positively charged. As they 
spin around their own axis, they constitute moving charges which generate a magnetic 
moment, so that a hydrogen nucleus constitutes a magnetic dipole. The spin, also 
defined as angular momentum 𝐽 is characterized by the nuclear spin quantum number 
𝐼, which is ½ for hydrogen nuclei (121,154–157):  
 𝐽 = ℎ[𝐼(𝐼 + 1)]
1
2 2-1 
Here, ℎ is the reduced Planck’s constant (
ℎ
2𝜋
). The z-component of 𝐽 is given by: 
 𝐽𝑧 =  ℎ𝑚𝐼 2-2 
Here, 𝑚𝐼 is the magnetic quantum number, which for hydrogen, (𝐼 =
1
2
) may take on 
the values -½ and ½ (121,154–157) This means that there are two potential 
orientations for the hydrogen spins. When placed within a static magnetic field, such 
Figure 2-1: The proton spins precess around the magnetic field of the scanner 𝐵0 with the Larmor 
frequency: 𝜔 = 𝛾𝐵0 (Courtesy of Martin Graves) 
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as that of an MRI scanner, all the z-components of 𝐽 align either in parallel or anti-
parallel with the field of the scanner 𝐵0. The relationship between the magnitude of 𝐽 
and 𝐽𝑧 is defined as 𝐽𝑧 = |𝐽|cos (𝛼). The angle 𝛼 is in between the direction of 𝐵0 and 
𝐽. By evaluating 𝐽 and 𝐽𝑧 in the above formulae with the known values for the spin 













cos (𝛼) 2-3 
From this, 𝛼 can be determined as:  






) = cos−1 (
1
√3
) = 54.7° 2-4 
Therefore 𝐽 is at an angle of 54.7° (the magic angle) in relation to 𝐵0.The spins precess 
around the z-axis of the magnetic field 𝐵0 with a specific frequency, the Larmor 
frequency, as shown in Figure 2-1. This is analogous to a gyroscope. The Larmor 
frequency is calculated as the product of the rationalised gyromagnetic ratio and the 
magnetic field strength of the scanner:  
 𝑓 = 𝛾𝐵0 2-5 
The rationalised gyromagnetic ratio 𝛾 =
𝛾
2𝜋
 is 42.56 MHz/T for hydrogen and is a 
nucleus-specific constant so that the spins of different nuclei precess at different 
frequencies around the direction of 𝐵0 (121,154–157).  
The anti-parallel and parallel spin orientations correspond to the two distinct quantized 
energy states the spins may be in. The anti-parallel spins are at a slightly energetically 
higher state. The energy difference between the two states is given by  
 Δ𝐸 = ℎ𝛾𝐵0 2-6 
Here, h is the reduced Planck’s constant and 𝛾 is the gyromagnetic ratio. The presence 
of the two distinct energy states is known as the nuclear Zeeman effect (121,154–
157). 
This is illustrated in Figure 2-2. The ratio of the parallel (N↑) to anti-parallel (N↓) spins 










Here 𝑘 is the Boltzmann constant and 𝛥𝐸 is the energy difference between the two 
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This is possible as 2𝜋γhB0 ≪ 𝑘𝑇, at body temperature and a clinical field strength. 
Here ℎ is the reduced Planck’s constant (
ℎ
2𝜋
), 𝛾 is the rationalised gyromagnetic ratio, 
and k the Boltzmann constant (121,155). Since the overall magnetization is given by 
the difference of nuclei aligned parallel and anti-parallel to 𝐵0 and the parallel spins 
are in a slight majority (
𝑁↑
𝑁↓
= 1.000004; at B0 = 1.5T, T = 37° C) they produce a net 
magnetization 𝑀0 in the direction of 𝐵0. This superimposed magnetic field change is 
however very small (several μT) compared to 𝐵0, which is typically several tesla, e.g. 
1.5 T or 3.0 T, and therefore impossible to detect (121).  
 
Figure 2-2: Spins aligned in parallel and anti-parallel with 𝐵0 are at a lower and higher energy level 
respectively. (courtesy of Martin Graves) 
In MRI, a radiofrequency (RF) pulse is therefore used to transfer energy to the spins 
so that their magnetization is rotated towards the transverse plane, where it can be 
detected. 
The larger number of spins makes it possible to apply classical mechanics to the 
hydrogen nuclei; the spins are grouped together. Before application of an RF pulse, 
all protons are precessing out of phase, so that the net magnetization only has a z-
component 𝑀𝑧, while its transverse components cancel out. The application of an RF 
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pulse then transfers energy to the spins and rotates the net magnetization from the 
longitudinal into or towards the transverse plane. The RF pulse is an electromagnetic 
wave, which oscillates at the radiofrequency part of the electromagnetic spectrum, 
more specifically it oscillates at the Larmor frequency. This is the resonant condition. 
It has a certain duration 𝑇 and magnetic field strength of magnitude 𝐵1. The angle by 
which the net magnetization is rotated by a simple RF pulse, the flip angle, can be 
calculated by 𝛼 = 𝛾𝐵1𝑇 (121,154–156). If chosen to be 90°, all of the magnetization in 
the z-direction (longitudinal direction), 𝑀𝑧, is flipped into the transverse plane to give 
𝑀𝑥𝑦 or the transverse magnetization. 𝑀𝑥𝑦 can then be measured by the voltage it 
induces in a receiver that only detects the magnetization in the transverse plane 
(121,154–156). 
 
Figure 2-3: The spectral density function 𝐽(𝜔) gives the probability at which a molecule rotates or 
tumbles at a given velocity. Here, the spectral density diagrams for three different tissue types are given. 
Blue indicates a tissue type, where the majority of molecules tumble at a lower frequency than the 
Larmor frequency, while the red curve shows a high abundance of molecules that tumble faster. Green 
indicates a tissue type where there is a high abundance of molecules tumbling at the Larmor frequency. 
(courtesy of Martin Graves) 
Besides classical mechanics, the rotation of the net magnetization can be described 
using an energy level model. The RF pulse has transferred energy to the spins. 
Through external stimulation, such as oscillating magnetic fields at the Larmor 
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frequency, they may release this energy and return to their initial state, i.e., they may 
“relax”. In classical mechanics this would correspond to a regrowth back to their 
original orientation in the longitudinal plane. The return to the initial state is stimulated 
by the surrounding molecules, which tumble (rotate, translate, or vibrate), so that they 
generate oscillating magnetic fields. In different tissues there is a higher or lower 
abundance of fields oscillating at Larmor frequency. The abundance of molecules 
which tumble at a certain frequency is given by the spectral density function, as shown 
in Figure 2-3. In materials such as fat where many molecules tumble almost at Larmor 
frequency, the relaxation is faster than in materials where the molecules tumble much 
faster such as in free fluids or in materials where they tumble much slower since they 
are bound (121). The effect on 𝑇1 is shown in Figure 2-4. The recovery of Mz can be 
described by an exponential function and a time constant T1: 𝑀𝑧 = 𝑀0 ·
(1 − exp (−
𝑡
𝑇1
)). The shorter the 𝑇1, the faster the signal recovery (121,154–157).  
 
Figure 2-4: Influence of the tumbling rate on 𝑇1 and 𝑇2 relaxation times (courtesy of Martin Graves) 
While 𝑇1 relaxation describes the recovery of 𝑀𝑧, in biological tissues 𝑀𝑥𝑦 decays 
much faster than 𝑀𝑧 recovers. Spins in the transverse plane within the net 
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magnetization precess at slightly different frequencies, so that they dephase 
eventually cancelling each other out. This decay is the free induction decay: it is 
characterized by the time constant 𝑇2
∗ (121,154–157). It consists of two components: 
first, there are spin-spin interactions: random movements of protons and molecules 
cause non-static changes in the local magnetic field that lead to a decay of the net 
magnetization. This decay is described by the time constant 𝑇2. If the molecule is 
hardly moving, the dipolar field will be relatively static and will cause the dephasing of 
nearby spins, i.e. enhance relaxation and shorten T2. If the tumbling rate is very fast, 
however, the field effects will average out, which results in a smaller dephasing effect, 
as shown in Figure 2-4 (121,154–157). Second, differences in local precession 
frequencies caused by static differences in the magnetic field Δ𝐵 cause a signal decay 
(121,154,155,157). This may be caused by local differences in magnetization, that 
arise from differences in material susceptibility or large-scale background 
inhomogeneities, which will be described in more detail later. This decay is described 
by the time constant 𝑇2
′. Therefore, 𝑇2
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∗) (121,154,155,157). Effects, that may cause confusion on T2
*w magnitude 
images are, for example chemical shift (158,159). Furthermore, the distribution of 
substances within a voxel on a microscopic level can cause differences in the 
estimation of the T2*. This may be a confounding factor when T2* is estimated in order 
to draw conclusions about the concentration of certain susceptibility sources within the 
voxel (160–163).  
2.1.2 MRI System 
The MRI system typically consists of a large static magnetic field generated by a 
superconducting magnet. Transmit and receive radiofrequency coils, and gradient 
coils subsequently serve to generate, record, and spatially encode an electromagnetic 
signal from the tissue that is placed inside the magnet bore (121).  
The static magnetic field is typically in either a horizontal or vertical orientation. In 
clinical systems, typically, a horizontal magnetic field is used and superconducting 
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magnets generate magnetic fields greater than approximately 0.6T. In a clinical setting 
1.5T and 3.0T are used but higher field strengths such as 7.0T are used in research 
and certain clinical applications. The magnet windings comprise an alloy of 
Niobium/Titanium and are immersed in a bath of liquid helium in order to keep them 
at 4.2° K and maintain superconductivity (121,154,155,157).  
In order to generate a detectable signal from the patient or tissue placed inside the 
magnet a radiofrequency transmit coil generates the RF pulse. The body transmit coil 
is located behind the external covers inside of the scanner bore. The MR signal, is 
spatially encoded via the gradient coils (121,154,155,157). The MR signal is then 
recorded by the receiver coils, as the precession of the nuclear magnetization induces 
a current in them. The raw MRI data are acquired with quadrature detection. 
Therefore, it is complex valued, which means that it has a real and imaginary part from 
which both a magnitude term, which is commonly used in clinical image analysis and 
a phase term, which is typically discarded, can be calculated. The receiver coils 
consist of either a single element or multiple elements, when they are called array 
coils. Surface receive-only coils for different anatomies are specifically designed so 
that they can be placed as closely as possible to the region of interest. The surface 
coils consist of multiple small coils, which produce high SNR in close proximity to the 
coil. The FOV for each loop is therefore small and excludes outside noise. Therefore, 
the signal from the region of interest will be high and the associated noise small, 
maximizing the signal-to-noise ratio (SNR) (121,154,155,157). In order to further 
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reduce the influence from external radiofrequency radiation, the magnet room is 
enclosed in an RF-shield, which serves as a Faraday cage and blocks out any outside 
electromagnetic interference (121). The gradient coils apply a linear variation in 
magnetic field in the three orthogonal directions that are superimposed onto the main 
static magnetic field. The coils, as illustrated in Figure 2-5 a) in the x and y direction 
are oriented in the Golay configuration and the coils for the gradient in the z-direction 
(Figure 2-5 b) are a Maxwell pair. The coils cause small variations in the magnetic field 
along each orthogonal direction. The gradients are applied as short duration pulses. 
The spatial variation of the field leads to a variation of the precession 
frequency/Larmor frequency of protons at different locations (e.g. 𝜔 = 𝛾(𝐵0 + zGz)). 
The resulting change in the signal phase and frequency can be used to spatially 
encode the signal recorded at any time. As the coils are switched on and off very 
rapidly a Lorentz force is generated, which causes the coils to flex, creating the loud 
noise inside the scanner (121,154,155,157). 




2.1.3 Slice Selection 
 
Figure 2-6: Slice selection gradients are applied during application of an RF pulse to selectively excite 
a slice of tissue (courtesy of Martin Graves) 
In the following, the different steps involved in MR image generation are described. 
For simplicity, a 2D sequence with a Cartesian readout will be considered. As 
described in section 2.1.1, the detection of an MRI signal requires excitation with an 
RF pulse. As previously described, the pulse has a certain length and amplitude, which 
determine its flip angle. Furthermore, it has a carrier component, which oscillates at 
the carrier frequency 𝑓0. In 2D MR imaging, a magnetic field gradient 𝐺𝑆𝑆 is applied in 
the slice-encode direction. Now the 𝐵0 varies linearly in the z-direction, as does the 
precession frequency of the local protons (𝜔 = 𝛾(𝐵0 + zGSS)). Therefore, the RF pulse 
will only excite a thin slice of protons that precess at the selected carrier frequency. 
The pulse also has an envelope that is multiplied with the carrier component. The 
envelope is typically an apodized sinc shaped pulse, so that the pulse’s Fourier 
Transform is similar to a rect function with a finite bandwidth. Therefore, the RF pulse 
will excite nuclei precessing at range frequencies centred around the carrier 
frequency. The slice width depends on the range of frequencies or bandwidth Δ𝜔 




2.1.4 Phase Encoding 
After flipping 𝑀0 into the transverse plane, another gradient, varying in a direction 
perpendicular to 𝐺𝑆𝑆, is applied for a duration 𝜏. Here it will be assumed that it is the y-
direction. As the magnetic field and therefore the precession frequency will vary 
according to the y-location of each proton, a different phase shift will be encoded into 
the signal according to the y-location. Therefore, this is called the phase-encode 
gradient 𝐺𝑃𝐸. In fact, the magnetic field at a specific y-location has the magnitude of 
𝐺𝑃𝐸𝑦 added onto 𝐵0, so that the phase accumulation due to 𝐺𝑃𝐸 at said location at time 
t will be 𝛾 ∫ 𝐺𝑃𝐸𝑦 𝑑𝑡
𝑡
0
. Therefore, after the gradient has been applied for a time period 
𝜏𝑃𝐸, a specific, constant phase shift is applied to each location in the y-direction: 




2.1.5 Frequency Encoding 
Finally, another gradient in a direction perpendicular to both 𝐺𝑆𝑆 and 𝐺𝑃𝐸 is applied in 
this case assuming this is the x-direction. In conventional sequences such as spin 
echo or gradient echo, which will be described in more detail, later on, the gradient will 
be applied during the time an echo is generated, during which time the data will be 
read out. The readout gradient or frequency encoding gradient varies linearly along 
the x-direction and has a specific magnetic field strength at each location, 𝑥𝐺𝐹𝐸, which 
alters the precession frequency along the x-direction, so that at the time a data point 
is recorded, 𝜏𝐹𝐸, the spins experience the following phase shift: 2𝜋𝑘𝑥(𝜏𝐹𝐸)𝑥 =




2.1.6 k-space  
Therefore, the signal at every single data-point from every single 2D location can be 
rewritten as 𝑆 ∝ 𝑆(𝑥, 𝑦)𝑒  𝑖2𝜋𝑘𝑦𝑦𝑒𝑖2𝜋𝑘𝑥𝑥. The signals from all points in the field of view 
can be combined by an integration operation: 𝑆 ∝ ∫ ∫ 𝑆(𝑥, 𝑦)𝑒  𝑖2𝜋𝑘𝑦𝑦𝑒𝑖2𝜋𝑘𝑥𝑥𝑑𝑥𝑑𝑦, which 
corresponds to a 2D Fourier transform operation. Therefore the image can be 
recovered from the measured signal in k-space by applying an inverse 2D Fourier 
Transform, and the signal recorded at time t corresponds to a point in Fourier or k-
space at location (𝑘𝑥, 𝑘𝑦) (121,154,155,164). 
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Following a single phase encode step, the echo signal is sampled 𝑁𝐹𝐸 times at 𝑁𝐹𝐸 
different time points during signal readout. This means that for each phase encode 
step a series of 𝑁𝐹𝐸 𝑘𝑥 values are acquired, a line in k-space is filled. By repeating the 
acquisition and each time varying the amplitude 𝐺𝑃𝐸, all of the points required to fill the 
entire k-space can be acquired. This is needed in order to apply an inverse 2D Fourier 
transform and reconstruct the image (121,154,155,164).  
The following relationships hold between resolution (Δ𝑥, Δ𝑦), field of view 
(𝐹𝑂𝑉𝐹𝐸 , 𝐹𝑂𝑉𝑃𝐸), spatial frequencies (frequency resolution = Δk𝑥, Δk𝑦), and spatial 
frequency FOV (𝐹𝑂𝑉𝑘𝑥 , 𝐹𝑂𝑉𝑘𝑦), i.e. the range of spatial frequencies. The pixel size is 
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The field of view is given by multiplying the resolution by the number of phase encode 








2.1.7 2D vs 3D Image Acquisition  
Instead of exciting a thin slice with the slice select gradient, a thick volume can be 
excited. A second phase encode gradient is then applied in the slice select or third 
direction. This means that the signal can be recovered by applying a 3D instead of a 
2D inverse Fourier transform to the acquired k-space (121,154,155,164).  
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2.1.8 Basic Pulse Sequences 
Spin Echo 
 
Figure 2-7: Spin echo imaging sequence (courtesy of Martin Graves) 
Spin Echo is one of the basic sequences in MRI. After an initial excitation by a 90° RF 
pulse, the transverse magnetization will quickly decay with T2*. While the dephasing 
caused by spin-spin interactions is irreversible since it is random and time averaged, 
the static de-phasing, for example caused by magnetic susceptibility inhomogeneities, 
can be reversed. After a specific time TE/2, an additional 180° RF pulse is applied. 
This will now flip the spins through 180° about the axis onto which it is applied. The 
spins that precess faster will be placed behind those precessing at a lower frequency, 
so that after an additional TE/2, they will have reversed the de-phasing caused by the 
static field inhomogeneities alone, resulting in a spin echo signal. The only dephasing 
that will have occurred at time TE will be due to the spin-spin interactions, which is 
governed by T2: 
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During the signal readout, the readout gradient is applied. In order to reverse the 
dephasing induced by the readout gradient and set the initial k-space position, a 
prewinder gradient applied. This is of the same polarity as the readout gradient as its 
effect is reversed by the 180° pulse (121,164). 
After a repetition time, TR, the longitudinal signal will recover and another 90° 
excitation pulse will be applied to generate a new echo. By adjusting TE and TR, 
different types of contrast can be achieved. If TR is very long, Mz will have completely 
recovered and the effect of differences in the T1 relaxation time between different 
tissue types on the signal is negligible. If the TE is long, the effect of differences in 
between the T2 values of different tissue types is enhanced. If the effects of both T1 
and T2 are minimized by a long TR and short TE, the contrast in between different 
tissue types will depend on differences in the proton density.  
T1 weighting is therefore achieved with a short TE and short TR, while T2 weighting is 
enhanced with a long TE and long TR. In proton density weighted images, the effects 
of both T1 and T2 are minimized, so that a PD weighting can be achieved with a long 
TR and short TE (121). 
In order to speed up the acquisition time, Fast Spin Echo (FSE) acquires multiple lines 
of k-space within a single repetition time by employing a train of refocusing pulses. 
These lines in k-space are acquired at different echo times. The effective echo time is 
determined by the time at which lines around the centre of k-space are acquired, which 
dominate the image contrast (121,154,155,164). 
Gradient Echo 
In gradient echo imaging, an initial excitation is followed by a conventional free 
induction decay (FID). After initial excitation with an RF pulse with a flip angle typically 
smaller than 90° a smaller amount of longitudinal magnetization will be flipped into the 
transverse plane. This requires a smaller repetition time for full signal recovery. The 





)]. Then the signal is read out at an echo time TE, during 
which the frequency encode gradient is applied. In order to avoid de-phasing due to 
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the frequency encode gradient and record the maximum signal in the middle of the 
frequency encode gradient, a pre-phasing gradient is applied in advance. The pre-
phasing gradient is of opposite polarity to the readout gradient and has half the area 
of the readout gradient. Therefore, it will accelerate the signal dephasing by increasing 
the precession frequency. The readout gradient will reverse this effect due to its 
opposite polarity to create a gradient echo after half of its area. After signal readout, 
gradient spoiling is applied. In combination with RF spoiling, this removes any residual 
transverse magnetization before application of the next RF pulse. 
 
Figure 2-8: Gradient echo imaging sequence (courtesy of Martin Graves) 
In spoiled gradient echo imaging, the steady state signal acquired at echo time TE can 
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 more heavily so that the acquired image is said to be T1-weighted. 
For a given TR, it is important to carefully select the flip angle in order to maximize 𝑇1w 
contrast while maximizing SNR, as shown in Figure 2-9.  
 
Figure 2-9: Dependence of the signal magnitude on the applied flip angle (courtesy of Martin Graves) 
A short TE (<15 ms) is required in order to minimize the T2* weighting which is given 
by the term exp (−
𝑇𝐸
𝑇2
∗ ), as this term then approaches unity.  
If TE is large, the term exp (−
𝑇𝐸
𝑇2
∗ ) dominates the signal equation. For a T2
*w image, TE 
should be as large as possible, while being short enough to maintain a high signal, 
while 𝛼 is smaller to minimize T1 weighting (121,154,155,164). 
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2.2 Magnetic Susceptibility in MRI 
2.2.1 Magnetic Susceptibility 
As previously described, the T2*-weighted imaging contrast arises from a variety of 
factors. On the one hand, the T2 relaxation time characterises spin-spin interactions. 
Furthermore, T2’ characterizes the de-phasing caused by static magnetic field 
inhomogeneities. These may originate from the MR system, affecting the external 
magnetic field (B0), or instead from magnetic susceptibility effects within the subject. 
Magnetic susceptibility (𝜒) is a material property that describes the magnetizability of 
an object in response to an external magnetic field with a flux density 𝐵0 and a 
magnetic field intensity 𝐻. Magnetization 𝑀 is defined as the magnetic dipole moment 
per unit volume and is proportional to the magnetic susceptibility: 𝑀 = 𝜒𝐻 (165,166). 
This means that the magnetic moments generated from paramagnetic materials, 
which are of positive susceptibility, align in parallel with 𝐻 and 𝐵0, while those within 
diamagnetic materials, of negative susceptibility, do so in the anti-parallel direction 
(165,166). Each magnetic dipole also has an associated magnetic field, which is of a 
characteristic shape that is shown in Figure 2-10. The field has two positive lobes in 
the direction of 𝐵0 and negative values around the centre, perpendicular to the 
direction of 𝐵0. It is zero-valued at an angle 54.7° to the direction of 𝐵0, which is 
referred to as the magic angle. 
 
Figure 2-10: A magnetic dipole can be visualized as a small bar magnet with the magnetic field lines 
given in (a). The magnitude of the unit dipole field in the direction of 𝐵0 is shown in (b) (I published this 
illustration in (153)) 
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The total field generated due to the susceptibility distribution Δ𝐵 can be described by 
a convolution operation, as represented by the convolution operator , between the 
susceptibility map and the unit dipole field or unit dipole kernel. This is scaled by the 
applied magnetic field strength of the scanner: Δ𝐵(𝑥, 𝑦, 𝑧) = 𝐵0(𝜒(𝑥, 𝑦, 𝑧) ⊗ 𝑑(𝑥, 𝑦, 𝑧)) 
(165–169). This can be simplified by applying a Fourier transform since a convolution 
in the image space corresponds to a multiplication in Fourier space, where k 
represents the spatial frequencies and Δ𝐵(𝑘𝑥 , 𝑘𝑦, 𝑘𝑧), Χ(𝑘𝑥, 𝑘𝑦, 𝑘𝑧), and 𝐷(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) 
are the Fourier transforms of Δ𝐵(𝑥, 𝑦, 𝑧), 𝜒(𝑥, 𝑦, 𝑧), and 𝑑(𝑥, 𝑦, 𝑧): Δ𝐵(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) =
𝐵0(Χ(𝑘𝑥, 𝑘𝑦, 𝑘𝑧)𝐷(𝑘𝑥, 𝑘𝑦, 𝑘𝑧)) (165–169). Δ𝐵(𝑥, 𝑦, 𝑧) can then be recovered by applying 
the inverse Fourier transform. This illustrates that the magnetic field distribution varies 
with the magnitude and shape of the underlying susceptibility distribution but also 
contains non-local effects due to the convolution operation. In chapter 3 these 
relationships will be illustrated further in numerical simulations.  
2.2.2 Relationship Between Magnetic Susceptibility and the Magnitude of the 
Complex Signal in Gradient Echo MRI 
As previously described, the field inhomogeneities created by the materials’ 
susceptibility contribute to the exponential free induction decay, which is characterized 









Gradient echo imaging acquires the signal of the free induction decay at a specific 
echo time and can therefore acquire 𝑇2
∗ weighted contrast, which shows qualitatively 
regions of interest with increased de-phasing. Multi-echo gradient echo acquires 
multiple signal readouts after an initial excitation pulse and therefore serves to sample 
the free induction decay at different time points. By fitting the signal model to the 
acquired samples, 𝑇2





∗) can be estimated to provide a 
quantitative measure of the amount of susceptibility induced dephasing. This has been 
demonstrated to be useful in a variety of applications, which will be explored in section 
2.2.5, for example when estimating varying levels of iron or contrast agent 
concentration. However, the value of T2* also contains T2 influences and also effects 
from tissue microstructure (160–162).  
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2.2.3 Relationship Between Magnetic Susceptibility and the Phase of Gradient 
Echo MRI 
While 𝑅2
∗-mapping is excellent at detecting and quantifying the presence of local 
dephasing it is not able to differentiate between sources of diamagnetism and 
paramagnetism as it only considers the signal magnitude. However, this may be 
necessary when the differentiation between the two is not immediately obvious, for 
example when dealing with diamagnetic calcification and paramagnetic haemorrhage. 
The information about the sign of the susceptibility source is contained within the 
phase of the MR signal. Raw MRI data acquired with quadrature detection are complex 
valued, which means that it has a real and imaginary part from which both a magnitude 
term, which is commonly used in clinical image analysis and a phase term, which is 
typically discarded, can be calculated.  
The 𝑇2
∗-weighted magnitude images do not only display local dephasing based on 
susceptibility differences alone but also contain information about 𝑇2 effects arising 
from spin-spin interactions. But on the phase images, the 𝑇2 effects are negligible 
(170). Instead the phase varies linearly with the echo time of the acquired signal. The 
slope of the phase variation with time is proportional to Δ𝐵.  
𝜙(𝑡)  =  𝜙0 − 2𝜋𝛾𝛥𝐵𝑡 2-15 
Here 𝜙0 is the initial phase offset and 𝛾 the normalized gyromagnetic ratio.  Therefore, 
the phase of a gradient echo signal is closely related to the distribution of field 
inhomogeneities. As diamagnetic and paramagnetic susceptibility sources create 
fields of opposite sign, this has allowed for the distinction between different types of 
materials using the signal phase (171–174). This is an advantage in comparison to 
gradient echo magnitude images, where sources of diamagnetism and 
paramagnetism appear as hypointensities. 
SWI is a post-processing methodology that makes use of the information contained in 
the phase by combining the anatomical information contained in the magnitude with 
phase information: 
Initially, so-called phase wraps are removed. While the term 𝜙0 − 2𝜋𝛾𝛥𝐵𝑡, may exceed 
the value 2𝜋, the measured signal phase is within the range [−𝜋 𝜋) and the displayed 
phase will become wrapped. Phase unwrapping algorithms may be employed to 
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remove these prior to background field removal. Subsequently background field 
effects need to be removed from the signal phase. Since the signal phase of a 𝑇2
∗𝑤 
gradient echo sequence does not only contain contributions of fields generated by 
susceptibility sources inside the region of interest but also from outside sources a 
background field removal technique is required. For example, when analysing the 
brain, the fields generated, for example, by local changes in iron concentration are 
obscured by background fields. These are typically large and slowly varying and are, 
for example, created by air tissue interfaces (170,175–177). Other contributions to the 
background field are shimming effects and inhomogeneities in the main magnetic field 
of the scanner (170,175–177).Therefore it is necessary to remove these confounding 
factors from the signal phase, which in SWI is often done by applying a high-pass filter 
as the background fields are usually large and varying at a low spatial frequency (178). 
This is frequently implemented by applying a low pass filter to the complex image and 
subsequently dividing the original complex image by the low-pass filtered image (178–
181). The phase of the result is now high-pass filtered. As the large slowly varying 
frequency components have been removed a lot of phase wrapping artifacts have 
been removed simultaneously, so that an additional dedicated phase unwrapping 
algorithm may not be required (178–181). The resulting filtered phase information can 
be interpreted on its own or it can be used to generate a phase mask that selectively 
suppresses the signal where the phase shift is either positive or negative, as it is 
assumed that these phase shifts are generated by diamagnetic or paramagnetic 
susceptibility sources respectively (171–174,178,180–182). For example, in 
susceptibility weighted venography, it is assumed that deoxygenated blood is of a 
positive susceptibility and will present on the phase images with a negative phase 
shift. Therefore, the mask is set to unity wherever the phase shift is positive, and 
normalized to be between zero and one where it is negative: 
𝑀𝑎𝑠𝑘(𝑥, 𝑦) = {
𝜋+𝜙(𝑥,𝑦)
𝜋
; 𝑖𝑓 𝜙(𝑥, 𝑦) ≤ 0
1; 𝑖𝑓 𝜙 > 0
  2-16 
The mask is subsequently multiplied n times with the magnitude image:  
𝑆𝑊𝐼 = 𝑀𝑎𝑔 × 𝑀𝑎𝑠𝑘𝑛 2-17 
The number of multiplications n is typically varied in order to optimize the contrast-to-
noise ratio (CNR) depending on the structure of interest and the echo time. A 
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commonly used value is n=4 (178,180,181). In addition to that, minimum intensity 
projections (miP) are applied frequently through the stack of slices to image the 
cerebral vasculature (178). This process is illustrated in Figure 2-11. 
 
Figure 2-11: Steps involved in SWI: The complex data consist of a phase (a) and magnitude image (b). 
In the first step, the phase is filtered (c) and subsequently turned into a phase mask (d). This mask is 
then multiplied n times with the magnitude image in order to acquire the susceptibility weighted image 
(e). An mIP can be applied for improved visualization of veins (f). (I published this illustration in (153))  
However, just as for 𝑇2
∗-weighted imaging or 𝑅2
∗-mapping, SWI depicts the variation in 
the local field rather than the underlying susceptibility distribution. As previously 
explained the field is non-local and a downstream result of the susceptibility map and 
depends on the field strength and orientation. Furthermore, it extends beyond the local 
susceptibility changes. The relationship between field and susceptibility is further 
explored in chapter 3. By calculating the susceptibility distribution directly, Quantitative 
Susceptibility Mapping (QSM) is able to circumvent these effects and create a direct 
and quantitative map of the underlying material properties (166,170). 
2.2.4 Quantitative Susceptibility Mapping 
QSM calculates the distribution of susceptibility values within a volume of interest 
(VOI). Typically, the phase values from different echo times of a multi-echo gradient 
echo sequence are used to calculate a map of field inhomogeneities. Due to the non-
locality of the fields generated by susceptibility variations, the measured field within 
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the VOI contains contributions that originate inside, Δ𝐵𝑖𝑛𝑡, and outside, Δ𝐵𝑒𝑥𝑡, the 
selected volume. In order to calculate the susceptibility map inside the VOI, however, 
it is necessary to remove the background field Δ𝐵𝑒𝑥𝑡 which is typically large and slowly 
varying; after the extraction of Δ𝐵𝑖𝑛𝑡 a mathematical operation called dipole field 
inversion can be applied in order to estimate the susceptibility map. This step involves 
the solution of an ill-posed problem so a variety of algorithms relying on several 
assumptions and regularisation parameters have been used to estimate the 
susceptibility map. QSM and the different algorithms used to implement it are 
described and illustrated in more detail in chapter 3.  
2.2.5 Applications of Quantitative Susceptibility Mapping 
In order to show the potential of both SWI and QSM, the following sections will illustrate 
the already existing applications of susceptibility-based contrast, which has proven to 
be a beneficial tool in many applications, such as neurodegenerative, oncological, and 
cardiovascular pathologies. 
Cerebral Imaging 
Susceptibility-based contrast has found many applications in brain imaging so that 
many of the initial QSM research has been applied in the brain. Varying myelin and 
iron concentrations—which are more diamagnetic and paramagnetic than water 
respectively—can be depicted on QSM, so that it can be used to provide highly 
detailed anatomical maps of the brain. QSM proved to be consistent with previously 
established techniques to measure iron concentrations in the brain. There was a high 
correlation with more established relaxation rate mapping MRI techniques and also 
post mortem iron values, X-ray fluorescence, inductively coupled plasma mass 
spectrometry, and QSM was consistent with histology (183–186). Simultaneously, 
QSM improved the CNR compared to SWI and T2*w imaging and T2*-mapping (187), 
so that it was able to detect structures which were consistent with histology, but might 
otherwise be missed (184,188,189). QSM directly quantified iron and myelin 
concentration without dependence of orientation or geometry of the ROI and non-local 
effects (186,189,190). These improvements suggest that QSM may be better in 
identifying targets in surgery planning for deep brain stimulation (DBS) (184,187,188) 
than conventionally used MRI techniques using susceptibility based contrast, which 
have previously been proved useful in this application (191). 
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Due to its quantitative nature, QSM can be used in longitudinal studies and track 
disease progress and structural changes over time that are caused by 
neurodegenerative diseases such as multiple sclerosis (MS), Parkinson’s disease 
(PD), and Alzheimer’s Disease (AD).  
MS is associated with demyelination and cerebral iron accumulation, the latter of which 
has been shown using T2*-mapping (192) and SWI (193). However, demyelination, 
which prolongs the 𝑇2
∗ value and iron accumulation, which shortens it, have 
counteracting effects, that may lead to a lack of detection sensitivity for techniques 
using the 𝑇2
∗ effect to monitor early disease stages (190,194). Both disease 
developments increase tissue susceptibility, which can be depicted with QSM so that 
it is more sensitive to these disease developments than 𝑇2
∗ mapping (190) and is 
suitable to monitor the disease in its early stages (190,195,196). Due to its quantitative 
nature QSM is able to track the development and progression of the disease over 
different stages and compare these to healthy tissue quantitatively (195,197). This is 
very promising since demyelination- and iron-induced susceptibility effects detected 
on MRI have previously shown to correlate with disease duration and clinical disability 
(192,198). 
AD and PD are also associated with elevated iron levels, which have been detected 
with susceptibility-based contrast (199–201) and with QSM (202–211). Susceptibility 
effects have served to monitor PD over time (212,213) and correlate iron levels with 
disease severity in terms of motor symptoms (214–216). This shows that QSM-
identified changes in iron concentration may allow for longitudinal, quantitative tracking 
of disease progression. 
Cerebral Haemorrhage 
A common pathology that exhibits large susceptibility differences is haemorrhages. 
Different blood products contained in haemorrhages are deoxyhaemoglobin, 
methaemoglobin, and/or hemosiderin, which are paramagnetic (217,218). In various 
studies, susceptibility-based imaging improved detection of haemorrhages due to a 
better lesion contrast than with other magnitude based techniques and/or CT 
(219,220). As previously discussed QSM can improve on SWI in several aspects. Due 
to the removal of non-local effects and its quantitative nature QSM could more 
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accurately estimate blood product volume (221) and distinguish them from veins more 
easily (222). 
This is advantageous in a variety of medical conditions where cerebral haemorrhages 
are present, such as stroke (223), cerebral cavernous malformations (224), and 
Traumatic Brain Injury (TBI) (222). QSM was not only able to provide excellent 
qualitative detection of lesions but was also able to quantitatively assess lesion size 
and iron content (221–224). This may allow for QSM to help understand disease 
developments in terms of progression but also treatment response and also 
determining disease severity (221–224). While suffering from several drawbacks in 
comparison to QSM, SWI has demonstrated the benefit of susceptibility based imaging 
since it was used to depict the occurrence and volume of microbleeds in order to 
assess their correlation with coma scores so that their importance as a marker of injury 
severity in patients with diffuse axonal injury could be evaluated (220).  
Blood Oxygenation and Venography 
Paramagnetic deoxyhaemoglobin is not only present in blood products but also in 
deoxygenated venous blood. Therefore cerebral venography is one of the most 
common applications of SWI (178) and QSM has shown potential to improve 
venogram image quality by removing non-local effects and sequence and scanner 
dependencies (225,226). For example, it has been demonstrated, that it can be 
assumed that veins in parallel to the magnetic field 𝐵0 will produce a negative phase 
shift. The detection of veins perpendicular to the magnetic field with a negative phase 
shift on SWI, however relies on asymmetric voxel dimensions (178). Due to the lack 
of orientation dependence in QSM, all veins will appear as paramagnetic, unrelated to 
their physical location. Furthermore, QSM offers a quantitative assessment of the 
susceptibility measured inside each vein, which is linearly related to oxygen saturation 
and therefore deoxyhaemoglobin content. In combination with cerebral blood flow 
measurements, this allows QSM to calculate further measures such as oxygen 
extraction or cerebral metabolic rate of oxygen (225–228). It has therefore 
demonstrated to be feasible to use QSM to not only monitor normal deoxyhaemoglobin 
levels (226) but also changes induced by CO2 inhalation (228) or caffeine 
administration (227). In addition to research settings, this technique has demonstrated 
promising potential in assessing stroke patients (229). 
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The mapping of cerebral oxygen levels can be extended even further in the temporal 
domain. Blood oxygen level dependent (BOLD) contrast uses the T2* effect in 
functional MRI (fMRI) (230) to measure brain activity over time and in response to 
stimuli. It has subsequently been suggested that acquiring dynamic susceptibility 
maps at different time points eliminates non-local effects present on T2* images and 
may provide a more direct measure of neuronal activity (231–233). 
Susceptibility-Based Contrast in Neuro-Oncology 
Blood products and haemorrhages play an important role in neuro-oncology, which is 
another field of frequent application of susceptibility-based contrast techniques.  
SWI was not only able to improve tumour visibility (234), but also provide a 
morphological assessment through a high detection sensitivity of haemorrhages and 
venous vascular networks (235) and improved their distinction from calcifications, 
necrosis and artifacts when compared to conventional MRI protocols (236). The 
improved characterization of the tumours, could be used to grade tumours (235) and 
differentiate between different tumour types (237) and metastases (238), which found 
application in initial screening, and diagnosis, monitoring and treatment decisions 
(235–238). While more experimental, QSM has shown potential for improvement of 
existing techniques further by improving the differentiation between blood products 
and calcification (239). 
Susceptibility-Based Contrast outside the Brain 
The majority of applications for QSM have been developed for imaging the brain since 
other anatomies offer several difficulties, such as increased motion or the presence of 
fat. However, differences in susceptibility are present everywhere in the body and may 
provide vital medical information about a large number of pathologies. 
As was shown in the brain, QSM and SWI were able to detect calcifications within 
breast tissue (240,241) and QSM detected calcifications in prostate cancer (242,243).  
The imaging of neurodegenerative diseases has shown that susceptibility-based 
contrast may be an excellent tool for monitoring changing tissue iron concentrations. 
Similarly, changing iron levels in the liver are a characteristic of liver disease so that 
SWI has been used in staging liver fibrosis by detecting increased iron content and 
collagen deposition (244,245) and in liver cirrhosis for identifying iron in siderotic 
nodules (246). There are fewer applications of QSM in the liver due to its location and 
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the complications arising from the presence of fat, but QSM has shown promise in 
monitoring liver iron concentration and showed a good correlation with the measured 
𝑇2
∗ values and biomagnetic liver susceptometry (247,248).  
Susceptibility effects are not only limited to endogenous sources but may also 
originate from exogenous contrast agents, such as paramagnetic gadolinium-based 
contrast agents (GBCA) and (ultra)small superparamagnetic iron oxide nanoparticles 
(USPIO). Contrast agent concentration is linearly related to the measured 
susceptibility, so that QSM is able to quantify the amount of contrast agent present in 
the anatomy. GBCAs have been applied primarily as a blood pool contrast agent in 
cerebral perfusion imaging and to create dynamic three-dimensional susceptibility 
maps (249,250). USPIOs and SPIOs have also been used as a blood pool agent for 
detection of microvasculopathy, e.g. in cerebral amyloidosis, where they seemed to 
be more sensitive to vascular leakage than dynamic contrast enhanced (DCE)-MRI 
(251). Furthermore, these types of contrast agents can be taken up by macrophages 
so that they have found application in detecting inflammatory activity in the liver and 
spleen (252) and also detect inflammatory activity in carotid artery plaques as 




Chapter 3 Quantitative Susceptibility 
Mapping: Background and Numerical 
Simulations 
Aspects of this work have been published in “Ruetten PPR, Gillard JH, Graves MJ. 
“Introduction to Quantitative Susceptibility Mapping and Susceptibility Weighted 
Imaging”. Br J Radiol. 2019;92(1101):20181016. doi:10.1259/bjr.20181016. (153) 
3.1 Introduction 
As discussed in the previous chapter, there are a wide variety of applications of 
susceptibility-based contrast in both the clinic and in research. To understand the 
challenges, scope for optimization, and potential in different anatomies and 
pathologies it is important to understand the underlying physical principles. These can 
subsequently be used in order to understand the different steps and algorithms 
involved in Quantitative Susceptibility Mapping (QSM). In the following, the theoretical 
underpinning of these algorithms will be explained and subsequently their application 
will be illustrated in numerical simulations and human brain imaging.  
3.2 Theory 
QSM consists of several steps: Initially, the complex images from a multi-echo gradient 
echo sequence are acquired. If multi-channel coils are used, the complex data from 
all channels need to be combined in a way that preserves the integrity of the phase 
information. Next, the map of magnetic field inhomogeneity is estimated by performing 
a fitting operation with the multi-echo data. During and after this process phase 
unwrapping may be required to eliminate unwanted aliasing effects. Subsequently 
background fields are removed and then a susceptibility map is generated from the 
internal field via dipole field inversion.  
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3.2.1 Relationship between Phase and Field 
After acquisition of the complex multi-echo gradient echo data, before estimation of 
Δ𝐵, it is important to consider the issue of coil combination of the complex gradient 
echo signal which is important when the signal is acquired using a multi-channel array 
coil. The image from each channel carries a coil specific phase offset, which needs to 
be considered when combining the images as otherwise artifacts may arise in the 
composite phase image (170,253,254). One approach is called the phase difference 
method, where the offset is removed by subtracting the phase images at two different 
echo times through complex division from one another. The difference images do not 
carry any offset and can be added together in a weighted manner (170,253–255). 
Other methods estimate the coil specific phase offset and subtract it from each coil 
image before combination (253,254,256). Another example are parallel imaging 
approaches such as SENSE (257) which may be used for magnitude and phase 
reconstruction. These methods use an a priori acquired reference scan using a body 
coil to reconstruct the coil images (170,253,257). 
As previously described, the phase 𝜙(𝑡) of the free induction decay signal varies 
linearly with time 𝑡, with an initial phase offset 𝜙0. Its slope is proportional to the 
normalized gyromagnetic ratio 𝛾, a constant, and the field inhomogeneity Δ𝐵 in the 
direction of 𝐵0 (258,259):  
𝜙(𝑡)  =  𝜙0 − 2𝜋𝛾𝛥𝐵𝑡  3-1 
Determining the slope of the phase variation for each voxel in order to estimate 𝛥𝐵 is 
frequently done using a least-squares algorithm (258–260). Other implementations 
have also estimated the phase from a single echo (217,258). While this description of 
the phase evolution over time holds true in the brain, in other parts of the body the 
presence of fat alters the signal model:  
𝑆 ∝ (𝑊 + 𝐹𝑒−𝑖2𝜋Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸)𝑒−𝑖2𝜋𝛾𝛥𝐵𝑇𝐸  3-2 
Fat differs in precession frequency from water by a frequency offset Δ𝑓𝑐ℎ𝑒𝑚. Here W is 
the water image and F is the fat image. Ignoring this effect leads to a phase shift being 
added onto the Δ𝐵 estimate, which manifests as an artifact and can lead to artifacts in 
susceptibility mapping as will be shown in chapters 5 and 6. Water-fat separation 
techniques aim to estimate the fat fraction within each voxel and estimate how much 
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this alters the local precession frequency. This can be used to simultaneously correct 
𝛥𝐵 within each voxel for QSM (166,241). An example for a water-fat separation 
technique, which will be discussed in more detail in chapters 5 and 6, is iterative 
decomposition of water and fat with echo asymmetry and least-squares estimation 
(IDEAL) (261,262). This algorithm uses the complex signal from a multi-echo gradient 
echo dataset and fits the signal model to this dataset. Δ𝐵, W, and F are iteratively 
determined. This has been used to remove chemical shift artifacts in several parts of 
the body. This methodology has been used in order to remove the chemical shift in 
the Δ𝐵 estimation in order to perform QSM in other parts of the body than the brain 
such as the liver (247,248,263–265), breast (241), spine (266), or ankle region (267).  
When estimating Δ𝐵 it is important to consider that the phase of a complex number is 
bound to the range between [−𝜋 𝜋). However, 𝜙0 − 2𝜋𝛾Δ𝐵 may exceed these values 
so that the measured phase 𝜙𝑤 becomes wrapped into the range [−𝜋 𝜋). This is a 
form of aliasing that can be corrected by phase unwrapping algorithms, which give a 
corrected phase estimate by adding an integer multiple (𝑘) of 2𝜋 onto the wrapped 
phase (258–260):  
𝜙𝑢𝑤 = 𝜙𝑤 + 𝑘2𝜋 3-3 
In QSM these phase wraps may occur in both the temporal and spatial domains. 
Temporal phase unwrapping is performed when a phase wrap has occurred between 
subsequent echoes, so that the slope can be correctly estimated. This is illustrated in 
section 3.4.2, Figure 3-16. Then a scaled version of Δ𝐵, (Δ𝜙 = 2𝜋𝛾Δ𝑇𝐸Δ𝐵) is 
estimated; this may contain phase wraps in the presence of large field 
inhomogeneities, which can be corrected with spatial phase unwrapping algorithms 
(166,268), such as graph-cut based approaches such as proposed and implemented 
in by Dong et al. (263) or using region growth phase unwrapping (269,270). Spatial 
phase unwrapping is illustrated in section 3.4.2, Figure 3-17. 
3.2.2 Masking 
A mask is typically applied in order to exclude regions of insufficient SNR from the 
analysis. Phase noise can lead to severe errors when estimating Δ𝐵, that may 
propagate into 𝐵𝑖𝑛𝑡 when removing the background field and also when estimating the 
susceptibility map (271). In the brain, the FSL’s Brain Extraction Tool (272) is 
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frequently used to extract a mask of the brain from the magnitude images. However, 
this application is limited to application in the brain and in its performance by signal 
voids close to the brain surface, e.g. due to abnormal brain anatomy such as lesions 
close to the brain surface, or due to strong field inhomogeneity effects at ultra-high 
field strengths (273).  
3.2.3 Background Field Removal 
Before estimating the susceptibility map inside the selected region of interest (ROI), it 
is important to consider that the estimated map of field inhomogeneities consists of 
contributions from fields that were generated by differences in susceptibility outside 
the ROI, the external or background field (𝐵𝑒𝑥𝑡), and from differences in susceptibility 
inside the ROI (𝐵𝑖𝑛𝑡). QSM only estimates the susceptibility distribution inside the ROI 
whilst the information about 𝐵𝑒𝑥𝑡 and the outside susceptibility distribution is 
incomplete. Therefore it is important to remove these fields and extract 𝐵𝑖𝑛𝑡 before the 
final step of QSM, the dipole field inversion (175). Large susceptibility differences, for 
example those between air and soft tissue or air and cortical bone, can generate large, 
spatially slowly varying background fields that obscure 𝐵𝑖𝑛𝑡, which without removal 
would cause severe errors in the susceptibility estimation. 
In phantom scans, the background field can be simply estimated by performing a 
reference scan (176,258,259,274). For example, if a sample, from which the 
susceptibility value is to be determined is placed within a water or gel bath, two scans 
are performed, one with the sample present and another one where it is absent 
(176,258,259,274). The susceptibility within the water or gel bath is relatively uniform 
so that the field measured in the absence of the high or low susceptibility sample can 
be assumed to be the background field, for example that generated by the air/water 
interface. However, this uniform background is typically impractical for in vivo scans. 
Instead it is most practical to estimate 𝐵𝑒𝑥𝑡 within a single scan and separate it from 
𝐵𝑖𝑛𝑡 by making certain assumptions about the physical and mathematical properties 
of both fields. A simple approach is to assume that the spatial frequencies at which 
𝐵𝑒𝑥𝑡 varies are very low and that it can be removed by high pass filtering the total 
estimated 𝐵𝑡𝑜𝑡𝑎𝑙. This requires a careful selection of the filter size and whilst this 
removes a large part of 𝐵𝑒𝑥𝑡, some residue may remain and in addition it may also 
remove slowly varying components of 𝐵𝑖𝑛𝑡 (166,175,178,225,275). Another approach 
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is geometry dependent artifact correction. By segmenting the magnitude image into 
regions of air and tissue, and assigning appropriate susceptibility values from the 
literature to the segments a so-called forward calculation can estimate the field 
induced by the air tissue interface (276). This technique however only achieves 
incomplete background field removal as it requires additional high pass filtering to 
remove residual fields (273,276). 
Therefore, it is necessary to characterize 𝐵𝑒𝑥𝑡 more accurately. It has been shown that 
𝐵𝑒𝑥𝑡 within the ROI can be better described as a harmonic function (167,176,277,278) 
and that fields generated from dipoles inside and outside the ROI are orthogonal to 
each other within the ROI (177). 
A harmonic function 𝑢 is one that satisfies the Laplace equation so that 𝛻2𝑢 = 0. The 
Sophisticated Harmonic Artifact Reduction (SHARP) algorithm makes use of the 
spherical mean value (SMV) property of harmonic functions to remove background 
fields (278). The mean value property holds for harmonic functions; this states that the 
harmonic function 𝑢, for example the background field, remains unchanged when 
convolved with a radially symmetric, non-negative, normalized function 𝜌: 𝑢(𝑟) = (𝜌 ⊗
𝑢)(𝑟). 
In the SHARP algorithm the total magnetic field 𝐵𝑡𝑜𝑡𝑎𝑙, which is the sum of 𝐵𝑖𝑛𝑡 and 
𝐵𝑒𝑥𝑡 is first convolved with a SMV kernel: 
𝐵′ = 𝜌 ⊗ 𝐵𝑡𝑜𝑡𝑎𝑙 = 𝜌 ⊗ 𝐵𝑖𝑛𝑡 + 𝐵𝑒𝑥𝑡  3-4 
Therefore, a function of 𝐵𝑖𝑛𝑡 can be extracted by subtracting 𝐵
′ from 𝐵𝑡𝑜𝑡𝑎𝑙, where 𝛿 is 
the unit impulse/Dirac function: 
𝐵′′ = 𝐵𝑡𝑜𝑡𝑎𝑙 − 𝐵
′ = (𝐵𝑒𝑥𝑡 + 𝐵𝑖𝑛𝑡)−(𝜌 ⊗ 𝐵𝑖𝑛𝑡 +
𝐵𝑒𝑥𝑡) =  𝐵𝑖𝑛𝑡 − 𝜌 ⊗ 𝐵𝑖𝑛𝑡  
= (𝛿 − 𝜌) ⊗ 𝐵𝑖𝑛𝑡     
3-5 
Since the convolution with 𝜌 has left 𝐵𝑒𝑥𝑡 unaffected it is removed from 𝐵
′′. 𝐵𝑖𝑛𝑡 can 
subsequently be extracted from 𝐵′′ by deconvolving it with the kernel 𝛿 − 𝜌. The kernel 
is calculated by subtracting one from the central voxel of 𝜌 and then multiplying the 
result with -1 (278). 
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𝐵𝑖𝑛𝑡 = (𝛿 − 𝜌) ⊗
−1 𝐵′′ 3-6 
This method improves the separation of 𝐵𝑒𝑥𝑡 and 𝐵𝑖𝑛𝑡 but results in a shrinking of the 
area of the ROI since the algorithm cannot be applied at the edges of the ROI. Other 
methods, based on the SMV property, that aim to improve the SHARP algorithm have 
also been proposed (279,280). The Regularized Enabled SHARP, for example, solves 
the deconvolution operation with a Tikhonov regularization (279). 
As mentioned above, the defining mathematical property of harmonic functions, such 
as 𝐵𝑒𝑥𝑡, is that they solve the Laplace equation within the region of interest: ∇
2𝐵𝑒𝑥𝑡 =
0. This implies simultaneously that 𝐵𝑖𝑛𝑡 solves Poisson’s equation: ∇
2𝐵𝑖𝑛𝑡 = ∇
2𝐵𝑡𝑜𝑡𝑎𝑙. 
In the Laplacian Boundary Value (LBV) algorithm (176) it is assumed that both 
properties hold to be true within the regions of interest and can be used to set up a 
system of partial differential equations. These can be solved with the assumption that 
𝐵𝑒𝑥𝑡 is much larger within the boundary region than 𝐵𝑖𝑛𝑡. This means that the values 
at the boundary pixels can be defined as 𝐵𝑒𝑥𝑡 = 𝐵𝑡𝑜𝑡𝑎𝑙 and 𝐵𝑖𝑛𝑡 = 0 (176). 
Another background field removal technique is the Projection onto Dipole Fields (PDF) 
method (177). In brain acquisitions , it has been demonstrated that fields generated 
by dipoles inside and outside of the ROI are orthogonal to each other (177). The PDF 
method assumes that 𝐵𝑒𝑥𝑡 can be calculated from a susceptibility distribution outside 
the ROI, but inside the FOV. In order to achieve this, a minimization problem is 
formulated based on the orthogonality assumption and the projection theorem in 
Hilbert space. This allows for the estimation of 𝐵𝑒𝑥𝑡 and 𝐵𝑖𝑛𝑡 within the ROI. In the 
border region, i.e. the voxels close to the edge of the ROI the orthogonality assumption 
does not hold anymore and the estimation of 𝐵𝑒𝑥𝑡 and 𝐵𝑖𝑛𝑡 will contain errors (177). 
3.2.4 Dipole Field Inversion 
After removing the background fields, the remaining field within the ROI, 𝐵𝑖𝑛𝑡, in the 
following also referred to as Δ𝐵(𝑥, 𝑦, 𝑧), with its Fourier transform being Δ𝐵(𝑘𝑥, 𝑘𝑦, 𝑘𝑧), 
is assumed to have been generated from the susceptibility variations within the ROI 
alone, 𝜒(𝑥, 𝑦, 𝑧), with its Fourier transform being Χ(𝑘𝑥, 𝑘𝑦, 𝑘𝑧). As described in chapter 
2 section 2.2.1, this relationship can be defined as Δ𝐵(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) =
𝐵0 (Χ(𝑘𝑥, 𝑘𝑦, 𝑘𝑧)𝐷(𝑘𝑥, 𝑘𝑦, 𝑘𝑧)). Here, 𝑑(𝑥, 𝑦, 𝑧) is the unit dipole kernel, and 
51 
 
𝐷(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) is its Fourier transform. As the map of field inhomogeneities 
Δ𝐵(𝑘𝑥, 𝑘𝑦, 𝑘𝑧), and the dipole kernel 𝐷(𝑘𝑥, 𝑘𝑦 , 𝑘𝑧) are known, the susceptibility map 
Χ(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) can be extracted by dividing Δ𝐵(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) by 𝐷(𝑘𝑥, 𝑘𝑦 , 𝑘𝑧) in Fourier 






). This corresponds to a deconvolution operation 









2  𝑓𝑜𝑟 𝑘 ≠
0. Therefore, values of 𝐷(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) are defined to be zero at spatial frequencies 
located on a cone surface at an angle 𝛽 = ±54.7° relative to the direction of 𝐵0, also 
defined as the magic angle. The division by zero is an ill-posed problem as its result 
is undefined. Furthermore, small values of 𝐷(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) in proximity to the zero-cone 
surface amplify noise (166,274,275).  
Another problem arising from the deconvolution operation is that the solution at the k-
space origin is either undefined (281) or defined to be zero (170), so that all 
susceptibility values are relative and not absolute. Several techniques have used 
different reference tissues, such as CSF, white matter, muscle tissue or urine (184).  
One approach to fill in the values on the zero value cone surface is to measure these 
values by acquiring additional MRI data. The Calculation of Susceptibility through 
Multiple Orientation Sampling (COSMOS) method (274) relies on at least three 
acquisitions. For each acquisition, the subject is rotated with respect to the other 
acquisitions and with respect to the magnetic field. Therefore, at most two zero-value 
cones overlap at each location, so that there is always one acquisition that can fill in 
the missing values. In cerebral applications, the rotation of the ROI has been achieved 
by the subject tilting their head. However, the downsides of this method are that the 
rotation angle needs to be sufficiently large and the total acquisition time is increased 
by a factor of three. Therefore, while providing excellent performance in terms of SNR, 
image quality, and CNR, these factors have limited the clinical feasibility of this 
technique (274). 
An ideal method should only require a single acquisition and the values within the zero 
value cone should be estimated. Several approaches have been proposed that use 
different types of regularization and solve the problem in k-space or in image space.  
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In order to perform the division in k-space, one set of approaches regularizes the 
dipole kernel. Replacing all values of 
1
𝐷(𝑘)
, where |D(k)| is below a certain threshold 𝛼, 
with zero (282) or a constant value 
1
𝑠𝑖𝑔𝑛(𝐷(𝐾))𝛼
 (253,275,283) eliminates the problem of 
dividing by zero or very small values. The choice of 𝛼 is crucial since a small 
regularization threshold will only replace values very close to the zero value cone. 
Noise in this region of k-space will be amplified and may obscure the susceptibility 
map. While increasing the threshold improves the image quality, it will also reduce 
contrast (275,282). An optimised solution has been proposed by Schweser et al. (283). 
Here, a large truncation threshold is used in order to minimize noise propagation. In 
order to account for the truncation induced underestimation, the Point Spread Function 
due to dipole modification is calculated. It is estimated that from this a constant scalar 
can be calculated, which can be used to correct for the underestimation. Furthermore, 
truncation of the dipole kernel also causes streaking artifacts, which primarily arise at 
the interfaces of two regions of homogeneous susceptibility (284,285). This inversion 
technique is highly computationally efficient but depending on quality of the underlying 
data quality may suffer in terms of image quality.  
In comparison, image-space based approaches use regularization/minimization 
operations to estimate the susceptibility map that will produce a field map that 
resembles most closely the measured field map data. In addition to that, anatomical 
information can be used to regularize the deconvolution operation.  
One example is the Morphology Enabled Dipole Inversion (MEDI) algorithm (281,286–
288). The minimization operation estimates the susceptibility map which produces a 
field with the minimum difference to the estimated 𝐵𝑖𝑛𝑡. A regularization term is added 
onto this data fidelity term. The regularization is based on the assumption that the 
tissue compartments found on the magnitude images are of uniform susceptibility. 
Therefore, all edges that are present on the susceptibility map, but not on the 
magnitude image, should be removed or minimized. This approach particularly aims 
to reduce streaking artifacts. In order to determine the strength of the regularization, 
the data fidelity term is multiplied by a regularization parameter 𝜆. Therefore, a smaller 
𝜆 will mean a stronger regularization and more strict removal of any gradients on the 
susceptibility map that are not present on the magnitude image. This means that the 
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map will be smoothed out accordingly, which can improve image quality but may also 
smooth out smaller details, that may be missed (281,286–288). 
3.3 Numerical Simulations 
3.3.1 Field Mapping 
Experimental Setup 
In order to illustrate the individual steps involved in QSM, synthetic field maps were 
generated based on a ground truth susceptibility map. These examples served to 
illustrate the relationship between the susceptibility distribution and field maps. In other 
cases, these maps underwent background field removal and dipole field inversion. The 
results are compared to the ground truth at each step. 
 
Figure 3-1: Susceptibility distribution of a paramagnetic (a) and a diamagnetic (b) sphere 
To demonstrate the effects of geometry and orientation in the magnetic field 
inhomogeneity map, three paramagnetic phantoms were evaluated in numerical 
simulations. A sphere (Figure 3-1 a)), a cylinder oriented parallel to B0 (Figure 3-2 a-
c) and a cylinder perpendicular to B0 (Figure 3-2 d-f), each of 1 ppm susceptibility, 
were placed in a background of 0 ppm susceptibility. Furthermore, a sphere of 




Figure 3-2: Susceptibility distribution of a cylinder in parallel (a-c), and perpendicular to (d-f) B0.The two 
cylinders are shown in the x-y (a, d), x-z (b, e), and y-z (c, f) planes. 
A forward calculation was performed to generate the field maps created by these 
susceptibility distributions. This corresponds to a convolution of the susceptibility map 
with the unit dipole kernel: (𝑑 ∗ 𝜒)(𝑟) (165,168,289). The simulations were performed 
in Matlab (The MathWorks, Natick, MA). The Fourier transformed dipole kernel 
𝐷(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) was generated using the MEDI toolbox 
(http://pre.weill.cornell.edu/mri/pages/qsm.html and 
http://pre.weill.cornell.edu/mri/pages/qsmreview.html). The resulting field maps were 
compared to the unit dipole kernel, which was also generated using the MEDI toolbox. 
This set of forward calculations served to illustrate the differences in field distributions 
from susceptibility distributions that differed in sign, geometry, and orientation. 
Results 
The field of a unit dipole, i.e. the field generated by an infinitely small susceptibility 
source, can be seen in Figure 3-3 from three different orientations. The main magnetic 
field is in the z-direction. The characteristic field has a positive lobe on either side of 
the dipole in parallel to the direction of the external magnetic field and there is a circular 




Figure 3-3:Unit dipole field in the x-y (a), x-z (b), and y-z (c) planes. The main magnetic field is in the z-
direction. 
The unit dipole is essentially an infinitely small spherical shape, which is why the field 
resembles that of the spherical phantom in Figure 3-4 a-c. When assessing the field 
generated by a negative sphere, it can be seen that it equals the field generated by 
the positive sphere, multiplied by a factor of -1 (Figure 3-4  d-f). 
 
Figure 3-4: Field generated by a paramagnetic (a-c) and diamagnetic sphere (d-f) in the x-y (a,d), x-z 
(b,e), and y-z (c,f) planes. B0 is in the z-direction. 
When considering the cylinders, it can be seen that the induced field distribution has 
positive lobes in the direction of the external magnetic field and negative lobes 
perpendicular to the magnetic fields (Figure 3-5). As there will be fields induced within 
the cylinders, we can see that when in parallel to the magnetic field, positive fields will 
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dominate the field map inside the cylinder parallel to 𝐵0 (Figure 3-5 a-c), and that when 
its orientation is perpendicular to the field, the negative fields will dominate (Figure 3-5 
d-f). This is in keeping with observations made regarding SWI for venous imaging 
(178). 
 
Figure 3-5: Field generated by a paramagnetic cylinder oriented in parallel (a-c) and perpendicular to 
𝐵0, shown in the x-y (a,d), x-z (b,e), and y-z (c,f) planes. 𝐵0 is in the z-direction 
3.3.2 Background Field Estimation 
Experimental Setup 
After exploring the differences in fields created by different susceptibility distributions, 
two background field removal algorithms, Projection onto Dipole Fields (PDF) and 
Laplacian Boundary Value (LBV), were evaluated using the following simulated 
arrangement. The codes for the background field removal algorithms were also 
obtained from the MEDI toolbox (http://pre.weill.cornell.edu/mri/pages/qsm.html and 
http://pre.weill.cornell.edu/mri/ pages/qsmreview.html). A field map was generated 
from six spherical phantoms (with susceptibilities in the range 0.5 ppm to 3 ppm, 
increasing in 0.5 ppm steps, which were chosen to simulate Gadolinium doped water 
phantoms with small variations in susceptibility that were biologically relevant) placed 
within a ‘water tank’ (a large cuboid volume with the susceptibility value set to 0 ppm 
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which is the susceptibility of water relative to air) in front of a background of 9.41 ppm 
susceptibility simulating air (290). The susceptibility distribution is shown in Figure 3-6.  
 
Figure 3-6: Susceptibility distribution for the numerical phantom simulations 
𝐵𝑖𝑛𝑡 for the cubic MRI-signal-generating volume, is generated considering only the 
susceptibility difference between water and the phantoms, while 𝐵𝑒𝑥𝑡 originates from 
the susceptibility difference between air and water. The fields created from only a 
water tank placed within air without any phantoms present (𝐵𝑒𝑥𝑡) and the field 
generated by the set of paramagnetic spheres placed within a background of uniform 
susceptibility (0 ppm), with their susceptibility set to the same value as the difference 
between the phantoms and water (𝐵𝑖𝑛𝑡) were calculated and served as ground truth 
estimates. 
Subsequently, the simulations were repeated with the addition of noise. In order to 
add complex Gaussian noise to the field map, it was assumed that the magnitude 𝑚 
of the signal was unity everywhere and noise was added to the signal to achieve 





(𝑛𝑜𝑖𝑠𝑒𝑟𝑒𝑎𝑙 + 𝑖 𝑛𝑜𝑖𝑠𝑒𝑖𝑚𝑎𝑔𝑖𝑛𝑎𝑟𝑦) 3-7 
In order to evaluate the performance of the algorithms, the 𝐵𝑖𝑛𝑡 estimates were visually 
compared to the ground truth with noise present. Difference images between the 
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ground truth without any noise present and the estimated 𝐵𝑖𝑛𝑡 were used to highlight 
errors. In order to analyse the error generated by the different background field 
removal algorithms with different noise levels in more detail, the field was divided into 
an inside region and a border region of 10 pixels. In the border region errors are most 
frequent. Subsequently the correlation between the estimated 𝐵𝑖𝑛𝑡 and the ground 
truth without any noise present was calculated in order to achieve a quality measure 
for the background field removal. 
Results 
When considering the ground truth of the simulation, it can be seen that the fields from 
the spherical phantoms inside the water tank are in fact the sum of the background 
field and the internal field as shown in Figure 3-7. The fields generated by the spheres 
overlap and decrease with distance. The background field is much larger and very 




Figure 3-7: The first row shows the total fields generated by the numerical phantoms (scaled to be given 
in radians) (a-c). The second row (d-f) show Bint as estimated using LBV (d), PDF (e), and the ground 
truth calculated via forward calculation (f). The third row shows the corresponding 𝐵𝑒𝑥𝑡 (g, h) and the 
ground truth calculated via forward calculation (i). 
The background field removal algorithms LBV and PDF estimated 𝐵𝑖𝑛𝑡 and 𝐵𝑒𝑥𝑡, which 
largely corresponded in shape, size, and orientation to the ground truth as shown in 
Figure 3-7: 𝐵𝑖𝑛𝑡 as estimated with LBV (Figure 3-7 d) and PDF (Figure 3-7 e) 
corresponded to the field generated by the phantoms alone without any background 
fields present (Figure 3-7 f). The background fields estimated with LBV (Figure 3-7 g) 
and PDF (Figure 3-7 h) corresponded to the field generated by an air- water interface 
(Figure 3-7 i).  
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In Figure 3-7 d) and e) it can be observed that there are small errors in the estimation 
of 𝐵𝑖𝑛𝑡. To evaluate these further, the ground truth, i.e. the field generated by the 
phantoms in water alone without any noise present was subtracted from the Bint 
estimates, which is shown in Figure 3-8. This was compared to the ground truth as 
calculated in the presence of noise from which the ground truth without any noise 
present was subtracted (Figure 3-8 c and f). 
 
Figure 3-8: The first row shows the internal fields estimated with LBV (a) and PDF (b) in comparison 
with the ground truth, which is the field generated in the absence of air (scaled to be given in radians) 
(c). The second row shows the deviation from all of those fields from the ground truth, as calculated in 
the absence of noise. 
In the border region, there are slight differences between the LBV (Figure 3-8 a, d) 
and PDF (Figure 3-8 b, e)) algorithms. The error in the border region is slightly larger 
for the PDF algorithm in comparison to LBV algorithm (Figure 3-8 d, e). In order to 
further classify the error in the boundary regions, the correlation between all voxels of 
the ground truth internal field without any noise present and the estimated internal 
fields at different noise levels was calculated. For reference, the correlation between 
the internal field with and without noise present was also calculated. Figure 3-9 shows 
two plots of Pearson’s correlation coefficient against the applied noise level. In the 
low-noise case, the LBV algorithm more accurately estimates the field components 
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around the boundary as shown by its larger Pearson’s correlation coefficient. While 
the overall correlation coefficient decreases with an increasing noise level, this may 
not be entirely due to errors in the background field estimation. In the boundary region, 
even the noisy ground truth estimate has a low correlation with the noiseless ground 
truth estimate (yellow line, Figure 3-9 a)). This is due to the overall small signal in the 
boundary region. As the noise level is increased, the performance of LBV reduced, as 
shown by the decreasing correlation coefficients. The results are worse than the 
ground truth but behave in a similar way. In contrast, the PDF algorithm had a low 
performance in the boundary region even at a high SNR and the correlation remained 
low. 
 
Figure 3-9: Pearson's correlation coefficient between 𝐵𝑖𝑛𝑡 with added noise and as estimated with LBV 
and PDF and the ground truth internal field. A) shows the results in the border regions and b) inside the 
region of interest. The correlation coefficient is plotted against different noise levels 
For the internal field (Figure 3-9 b), both PDF and LBV had an excellent agreement 
with the ground truth. With increasing noise level, the correlation coefficient 
decreased. This was due to the increase in noise since the correlation between the 
ground truth with and without added noise decreased by a similar amount.  
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3.3.3 Dipole Field Inversion 
Experimental Setup 
In a third simulation, the effect of differences in SNR on the dipole field inversion was 
evaluated using two different methodologies: truncated k-space division (TKD) and 
Morphology Enabled Dipole Inversion (MEDI). The codes for the relevant algorithms 
were from the MEDI toolbox (http://pre.weill.cornell.edu/mri/pages/qsm.html and 
http://pre.weill.cornell.edu/mri/pages/qsmreview.html). The code for the corrected 
TKD algorithm was from the toolbox “MRI susceptibility calculation methods” (available 
at https://xip.uclb.com/i/software/mri_qsm_tkd.html (275,283)). A similar susceptibility 
distribution was used as in the background field removal section. In order to minimize 
the errors introduced by background field removal, 𝐵𝑖𝑛𝑡 as generated in the previous 
simulation from the spherical phantoms and water alone was used, without any air 
present. Furthermore, a point source of noise was added onto Δ𝐵𝑖𝑛𝑡 by assigning a 
single voxel the value 3.04 in order to illustrate the streaking artefact caused by these 
point sources of granular noise. Subsequently the MEDI algorithm and the TKD 
algorithm were evaluated with varying regularization parameters 𝜆 (10, 100, 1000) and 
𝛼 (0.1, 0.2, 0.3). Furthermore, the TKD approach, which corrects for the 
underestimation, which was proposed by Schweser et al. (283) was employed. Here, 
a threshold value 𝛼 of 2/3 was used and subsequently, the susceptibility map was 
corrected with a scaling factor in order to avoid underestimation. 
Results 
First, the TKD results were assessed. When varying the regularization parameter of 
the TKD algorithm the following was observed: With a small regularization parameter, 
the algorithm correctly estimated the paramagnetic susceptibility values within the 
spherical phantoms. As the regularization parameter increased, the algorithm slightly 
underestimated the susceptibility (Figure 3-10). This means the regularized region 
gets larger in the regularized k-space, which leads to greater underestimation. The 
PSF corrected implementation leads to an overestimation of the susceptibility values 
within the spheres. The overestimation is in part inherent to this methodology and in 
other parts due to the increased truncation induced streaking artefact surrounding the 
spheres, which is more pronounced in this method. However, as different noise levels 
were assessed, it can be seen that a stronger regularization reduced noise and the 
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streaking artefact from the point source in the susceptibility maps. A stronger 
regularization also leads to a more pronounced truncation induced artefact at the 
boundary of the high susceptibility spheres and the surrounding water. Figure 3-11 
shows the shape of the streaking artifact by looking at Figure 3-10 from a different 
orientation and changing the range of voxel values.  
 
Figure 3-10: QSM using TKD estimated with different noise levels (row 1(a-d): SNR = 100, row 2 (e-h): 
SNR = 50, row 3 (i-l): SNR = 10) and different regularization parameters (column 1 (a,e,i): α = 0.1, 
column 2 (b,f,j): α = 0.2, column 3 (c,g,k): α = 0.3), column 4 (d,h,l): corrected TKD) 
In order to illustrate the effect of varying the regularization parameters on the reduction 
in image contrast, Figure 3-12 a-c, show a plot of the estimated mean susceptibility 
values (y-axis) against the ground truth values (x-axis) within each phantom. To 
summarize Figure 3-12 d) shows the slope for each plot. A slope of 1 would signify a 
perfect estimation of the susceptibility values. A smaller slope indicates that the 




Figure 3-11: TKD images displayed with a window level that shows the characteristic streaking artifact 
Here we can see that with increasing regularization parameter the slope is decreasing, 
which means that the TKD algorithm underestimates the true susceptibility values 
within the spheres. As described above, the corrected TKD algorithm lead to an 
overestimation of the susceptibility values. However, increasing noise did not have an 
effect on the relationship between susceptibility underestimation and regularization 
parameter. From Figure 3-10 and Figure 3-11 it can, however, be seen that a higher 




Figure 3-12: These graphs plot the estimated against the true susceptibility values in ppm as estimated 
with TKD and varying regularization parameters (a-c). The noise conditions were varied from SNR = 10 
(a), SNR = 50 (b), and SNR = 100 (c). D) summarizes the findings by plotting the slope for each graph 
against the applied regularization parameter. 
Subsequently, the MEDI algorithm was assessed. As described in section 3.3.2, it was 
assumed, that the magnitude of the images was unity everywhere, before noise was 
added. As the regularization parameter 𝜆 decreased, the susceptibility differences 
between the spherical phantoms and the background were reduced as shown in 




Figure 3-13: QSM using MEDI estimated with different noise levels (row 1 (a-c): SNR = 100, row 2 (d-
f): SNR = 50, row 3 (g-i): SNR = 10) and different regularization parameters (column 1 (a,d,g): λ = 1000, 
column 2 (b,e,h): λ = 100, column 3 (c,f,i): λ = 10) 
At the same time, noise and streaking artifacts were reduced (Figure 3-13 and Figure 
3-14). Figure 3-14 shows the streaking artifact by looking at Figure 3-13 from a 
different orientation and changing the range of the grayscale. This illustrates that at 
different noise levels, the regularization parameters need to be carefully chosen. A 
very high regularization parameter might be acceptable when the SNR is high (Figure 
3-14 a, b) but at a lower SNR, the image quality may be too low (Figure 3-14 g, h) and 
a much stronger regularization may be required (Figure 3-14 i). For all noise levels 




Figure 3-14: MEDI images with a windowing that illustrates the shape of the characteristic streaking 
artifact 
In order to illustrate the effect of varying the regularization parameters on the reduction 
in image contrast, Figure 3-15 shows a plot of the estimated against the ground truth 
susceptibility values within each phantom. A plot of the slope against regularization 
parameter at the respective noise value summarizes these findings (Figure 3-15 d). 
The smaller the regularization parameter, the smaller the slope, i.e. the higher the 
underestimation of the susceptibility differences. Both, the choice of 𝜆 and the noise 
level had an effect on the susceptibility underestimation. At relatively high SNRs of 50 
and 100, a 𝜆 of 100 and 1000 produced similar results. However, at a very low SNR 
of 10, the only a 𝜆 of 100 did not lead to great underestimation. A 𝜆  of 10 consistently 
led to a reduction of the slope for all SNRs. On Figure 3-14 (c, f, i) this can be seen by 




Figure 3-15: These graphs plot the estimated against the true susceptibility values in ppm as estimated 
with MEDI and varying regularization parameters (a-c). The noise conditions were varied from SNR = 
10 (a), SNR = 50 (b), and SNR = 100 (c). D) summarizes the findings by plotting the slope for each 
graph against the applied regularization parameter. 
3.4 Human Brain Imaging 
3.4.1 Experimental Setup 
In addition to the numerical simulations, images from a brain of a single subject in a 
patient study were processed. The data were acquired at 1.5T (MR 450, GE 
Healthcare, Waukesha, WI) with a multi-echo gradient echo sequence (Susceptibility-
weighted Angiography (SWAN), GE Healthcare, Waukesha, WI). The data were 
acquired as part of the PEMA study, part of which has been published in (291). The 
data were provided by courtesy of Dr Andrew Priest. Magnitude and phase images 
were processed for QSM by estimating Δ𝐵 using a least squares algorithm (258–260), 
provided in the MEDI toolbox followed by background field removal and dipole field 
inversion. 
In order to illustrate the different steps of the QSM algorithm, the background field was 
removed using both the LBV and PDF algorithms and the dipole field inversion was 
performed using MEDI (Regularization Parameter = 10, 320 & 1000) and TKD 
(Regularization Parameter = 0.07, 0.2 & 0.5; corrected TKD). The codes for Δ𝐵 
estimation, phase unwrapping, background field removal, and dipole field inversion 
were from the Matlab MEDI toolbox (http://pre.weill.cornell.edu/mri/pages/qsm.html 
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and http://pre.weill.cornell.edu/mri/ pages/qsmreview.html). The code for the corrected 
TKD algorithm was from the toolbox “MRI susceptibility calculation methods” (available 
at https://xip.uclb.com/i/software/mri_qsm_tkd.html (275,283)). 
3.4.2 Results 
Field Map Estimation and Phase Unwrapping 
The field map of the complex gradient echo images was acquired from the variation of 
the phase images with echo time. Figure 3-16 shows the phase images of a single 
slice acquired at the four different echo times (TE = 6.5,13.2,20.0,26.7 ms). It is 
assumed that the phase varies linearly with time and that its slope gives Δ𝐵 (as 
illustrated in Figure 3-16 b). This can be estimated by fitting on the complex data. 
During this process it is necessary to remove any phase wraps between subsequent 
echoes as demonstrated in Figure 3-16 b). The resulting temporally unwrapped map 
of 𝛥𝐵 (scaled by a factor of 𝛾2𝜋𝛥𝑇𝐸) is shown in Figure 3-16 c). The code for the  𝛥𝐵 
estimation stems from the MEDI toolbox (258–260). 
 
Figure 3-16: A map of field inhomogeneities (scaled to be given in radians) (c) can be estimated from 
the linear phase variation with echo time (b) from gradient echo phase images acquired at different 
echo times (a). Phase wraps may occur in between subsequent, which need to be corrected as shown 
in b). (I published this illustration in (153)) 
The remaining phase wraps can be removed as demonstrated in Figure 3-17 with a 
graph-cut based spatial phase unwrapping algorithm as proposed in (263). The code 
for the phase unwrapping stems from the MEDI toolbox (263). Integer multiples of 2𝜋, 
(𝑘2𝜋), are added onto the wrapped phase map in order to achieve a completely 




Figure 3-17: Phase wraps may occur, in regions where the field inhomogeneity is too large (a). These 
can be identified by phase unwrapping algorithms, which add an integer multiple of 2𝜋 (b) onto the 
wrapped map of field inhomogeneities (scaled to be given in radians) (a) in order to calculate an 
unwrapped map of field inhomogeneities (c). (I published this illustration in (153)) 
Background Field Removal 
The unwrapped field map contains contributions from 𝐵𝑖𝑛𝑡 and 𝐵𝑒𝑥𝑡. These can be 
separated using the two background field removal techniques that were demonstrated 
in the numerical simulation (LBV (176) and PDF (177)). The codes for the background 
field removal stems from the MEDI toolbox. As expected, the contributions from the 
background field and the internal field look similar when estimated with both 
techniques (LBV: Figure 3-18 a, PDF: Figure 3-18 b). 𝐵𝑒𝑥𝑡  is large and slowly varying 
and dominates the image, obscuring 𝐵𝑖𝑛𝑡 (Figure 3-18 d, e). Here, these contributions 
originate from air tissue interfaces. Due to different assumptions for the boundary 
conditions, there are small differences between the two techniques near the boundary 
indicated by the black circles on the LBV and PDF images, and more clearly visible on 
their difference image (Figure 3-18 c)). However, these differences are limited to the 





Figure 3-18: 𝐵𝑖𝑛𝑡 (a, b) and 𝐵𝑒𝑥𝑡 (d,e) (scaled to be given in radians) estimated using LBV (a, d), and 
PDF (b, e). The difference image between the two methods highlights the differences between the two 
approaches (c). (I published aspects of these results in (153)) 
Dipole Field Inversion 
The results estimated with the different dipole field inversion algorithms confirm the 
observations made in the numerical simulations. The susceptibility maps estimated 
using the TKD algorithm with a low threshold value (Figure 3-19 a), e), 𝛼 = 0.07) 
exhibits the characteristic streaking artifacts and noise. An increased threshold leads 
to an improvement in image quality and lower streaking artifacts and noise (Figure 
3-19 b, f, 𝛼 = 0.2), but a simultaneous reduction in contrast (Figure 3-19 c, g, 𝛼 = 0.5). 
The reduction in contrast can be counteracted by using the corrected TKD method, 




Figure 3-19: Susceptibility maps estimated with TKD; The first row (a-d) shows the susceptibility maps 
in axial and the second row (e-h) in sagittal orientation. The values of the regularization parameter 𝛼 
are 0.07 (a, e), 0.2 (b, f) and 0.5 (c, g) in the first, second and third column respectively. The fourth 
column shows the results with the corrected TKD method. (I published aspects of these results in (153)) 
The MEDI algorithm improves the image quality and removes much of the streaking 
artifact. In comparison to a large regularization parameter 𝜆 (Figure 3-20 c, f; 𝜆 =
1000), a reduction leads to a noticeable suppression of streaking artifacts (Figure 3-20 
b, e; 𝜆 = 320). However, an overly small choice of 𝜆 (Figure 3-20 a, d; 𝜆 = 10), can 
lead to over-smoothing of the data. 
 
Figure 3-20: Susceptibility Maps estimated with MEDI in axial (a-c) and in sagittal orientation (d-f). The 
values of the regularization parameter 𝜆 are 10 (a, d), 320 (b, e) and 1000 (c, f) in the first, second and 




These simulations and the in vivo data illustrated the size and shape of different 
magnetic field inhomogeneities which depend on the geometry, orientation and 
susceptibility of the underlying susceptibility distribution. These non-local effects of 
different fields then overlap. This illustrates the advantages that QSM has over SWI 
that has been demonstrated in various studies. The elimination of the non-local effects 
and geometry dependence allows for a better differentiation between paramagnetic 
and diamagnetic substances (171) as has previously been shown in the brain and a 
more accurate assessment of their volumes as has been shown in cerebral hematoma 
volume assessment (221). The non-local effects also lead to the obscuring of internal 
fields by background fields. This leads to a requirement for background field removal 
techniques to extract the internal field generated within a certain ROI. Different 
algorithms vary in their performance. Errors and differences between different 
techniques primarily occur in the boundary region of the mask that is applied before 
the background field removal. It is important that these errors remain as small as 
possible as they may affect the susceptibility maps and cause errors in the quantitative 
assessment of local susceptibility differences and the qualitative assessment, as they 
may obscure the internal susceptibility map. While different noise levels degrade the 
overall performance of the algorithms, it was shown that the errors remain in the 
boundary region, so that the effects on the susceptibility distribution inside the region 
of interest remain small. 
Furthermore, the application of different dipole field inversion techniques showed the 
importance of the regularization parameter. Under different noise conditions, a 
reduction in streaking artefact can be seen by choosing a stronger regularization but 
the improvement in image quality often comes at a cost. Stronger regularization led to 
an underestimation of susceptibility differences. Furthermore, when the regularization 
was too strong, the MEDI algorithm smoothed the susceptibility maps which lead to a 
loss of detail. 
3.6 Conclusion 
This chapter illustrates the different steps involved in QSM and illustrates the fields 
and effects of noise that are involved in each step. Understanding the principles and 
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steps involved in this post-processing technique is important in order to improve on 
the existing techniques, for example by including a water-fat separation technique into 





Chapter 4 Susceptibility Weighted 
Imaging and R2*-Mapping for the 
Detection of Carotid Artery Plaque 
Calcification and USPIO Uptake 
Aspects of this work were presented in Ruetten PPR, et al. “Calcification and USPIO 
detection in Carotid Artery Plaque using QSM and SWI”. In: Proceedings of the 27th 
Annual Meeting of ISMRM. ; 2019:2090 (292) 
4.1 Introduction 
As described in chapter 1 section 1.5, ultrasmall superparamagnetic iron oxide 
(USPIO) nanoparticles can serve as an MRI contrast agent. After intravenous 
injection, they are taken up by macrophages. Their detection may therefore serve to 
identify inflammation, which is helpful in carotid atherosclerotic plaques, where it is a 
marker of vulnerability to rupture.  
Due to the USPIO’s strong paramagnetism the 𝑅2
∗-value is increased drastically in 
high-uptake regions (149). In the past USPIO-uptake has therefore been identified 
with two gradient echo acquisitions, that are acquired before and after contrast agent 
administration. The USPIO-uptake is then identified by a drop in 𝑇2
∗w signal intensity 
on the magnitude images or, if multiple echo times are acquired, an 𝑅2
∗ map can be 
generated and USPIO-uptake is identified by an increase in 𝑅2
∗-value 
(126,137,138,141–143). 
A comparison of pre- and post-contrast scans is necessary in order to distinguish 
paramagnetic USPIO-uptake from other strong susceptibility sources within the plaque 
such as calcification or intraplaque haemorrhage. A wide variety of sequences have 
attempted to display USPIO-uptake with positive contrast, as was described in chapter 




∗-weighted gradient echo contrast and positive contrast are generated from 
local field inhomogeneities created by changes in tissue susceptibility (149,294). In 
conventional gradient echo imaging, only the magnitude images are used while the 
important information contained within the phase from gradient echo acquisitions, 
which varies linearly with the field inhomogeneity, is discarded. However, the different 
effects caused by the field inhomogeneities are used in positive contrast techniques 
as described in chapter 1 section 1.5.2. Susceptibility weighted imaging (SWI) 
improves on 𝑇2
∗w gradient echo imaging by combining 𝑇2
∗w magnitude images with the 
phase information, which includes information about the magnitude and sign of the 
local field inhomogeneities in order to generate a new type of contrast (178). 
Furthermore, it does not require an additional, dedicated sequence like many positive 
contrast imaging techniques. The SWI phase images may also be analysed on their 
own. A detailed description of the implementation and applications of SWI can be 
found in chapter 2 section 2.2.3 and chapter 2 section 2.2.5.  
A variety of studies have therefore used filtered phase images and SWI to image 
strongly paramagnetic materials, such as paramagnetic deoxygenated venous blood 
(178), haemorrhages (171–174), and iron oxide nanoparticles (295) or diamagnetic 
calcification (171–174,296–300). In particular, it has been suggested that due to the 
different signs of their susceptibilities, the fields generated by paramagnetic and 
diamagnetic materials may be distinguished with SWI and filtered phase images in 
several studies (171–174). It has been assumed that the fields generated by 
paramagnetic materials are positive while diamagnetic fields are negative. Therefore 
it is frequently assumed that the phase shifts from diamagnetic materials such as 
calcification and paramagnetic materials such as USPIO uptake are associated with 
positive and negative phase shifts in a right handed system respectively 
(173,174,301). In vascular imaging, SWI has been used to image carotid plaque 
calcification and distinguish the lumen from the more diamagnetic vessel wall 
(296,297,302).  
Due to its ability to distinguish between paramagnetic and diamagnetic materials and 
the promise SWI has shown in previous studies, this study explores SWI and filtered 
phase images in imaging of carotid artery plaques. It was used to confirm that SWI 
and filtered phase images can image carotid plaque calcification and is proposed as 
a novel method for imaging USPIO-uptake in carotid artery plaques. The underlying 
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hypothesis is that SWI and filtered phase images are able to distinguish materials of 
different susceptibility in carotid artery plaques, i.e. calcification and USPIO-uptake. 
While previous “positive contrast” methods to image USPIO contrast rely on dedicated 
sequences, SWI is complementary to frequently used R2*-mapping imaging protocols.  
In the following, a patient group with carotid artery disease underwent two MRI 
examinations before and after USPIO injection. The feasibility, benefits, and 
challenges of using SWI and filtered phase images in conjunction with a conventional 
MRI imaging protocol were subsequently explored. 
4.2 Methods 
4.2.1 Data Acquisition 
Seven patients (1 woman and 6 men, mean age 70±7.28 years) with moderate to 
severe carotid artery disease (i.e. 50-99% luminal stenosis on carotid duplex imaging) 
were scanned at 1.5T (MR450w, GE Healthcare, Waukesha, WI). Four out of those 
patients are also analysed in Chapter 6. The patient recruitment was performed by Dr 
Ammara Usman. Prior to the study patients were screened to minimize potential 
contraindications of Ferumoxytol contrast agents. This included a review of their 
medical history, while screening and cross-checking at the time of recruitment and 
consent. The following exclusion criteria were used: History of atopy, asthma or 
allergic reaction to contrast media, iron or dextran or a known documented history of 
haemochromatosis. Furthermore, patients with immune inflammatory conditions, e.g. 
systemic lupus erythematosus, rheumatoid arthritis were excluded. All of the 
participants gave informed consent and the study had ethical approval from the East 
of England – Cambridge Central Research Ethics Committee. Two MRI examinations 
were performed per patient, one was performed before and the other one 48 hours 
after 5mg/kg USPIO-injection (Ferumoxytol, AMAG Pharmaceuticals, Lexington MA). 
The study protocol comprised: 3D Time-of-Flight (TOF) MRA; black-blood, fat 
suppressed T1-w 3D fast spin echo (CUBE); and a black-blood, fat suppressed, 3D 
multi-echo gradient echo acquisition (Susceptibility Weighted Angiography, SWAN). 
For blood suppression DANTE (Delay alternating with nutation for tailored excitation) 
preparation pulses were used in both the CUBE and SWAN sequence (124). The 
sequence development for the black blood preparation was done by Dr Jianmin Yuan. 
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In four cases bright-blood SWAN without fat suppression was also acquired and the 
results were compared to the black-blood sequence. For bright blood SWI, the same 
sequence with the black blood preparation turned off was used but bipolar echo 
readouts were used. In the sequence, the number of echoes could be set manually. 
The T2*-weighted SWAN sequence was also used for R2* mapping and SWI while the 
multi-contrast protocol was used for validation. The sequence parameters are given in 
Table 4-1. 




























3:07 5:47 7:24 7:38 
Table 4-1: MRI Sequence Parameters *the slice thickness is interpolated from the acquired 2 mm to 1 
mm using zero-filling 
4.2.2 Data Processing 
Both 𝑇2
∗w multi-echo gradient echo datasets were further processed to generate SWI 
and filtered phase images. For SWI, the raw MRI data were reconstructed using 
ASSET, which is similar to the SENSE technique (257) using a customised Matlab 
code written in GE’s Orchestra framework, where Calibration scans were available. If 
the Calibration scans were not available the PULSAR toolbox was used for SENSE 
reconstruction (303). The SWI images were calculated for all of the echo times. The 
𝑇2




mapping, were generated using the GE scanner recon as this had been done in 
previous studies using T2*w GRE images and R2* maps. 
𝑅2
∗-mapping was performed with in-house-developed Matlab code provided by Dr 
Jianmin Yuan that fitted the formula 𝑆 ∙ 𝑒𝑥𝑝(−𝑅2
∗ ∙ 𝑇𝐸) to the acquired multi-echo 
gradient echo data using Levenberg-Marquardt on a voxel by voxel basis. This was 
done within the vessel wall and the plaque region, as outlined on the magnitude 
images. The DANTE CUBE and 3D TOF images were used as an aid to distinguish 
lumen from vessel wall, when necessary. On the filtered phase images and SWI, I 
outlined regions of calcification, normal plaque regions, and regions containing 
USPIO. Due to the poor SNR of the black blood images, the mean 𝑅2
∗ value was also 
calculated for each ROI on each slice. This was used later on for quantitative analysis. 
For both SWI and filtered phase images, the phase images from the 𝑇2
∗w gradient echo 
acquisition were processed for all echo times. As previously described in chapters 2 
and 3, it is important to consider only the field inhomogeneities that are generated 
within the region of interest, which are obscured by background fields, for example by 
air tissue interfaces. Therefore, the phase images were high-pass filtered. Therefore, 
a 2D 28×28 low pass Fermi filter with a full width half maximum of 18.7 pixels was 
applied to the complex data. The code for the low pass filter was provided by Dr 
Andrew Priest. The low pass filtered images served as an estimate for the background 
field and were then subtracted from the original phase images via complex division. 
The resulting high-pass filtered phase images could be interpreted by themselves and 
were also further processed to generate SWI. Since paramagnetic and diamagnetic 
susceptibility sources generate different kinds of fields it was assumed that the phase 
shifts from diamagnetic calcification and paramagnetic USPIO uptake were associated 
with positive and negative phase shifts in a right handed system respectively 
(173,174,301). 
Two sets of phase masks were then generated to enhance negative (equation 4-1) 
and positive phase (equation 4-2) shifts respectively: 
𝑀𝑎𝑠𝑘(𝑥, 𝑦) = {
𝜋 + 𝜙(𝑥, 𝑦)
𝜋
; 𝑖𝑓 𝜙(𝑥, 𝑦) ≤ 0




𝑀𝑎𝑠𝑘(𝑥, 𝑦) = {
𝜋 − 𝜙(𝑥, 𝑦)
𝜋
; 𝑖𝑓 𝜙(𝑥, 𝑦) ≥ 0
1; 𝑖𝑓 𝜙 < 0
 
4-2 
The phase masks were subsequently multiplied four times with the magnitude data. 
4.2.3 Data Analysis 
In addition to SWI and filtered phase images, 𝑅2
∗ maps and normalized 𝑇2
∗w images 
were also generated from the gradient echo dataset. For normalization, I manually 
outlined a region of sternocleidomastoid muscle on the 𝑇2
∗w magnitude images and 
normalized the signal intensity within the carotid plaques with this value. 
SWI, filtered phase images, 𝑅2
∗ maps, 𝑇2
∗w images and the remaining images from the 
multi-contrast protocol were subsequently centred on the carotid bifurcation to enable 
comparison of pre- and post-contrast images.  
Each set of SWI showed darker regions for calcification or USPIO. On the high-pass 
filtered-phase image, calcification was identified by a positive phase shift and USPIO 
uptake by a negative one. Regions of USPIO uptake, calcification, and normal tissue 
were outlined based on the SWI and filtered phase images and the results were 
compared qualitatively to the multi-contrast protocol. Calcification was identified as 
dark regions on all acquisitions with an increased 𝑅2
∗ value. In three cases CT images 
were also available. USPIO-uptake was identified by comparing pre- and post-contrast 
images; uptake was identified by increased 𝑅2
∗ and hypointensity on 𝑇2
∗w images and 
as hyperintensities on 𝑇1w images, if the USPIO-concentration was low.  Besides 
increasing 𝑅2
∗, USPIOs shorten 𝑇2
∗ and 𝑇1. In low concentrations the contrast agent 
therefore appears as hyperintensities on 𝑇1 weighted images (127). 
For quantitative analysis the images from the black blood gradient echo dataset were 
assessed. Regions of USPIO uptake, calcification, and normal tissue were outlined on 
filtered phase images and SWI. Within each ROI as outlined on SWI/filtered phase 
images the mean 𝑅2
∗-value was calculated and the mean 𝑇2
∗ signal intensity values 
from the third echo time (TE = 15.9 ms) relative to the sternocleidomastoid muscle 
(relative signal intensity is abbreviated to rSI) was measured. The mean values 
calculated for each patient were compared to each other in box-plot form. 
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4.2.4 Histological Analysis 
In two patients, who underwent carotid endarterectomy after both MRI acquisitions, 
histological data were available, which served to validate the presence of either 
calcification or USPIO contrast agents. The specimens were decalcified, sliced at 3 
mm intervals and subsequently embedded in paraffin wax. Thin sections, cut at 3 µm 
thickness, were stained with Haematoxylin and Eosin (H&E), Perl’s Prussian Blue and 
Elastic Van Gieson Stain. The histopathological analysis was performed by the tissue 
bank team and Dr Alison Cluroe, the consultant histopathologist. The large spacing of 
the thin histology slides, compared to the tight spacing of thick MRI slices, limited the 









Figure 4-1: Pre- (a-d, f-j) and post-contrast images (k-s) from the multi-contrast protocol. Calcification 
is identified by a positive phase shift on the filtered phase images of both bright (TE=4.4 ms) (d, n) and 
black blood (TE = 5 ms) (c, m) gradient echo filtered phase images as indicated by the yellow arrows. 
The signal in this region was selectively suppressed on the SWI specifically used to detect diamagnetic 
materials (a, k) but not on the SWI used for detection of paramagnetic materials (b, l). The SWI images 
are generated from the first echo time (TE = 5 ms). Correspondingly, calcification appeared hypointense 
on the T2*w bright (TE = 15.1 ms) (g, p) and black blood (15.9 ms) (f, o) images, 3D TOF (i, r) and T1w 
CUBE (j, s). Calcification furthermore led to hyperintensities on R2* maps. (h, q). CT showed increased 
Hounsfield units in the location of the calcification (e). USPIO-contrast agent uptake could be detected 
as hypointensities on the post-contrast filtered phase images (m, n) and selective signal suppression 
on the corresponding SWI (l) as indicated by the red arrow. This corresponded to a decrease in signal 
intensity on T2*w gradient echo (o, p), and a signal increase on the R2* maps (q) and T1w CUBE (s). (I 
presented aspects of these results at (292)) 
A comparison of the SWI pre-contrast images showed improved visualisation in all 
cases of the calcification on the diamagnetic SWI, due to a positive value on the filtered 
phase. On the “diamagnetic” SWI, the signal within regions of calcification was 
suppressed selectively. Figure 4-1 & Figure 4-2 show the images from the multi-
contrast protocol before and after contrast-agent administration. The hyperintensities, 
identifying calcification on the filtered phase images (Figure 4-1 c, d, m, n; Figure 4-2 
c, d, l, m), were consistent with the findings from the other sequences, i.e. an increase 
in R2* (Figure 4-1 h, q; Figure 4-2 g, p) in comparison to “normal” plaque regions, that 
did not contain any susceptibility sources, and hypointensities detected on all other 
contrast weightings and an increase in Hounsfield Units as detected on CT images 
(Figure 4-1 e). The two examples on Figure 4-1 & Figure 4-2 are relatively lightly 
calcified plaques. Here, the paramagnetic SWI demonstrated USPIO-uptake (Figure 
4-1 l, Figure 4-2 k), due to a negative value on the filtered phase image (Figure 4-1 m, 
n, Figure 4-2 l, m). This was consistent with an increase in R2* value (Figure 4-1 q, 
Figure 4-2 p)/decrease in T2*w rSI (Figure 4-1 o, p; Figure 4-2 n, o) when comparing 
images acquired pre- and post-contrast administration. SWI processing allowed for a 










Figure 4-2: Pre- (a-i) and post-contrast images (j-r) from the multi-contrast protocol. Calcification is 
identified by a positive phase shift on the filtered phase images of both bright (c, l) and black blood (d, 
m) gradient echo filtered phase images as indicated by the yellow arrows. The signal in this region was 
selectively suppressed on the SWI specifically used to detect diamagnetic materials (a, j) but not on the 
SWI used for detection of paramagnetic materials (b, k). Correspondingly, calcification appeared as 
hypointense on the T2*w bright (f, o) and black blood (e, n) images, 3D TOF (h, q) and T1w CUBE (i, r). 
It furthermore led to hyperintensities on R2* maps (g, p). USPIO-contrast agent uptake could be 
detected as hypointensities on the post-contrast filtered phase images (l, m) and selective signal 
suppression on the corresponding SWI (k) as indicated by the red arrow. This corresponded to a 
decrease in signal intensity on T2*w gradient echo (n, o), and a signal increase on the R2* maps (p) and 
T1w CUBE (r). (I presented aspects of these results at (292)) 
In heavily calcified plaques, however, it was more difficult to clearly outline and 
distinguish between regions of USPIO uptake and calcification. Figure 4-3 shows a 
heavily calcified plaque. On the pre-contrast filtered phase image (Figure 4-3  c, d), 
plaques were hyperintense due to large regions of calcification, which was confirmed 
with a CT image (Figure 4-3 e). On the post-contrast images, however, the signal 
phase within the plaque was inhomogeneous (Figure 4-3 m, n) and there were regions 
of hyper- and hypointensity. Due to the non-local effects and geometry- and 
orientation-dependence of the magnetic field inhomogeneities, it is difficult to 









Figure 4-3: Pre- (a-d, f-j) and post-contrast images (k-s) from the multi-contrast protocol. On the pre-
contrast images calcification is identified by a positive phase shift on the filtered phase images of both 
bright (c) and black blood (d) gradient echo images as indicated by the yellow arrows. The signal in this 
region was selectively suppressed on the SWI specifically used to detect diamagnetic materials (a) but 
not on the SWI used for detection of paramagnetic materials (b). Correspondingly, calcification 
appeared as hypointense on the T2*w bright (f) and black blood (g) images, 3D TOF (i) and T1w CUBE 
(j). It furthermore led to hyperintensities on R2* maps (h) and CT (e). USPIO-contrast agent uptake 
rendered the signal in the post-contrast filtered phase images (m, n) inhomogeneous (red arrow). The 
plaques appeared hypointense on all the other contrast weightings and exhibited a high R2* value. 
For quantitative analysis of these results, regions of calcification, USPIO uptake, and 
normal plaque tissue were outlined on the SWI images and filtered phase images on 
all patients and the mean R2* values and T2*w rSI values were measured within those 
regions. For illustration purposes, Figure 4-4 shows the ROIs superimposed on a T2*w 
image.  
 
Figure 4-4: ROIs for normal plaque tissue (blue), USPIO-contrast agent (green) and calcification (red) 
as outlined on SWI superimposed on a T2*w image 
In order to confirm the presence of susceptibility-induced de-phasing, the 
corresponding boxplots are shown in Figure 4-5. Here it can be seen that on the post-
contrast images the normal tissues have increased R2* values / decreased T2* rSI in 
comparison to the pre-contrast analysis. This may be due to the increase in field 
inhomogeneities on the post-contrast images due to the presence of USPIO-contrast 
agents that are non-local and may increase the overall R2*. Both calcification and 
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USPIO uptake exhibited increased R2* / decreased T2* rSI values relative to normal 
tissue. 
 
Figure 4-5: SWI allows for the distinction between normal plaque regions and ROIs containing 
calcification and USPIO uptake. The R2* and T2* rSIs confirm that there is an increase in R2* in regions 
of calcification and USPIO uptake relative to normal tissue. The overall R2* on the post-contrast images 
is increased. (I presented aspects of these results at (292)) 
When comparing black-blood and bright-blood SWI methodologies and filtered phase 
images, several differences could be noted. Figure 4-1 & Figure 4-2 show lightly 
calcified plaques (i.e. plaque region did not contain large amounts of hypointensities 
on T2*w GRE pre-contrast images). Figure 4-1 & Figure 4-2 show T2*w GRE magnitude 





Figure 4-6: Black blood imaging and bright blood imaging at early echo times allow for a clear 
delineation of the lumen in lightly calcified plaques 
In order to illustrate the distinction between lumen and vessel wall/plaque, Figure 4-6 
& Figure 4-7 show the same imaging locations at an earlier echo time (TEbright = 4.4 
ms; TEblack = 5 ms) in order to achieve the highest amount of SNR. On Figure 4-6 the 
lumen and plaque region and vessel wall could be easily distinguished on the pre-
contrast T2*w magnitude images using either black-blood or bright-blood imaging 
(Figure 4-6 c), d). The CNR is relatively high in both cases (CNRbright = 16.9, CNRblack 
= 33.5). The same is true for Figure 4-7 but the CNR was lower (CNRbright = 5.3, 
CNRblack = 24.3). The distinction between lumen and plaque region is much more 





Figure 4-7: Black blood imaging and bright blood imaging at early echo times allow for a clear 
delineation of the lumen in lightly calcified plaques 
However, when the plaque region is hypointense, for example due to juxtaluminal 
calcification, the distinction is rather difficult on the black-blood images, as shown in 
Figure 4-3. Figure 4-8 shows the corresponding magnitude images at the shorter echo 
times. Without the presence of additional MRI sequences, such as 3D TOF MRA 
(Figure 4-8 e), it is impossible to distinguish between calcified plaques or vessel wall 
and the lumen on black blood T2*w GRE (Figure 4-8 d). On the bright-blood magnitude 
images (Figure 4-8 c), in contrast, the bright blood can be clearly distinguished from 
the more hypointense plaque region and the calcification. On the simultaneously 
acquired phase images of the bright-blood images, the lumen stands in strong contrast 
to the hyperintense calcification. Therefore, the CNR is much higher on the bright 
blood images ((CNRbright = 6.3, CNRblack = 0.2). On the black-blood images, the low-





Figure 4-8: Bright blood imaging improves a clear delineation of the lumen in heavily calcified plaques: 
Another example of juxtaluminal calcification is shown on Figure 4-9. On bright-blood 
gradient echo imaging and 3D TOF MRA, the calcified vessel wall region is clearly 
visible. However, it is difficult to distinguish hypointense calcification from the 
hypointense lumen on both black-blood FSE (DANTE CUBE), and black-blood 
gradient echo imaging. On the filtered phase image of the bright-blood gradient echo 
sequence, the hyperintense calcification is much easier to distinguish from the lumen 
than on the black-blood image, where there is a large amount of phase noise within 
the lumen due to insufficient SNR. The CNR between lumen and vessel wall is similar 
in both cases (CNRbright = 18.3, CNRblack = 19.3) but the CNR between lumen and 
calcification is much lower in the case when black blood imaging is applied 
(CNRbright=31.3, CNRblack=10.0). While CNR was recorded for all cases, it was a highly 
variable measure. In Figure 4-7, for example the lumen can be clearly delineated on 
the bright blood images, while on Figure 4-9, the calcification may be easily missed on 




Figure 4-9: Black blood imaging may lead to difficulties in identifying juxtaluminal calcification (yellow 
arrow) 
4.3.1 Histological Validation 
The histological results that were available came from the patients shown in Figure 
4-2 and Figure 4-3, which were lightly and heavily calcified plaques respectively. In 
the lightly calcified plaque, USPIO uptake as depicted on SWI and filtered phase 
images was confirmed by the multi-contrast protocol.  Figure 4-10 shows the 
histological result for the same plaque. Due to Perl’s Prussian Blue staining, the 
USPIO nanoparticles are stained blue and the calcification appears as pale regions 
on both Prussian Blue and Haematoxylin and Eosin staining due to decalcification. 
This confirms the depiction of USPIO uptake and calcification as seen on MRI. In the 
heavily calcified plaque shown in Figure 4-11, USPIO uptake could lead to a more 
inhomogeneous signal on the filtered phase image and ambiguous results on the 
corresponding SWI images. The corresponding histology slices show that there are 
widely dispersed iron particles in the overlying fibrotic tissue and the space between 
calcifications in keeping with USPIO uptake. Again, the iron particles are stained blue 
using a Perl’s Prussian blue stain and the calcification appeared as pale nodules 




Figure 4-10: The presence of calcification and USPIO-uptake identified on SWI and filtered phase 
images is confirmed by histology. Perl’s staining has coloured iron particles next to the lumen blue and 






Figure 4-11: USPIO uptake in a heavily calcified plaque rendered the phase more inhomogeneous on 
the post-contrast acquisition. This was confirmed in the histological analysis. The Perl’s staining showed 
iron particles interspersed with calcified nodules. The green box indicates the plaque location. 
4.4 Discussion 
This study evaluated SWI for the identification of plaque calcification and USPIO 
uptake. As discussed in previous studies, SWI can be used to identify plaque 
calcification and distinguish between lumen and vessel wall and plaque (296,297,302). 
Due to its diamagnetism, calcification is easily identifiable on the filtered phase images 
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and can enhance the contrast between calcification and the surrounding tissue 
selectively on the susceptibility weighted images. This is in accordance with previously 
presented results (171–174,296–300,302). 
In lightly calcified plaques SWI and filtered phase images allowed for a clear 
delineation of the regions of calcification and of USPIO uptake. This simplifies USPIO-
uptake detection in comparison to T2*w imaging or R2* mapping. These techniques 
require a comparison of pre- and post-contrast images or quadrant analysis in order 
to detect USPIO-uptake (126,137,138,141–143). When there is little or no overlap 
between the calcification and USPIO uptake regions, SWI renders the need for a pre-
contrast scan unnecessary. This is in accordance with studies where the different 
magnetic field inhomogeneities generated by paramagnetic and diamagnetic materials 
have been used to distinguish haemorrhage from calcification (171–174).  
Several positive contrast techniques have been proposed to make use of the changes 
in local field inhomogeneities to selectively enhance the signal from the local field 
inhomogeneities. GRASP (151) and IRON (148,293) use the shifts in phase or local 
precession frequency caused by the local field inhomogeneities to suppress signal 
from other regions selectively. By acquiring the phase data along with the magnitude 
data, there is no need to use dedicated sequences such as GRASP or IRON. Instead, 
SWI provides phase information which has a linear relationship with the field 
inhomogeneity. In addition, SWI not only provides information about the local field 
inhomogeneities but also provides detailed high resolution anatomical information 
from the magnitude images. Furthermore, quantitative information can be extracted 
from R2* mapping (which can be additionally generated from the same imaging 
sequence). SWI is therefore complementary to the conventionally used USPIO-
imaging protocol but provides valuable positive contrast. 
There has been research into using black-blood gradient echo imaging in order to 
improve the contrast between vessel wall and lumen (304). The work in this chapter 
has demonstrated the advantages of black-blood methods for evaluating lightly 
calcified plaques. However, for cases of juxtaluminal calcification, both plaque and 
lumen were hypointense so that the plaque border was difficult or impossible to 
distinguish from the lumen on the 𝑇2
∗w magnitude images. Therefore, it is proposed 
here that it is advantageous to use bright-blood gradient echo imaging. 
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In heavily calcified plaques, however, it was difficult to distinguish between calcification 
and USPIO-uptake on SWI and filtered phase images. The non-local effects of the 
local field inhomogeneities overlap, making it difficult to outline regions of USPIO-
uptake and distinguish them from calcification, especially when USPIO nanoparticles 
are interspersed with calcification. This makes the analysis difficult and while there is 
a qualitative change in the post-contrast phase images in comparison to the pre-
contrast images, it is difficult to identify regions of USPIO-uptake and calcification 
individually. The presented quantitative analysis is therefore limited in that for heavily 
calcified plaques the outlined USPIO-regions may accidentally include regions of 
calcification adjacent to the UPSIO-uptake regions and outlined calcification regions 
may include USPIO contrast agent. While it has been hypothesized that large regions 
of macrocalcification may counter macrophage activity (74,75), the frequency of co-
localized calcification and USPIO-uptake was high in this study. Furthermore, non-
local effects introduce errors in the estimation of areas of USPIO-uptake and 
calcification and are dependent on orientation and geometry of the underlying 
anatomy. It has been shown in cerebral applications that Quantitative Susceptibility 
Mapping may improve the distinction between diamagnetic and paramagnetic 
materials in comparison to SWI (171). Furthermore, QSM removes non-local effects 
and provides a quantitative estimate for the local susceptibility. The following chapters 
will therefore explore how quantitative susceptibility mapping can be performed in the 
neck and the additional benefits it offers when analysing carotid artery plaques with 
and without USPIO-contrast agent uptake.  
4.5 Conclusion 
This chapter shows that SWI can identify USPIO uptake and distinguish it from 
calcification. By displaying the differences in fields generated by paramagnetic and 
diamagnetic materials, SWI uses similar principles to positive contrast imaging 
methods but is a technique whose acquisition is identical to frequently used 𝑇2
∗w multi-
echo gradient echo imaging. This may allow for an improved analysis of USPIO-




Chapter 5 Joint Quantitative 
Susceptibility Mapping and Water-Fat 
Separation: Volunteer Study 
Aspects of this work are published in the article Ruetten PPR, et al. “Simultaneous 
MRI water‐fat separation and quantitative susceptibility mapping of carotid artery 
plaque pre‐ and post‐ultrasmall superparamagnetic iron oxide‐uptake”. Magn Reson 
Med. 2020;84(2):686–697. doi:10.1002/mrm.28151 (305). Other parts of this work 
have been presented at various conferences (Ruetten PPR, et al. “Quantitative 
Susceptibility Mapping of the Carotid Artery Wall using IDEAL”, Proc. 34th Ann. Sci. 
Meeting ESMRMB, 2017:20 (306); Ruetten PPR, et al. “Quantitative Susceptibility 
Mapping of the Carotid Artery Walls”, Proc. MRC Symposium, 2017 (307); Ruetten 
PPR, et al. “Phase Corrected Bipolar Acquisition for Simultaneous Water-Fat 
Separation and Quantitative Susceptibility Mapping of the Carotid Artery Wall”, Proc. 
26th Ann. Meeting of ISMRM. ; 2018:2194 (308); Ruetten PPR, et al. “Simultaneous 
Water-Fat Separation and Quantitative Susceptibility Mapping of the Carotid Artery 
Wall: Sequence and Processing Considerations”, Proc. 30th Ann. Int. Conf. SMRA, 
2018:A52 (309)) 
5.1 Introduction 
Quantitative Susceptibility Mapping (QSM) was introduced in the previous chapters 2 
and 3 as an MRI technique that can visualize and quantify the underlying susceptibility 
distributions which generate contrast in 𝑇2
∗w images and Susceptibility Weighted 
Imaging (SWI). QSM has been proposed for carotid plaque imaging (292,310–313) 
due to its ability to depict and distinguish between calcifications and haemorrhage 
(171) and also to quantify iron concentrations (248), which may play a role in the 
imaging of iron oxide based contrast agents in carotid plaques for imaging 
inflammation. Furthermore, QSM has often been cited to improve on existing 
techniques that generate contrast based on magnetic susceptibility differences (171): 
Both 𝑇2
∗w imaging and SWI generate contrast based on the distribution of magnetic 
field inhomogeneities. These are generated by the underlying susceptibility 
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distribution, but their signal variations are non-local, orientation- and geometry-
dependent. Furthermore, SWI is non-quantitative and the quantification of 𝑅2
∗ values 
suffers from background field artifacts, which are typically not corrected in imaging of 
carotid plaques (137,144). QSM, on the other hand, directly quantifies the underlying 
susceptibility distribution. It has been shown to improve the distinction between 
paramagnetic and diamagnetic materials in comparison with gradient echo phase 
images used in SWI (171) and its quantitative nature has been used to measure 
ultrasmall superparamagnetic iron oxide (USPIO) contrast agent concentration (295). 
QSM processes the complex data from a conventional multi-echo gradient echo 
sequence, which is typically used in 𝑅2
∗-mapping and is therefore complementary to 
conventional imaging protocols. QSM uses the phase data which are often discarded 
and estimates the distribution of underlying susceptibility via a series of post-
processing steps.  
After estimation of field inhomogeneities, the background field is removed, and then 
the dipole field inversion is performed. To estimate a map of the field inhomogeneities, 
in the brain where QSM has most widely been applied, it can be assumed that the 
phase varies linearly with time. However, in the neck this assumption does not hold. 
In the neck fat is present, which differs in precession frequency from water. This type 
of chemical shift artifact is problematic when estimating Δ𝐵 with the same methodology 
as is done in the brain. Previous studies performing QSM in the neck and of the carotid 
arteries have neglected this type of artifact (310,312) or used single echo phase data 
at an in-phase echo time (313). It has been acknowledged that this poses a limitation, 
since the artifact caused by the shift in precession frequency may propagate onto the 
susceptibility maps. Water-fat separation is a field in which complex multi-echo 
gradient echo data are processed to identify the fat-fraction within each voxel and 
correct the Δ𝐵 estimate accordingly. Water-fat separation has been widely explored in 
research but is also used clinically for fat suppression or quantitative fat fraction 
mapping in liver imaging. In this research a Dixon-based water fat separation 
technique, Iterative Decomposition of water and fat with Echo Asymmetric and Least-
squares estimation (IDEAL), was used to quantify the fat fraction within each voxel 
and correct for the associated error on the resulting map of field inhomogeneities 
(261,262). IDEAL water fat separation has been used to correct chemical shift related 
artifacts during Δ𝐵 estimation in order to perform QSM in other parts of the body than 
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the brain such as the liver (247,248,263–265), breast (241), spine (266), or ankle 
region (267). 
Furthermore, it is always important to exclude voxels of insufficient SNR with a tissue 
mask in QSM. In particular regions of bone and air do not produce sufficient signal, so 
that the phase values in those regions may take on any value in between −𝜋 and 𝜋. 
In brain imaging a multi-channel head coil with relatively uniform coil sensitivity is 
typically used. Furthermore, the brain does not have any air or bone inclusions. A 
tissue mask for the brain can therefore typically be selected by threshold-based 
approaches or the brain extraction tool (272). In carotid imaging in our group, however, 
a dedicated four channel surface coil has been shown to produce the highest SNR. 
This type of coil however has an inhomogeneous coil sensitivity and therefore the 
masking process as used in the brain is unsuitable. 
In the following chapter, susceptibility maps of the neck and the carotid artery wall 
were generated by using QSM in conjunction with water fat separation and taking into 
account the anatomy of the neck. The methodology was tested in a computational 
simulation, a phantom experiment, and a volunteer study.  
5.1.1 Theory 
In the initial Δ𝐵 estimation during QSM, typically, no chemical shift effects are 
considered and the complex gradient echo signal is modelled as 𝑆(𝑡) ∝ 𝑒−𝑖∙𝛾∙𝛥𝐵∙𝑇𝐸. 
Therefore, the phase variation over time is linear (𝜑 = −𝛾 ∙ 𝛥𝐵 ∙ 𝑇𝐸) and its slope 𝛾 ∙
𝛥𝐵 is proportional to Δ𝐵, as the gyromagnetic ratio 𝛾 is a known constant. Typically a 
least squares algorithm which weights the data points according to their individual 
SNR can be used to estimate Δ𝐵 as implemented in the MEDI toolbox (258–260).  
The presence of fat alters this behaviour. In this work, it is assumed that the precession 
frequency of fat varies by 3.4 ppm from that of water, which corresponds to Δ𝑓𝑐ℎ𝑒𝑚 =  
-220 Hz at 1.5T and -440 Hz at 3.0 T. Therefore, the signal model needs to be adjusted 
to take into account the presence of fat: 
𝑆 =  (𝑊 + 𝐹 ∙ 𝑒−𝑖∙2𝜋∙𝛥𝑓𝑐ℎ𝑒𝑚∙𝑇𝐸)𝑒−𝑖∙𝛾∙𝛥𝐵∙𝑇𝐸 5-1 
This explains the errors caused when using a conventional Δ𝐵 estimation method. For 
example, in a voxel containing 100% fat, the estimated Δ𝐵 value would be offset by 
220 Hz from the actual value.  
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Iterative decomposition of water and fat with echo asymmetry and least-squares 
estimation (IDEAL) is a water-fat separation method, which uses the complex signal 
from a multi-echo gradient echo sequence in order to fit the signal model to this data 
by determining Δ𝐵, the water image W, and the fat image F.  
In this implementation the T2* IDEAL algorithm was used (241,261,262), which 
includes R2* estimation. Furthermore, the complex conjugate of the acquired signal 
(S*) was taken for estimation of water and fat fraction and Δ𝐵, so that the signal model 
could be written as: 
𝑆𝑖
∗ = (𝑊 + 𝐹 exp(2𝜋𝑖𝛥𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖)) exp(2𝜋𝑖𝜓𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒𝑇𝐸𝑖) 5-2 
Here 𝜓 is defined as 𝜓 = 𝛾 ∙ Δ𝐵 + 𝑖𝑅2
∗
2𝜋
. From an initial estimate of Δ𝐵, R2* and the 
recorded signal Si at each echo time TEi, the water and fat image W and F can be 
estimated in step 1: In order to do this, Si* is divided by exp(2𝜋𝑖𝜓𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒𝑇𝐸𝑖), which 




= 𝑊 + 𝐹 exp(2𝜋𝑖𝛥𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖) 5-3 






?̂? = 𝐁𝛒 5-4 
With 𝐬 = [ŝ1 ŝ2 ŝ3 … ŝ𝑁]
𝑇; 𝐁 = [
1    exp(2𝜋𝑖Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸1)
1    exp(2𝜋𝑖Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸2)
…
1    exp(2𝜋𝑖Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑁
]; 𝛒 = [
𝑤
𝑓 ]  
W and F can now be calculated via least squares inversion. This concludes step 1. In 
step 2, a new system of equations is set up to iteratively update 𝜓, where W, F, and 
𝜓 are rewritten as 𝑊 = 𝑊𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝑊, 𝐹 =  𝐹𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝐹, and 𝜓 = 𝜓𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝜓: 
𝑆𝑖
∗ = (𝑊𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝑊 + (𝐹𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝐹) exp(2𝜋𝑖𝛥𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖)) 
exp(2𝜋𝑖(𝜓𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝜓)𝑇𝐸𝑖) 
5-5 
So that:  
𝑠?̂? = (𝑊𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝑊 + (𝐹𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝐹) exp(2𝜋𝑖𝛥𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖)) exp(𝑖2𝜋Δ𝜓𝑇𝐸𝑖)  5-6 
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Via Taylor expansion, exp(𝑖2𝜋Δ𝜓𝑇𝐸), can be rewritten as 1 + 𝑖2𝜋Δψ𝑇𝐸 this can be 
written as: 
𝑠?̂? = (𝑊𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝑊 + (𝐹𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + Δ𝐹) exp(2𝜋𝑖𝛥𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖))(1 + 𝑖2𝜋Δψ𝑇𝐸𝑖) 5-7 
Subsequently it is assumed that the terms 𝑖2𝜋𝑇𝐸𝑖Δ𝜓Δ𝑊 and 
𝑖2𝜋𝑇𝐸𝑖Δ𝜓Δ𝐹𝑒𝑥𝑝(𝑖2𝜋Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖) can be ignored. The formula is then simplified to: 
𝑠?̂? = (𝑊𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + 𝐹𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 exp(2𝜋𝑖𝛥𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖)) + 
Δ𝑊 + Δ𝐹𝑒𝑥𝑝(𝑖2𝜋Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖) + 
(𝑊𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + 𝐹𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 exp(2𝜋𝑖𝛥𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖))𝑖2𝜋Δψ𝑇𝐸𝑖) 
5-8 
This can be rearranged as:  
𝑆?̂?
̂ = 𝑆?̂? − (𝑊𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + 𝐹𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 exp(𝑖2𝜋𝛥𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖)) = 
Δ𝑊 + Δ𝐹𝑒𝑥𝑝(𝑖2𝜋Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖) + 
(𝑊𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 + 𝐹𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 exp(𝑖2𝜋𝛥𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑖))𝑗2𝜋Δψ𝑇𝐸𝑖) 
5-9 
 
In order to include the information from all TE, this is rewritten in matrix form as:  










(𝑊 + 𝐹 + exp(2𝜋𝑖Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸1))𝑖2𝜋𝑇𝐸1    1    exp (2𝜋𝑖Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸1)
(𝑊 + 𝐹 + exp(2𝜋𝑖Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸2))𝑖2𝜋𝑇𝐸2    1    exp (2𝜋𝑖Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸2)
…
(𝑊 + 𝐹 + exp(2𝜋𝑖Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑁))𝑖2𝜋𝑇𝐸𝑁    1    exp (2𝜋𝑖Δ𝑓𝑐ℎ𝑒𝑚𝑇𝐸𝑁)
] 5-12 
Δ𝜓, Δ𝑊, and Δ𝐹 can be estimated via least squares inversion and 𝜓 is updated to 𝜓 +
Δ𝜓. This concludes step 2. Subsequently, a new iteration of the algorithm starts and 
continues with step 1. W and F are again estimated based on the updated value of 
Δ𝜓. Subsequently, each step is repeated and W, F, and Δ𝜓 are updated iteratively. 
This was repeated for 20 iterations. For the initial estimate of R2*, zero was chosen. 
Based on an initial estimate of Δ𝐵, the T2* IDEAL algorithm iteratively determines the 
water and fat image and then updates the Δ𝜓 and Δ𝐵 estimate accordingly. The 
robustness of the T2* IDEAL algorithm depends on the accuracy of the initial estimate 
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of Δ𝐵 and the SNR and echo spacing of the acquired data. In this research, the 
background field serves as an initial estimate of Δ𝐵 for the water-fat separation. In 
chapter 3, it was shown that the background field in the brain is of a very high 
magnitude in comparison to the internal fields. The background field in the neck is 
even larger due to the presence of large susceptibility differences around air in the 
throat and bone in the vertebral column. It can be therefore assumed that it is the 
dominant field component in the neck. Furthermore, the fields are of the largest 
magnitude at the tissue interfaces, so that they have a stronger effect in the neck, 
which has typically a smaller diameter than the brain. 
5.2 Methods 
QSM in combination with T2* IDEAL water-fat separation was performed in numerical 
simulations and phantom experiments. To ensure consistency in the experimental 
setup the numerical simulations were modelled after the phantom scan. The 
experimental setup consisted of a water tank into which a table tennis ball was 
suspended, which contained vegetable oil. Figure 5-1 a shows a magnitude image of 
the experimental set-up. The phantom was then scanned on a 1.5T GE system 
(MR450w, GE Healthcare, Waukesha, WI) using a multi-echo gradient echo sequence 
(Table 5-1). 
 
Figure 5-1: Magnitude image of the Experimental Setup (a) and ground truth susceptibility distribution 
for the numerical simulation (b) 
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For the numerical simulations a synthetic susceptibility distribution was designed as 
follows: The background was assigned a susceptibility of 9.41 ppm, which was 
supposed to simulate air relative to water. The susceptibility of water (0 ppm) was 
assigned to a cuboid shape to simulate the water tank. Within the cuboid a sphere of 
0.61 ppm susceptibility was placed, which is a literature value found for the 
susceptibility of vegetable oil relative to water in order to simulate the oil phantom 
(314). The synthetic susceptibility map is shown in Figure 5-1 b. A forward calculation 
was performed that calculated Δ𝐵 at each voxel on the basis of the susceptibility map 
as described in chapter 3. For the calculation of the dipole kernel, the MEDI toolbox 
was used. Subsequently a chemical shift of -220 Hz was added onto the voxels within 
the fat phantom. Subsequently the expected phase values were calculated at each 
echo time. 
After ethical approval and informed consent, ten healthy volunteers (3 women and 7 
men aged 30.7±10.7 years, range 23-55 years) were scanned on a 1.5T MR system 
(MR450w, GE Healthcare, Waukesha, WI) using a similar 3D multi-echo gradient echo 
sequence to the phantom scans with different parameters due to changes in the field 
of view. The voxel size was chosen to be consistent with the resolution used for T2*w 
imaging and SWI in chapter 4. Dr Jianmin Yuan provided the multi-echo gradient echo 
sequence, where minor changes to the GE product sequence were made such as a 
modifiable number of echoes. 
Table 5-1: Sequence Parameters *the slice thickness is interpolated from the acquired 2 mm to 1 mm 
using zero-filling 
In the volunteer scans, the raw MRI data were acquired and reconstructed using 
parallel imaging (ASSET, similar to the SENSE technique (257)) using customised 
Matlab code written within GE’s orchestra framework, to produce both magnitude and 
phase images for each echo. For the phantom scan, ASSET coil combination was not 
 Phantom experiments Volunteer Scans 
TE1/Δ𝑇𝐸/TR [ms] 1.72/1.58/50.3 4.4/4.1/88.2 (unipolar) 
Number of echoes 16 6 
Spatial Resolution [mm3] 2.2 × 2.0 × 2.0 0.625 × 0.625 × 1.0* 
Field of View [mm3] 220 × 220 × 160 140 × 140 × 60 
Bandwidth [kHz] ±83.3 ±83.3 
Acquisition Time [m:s] 5:10 7:38 
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required since a single channel coil was used and the magnitude and phase images 
were reconstructed using a similar custom code written within the orchestra 
framework.  
The reconstructed images from all scans were processed as follows. From the 
complex multi-echo datasets, Δ𝐵𝑢𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 was estimated without taking into account 
the errors caused by the chemical shift of fat (258–260). All images were inspected, 
and in some volunteer scans additional spatial phase unwrapping of the scaled Δ𝐵 
was required and a graph-cut-based approach was used (263). The algorithm was 
chosen due to its robust performance in removing phase wraps and the code used 
was taken from the MEDI toolbox.  
Subsequently a Mask was generated based on the magnitude images. This was 
straightforward in the phantom experiments and numerical simulations. In the 
numerical simulations, the area of the water tank was known. In the phantom 
experiments, the Mask could be extracted by applying a threshold to the magnitude 
images and extracting the cuboid shape of the water tank. Subsequently, I checked 
every slice to make sure that all voxels of insufficient signal intensity were excluded 
manually from the analysis. The Mask was adjusted accordingly. In the volunteer 
scans, I drew the Mask manually using the magnitude images of the first echo, which 
gave the maximal SNR, and using the uncorrected field maps for additional validation. 
A threshold-based approach was not feasible due to the large signal inhomogeneity 
of the surface coil. Care was taken when drawing the Mask in order to maximize the 
masked region while excluding voxels of insufficient SNR, which may cause artifacts 
during the subsequent processing steps. Furthermore, it was important to draw the 
mask in a way that minimized the presence of susceptibility variations within its 
boundary region since this may cause artifacts during the background field removal 
process. Therefore, the boundary was drawn through regions of relatively uniform 
susceptibility, i.e. muscle tissue, and the number of susceptibility variations inside the 
boundary region, i.e. caused by regions of fat was minimized. Furthermore, the 
boundary of the region of interest was placed as far away from the carotid artery wall 
as possible in order to minimize the errors caused by the background field removal, 
which primarily arise near the boundary of the masked region. 
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Subsequently the background field within the Masked region was estimated using the 
Laplacian Boundary Value algorithm (176), which I chose due to its robust 
performance in removing any background fields as demonstrated in previous 
publications (273), chapter 3, and the cases presented here. This served as an input 
to the T2* IDEAL algorithm, which estimated the field map corrected for the chemical 
shift Δ𝐵𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 (241,261). Due to the large number of echoes, the T2
* IDEAL algorithm 
was performed twice in the phantom experiments. Initially Δ𝐵 was estimated using 4 
echoes only, to maximize the bandwidth for unambiguous water-fat separation. This 
estimate of Δ𝐵 contained fewer artifacts in comparison to the estimate using all 16 
echoes in the region where there were large field inhomogeneities for example due to 
air. Subsequently, the T2* IDEAL algorithm was repeated using all 16 echo times, with 
the Δ𝐵 estimate as an initial estimate for T2* IDEAL. This served to maximize SNR. 
For consistency, the same approach was used in the numerical simulations. A similar 
problem was not encountered in the volunteer scans, which is why all six echoes could 
be used for T2* IDEAL estimation from the beginning.  
In chapter 3, it was shown that errors may occur primarily at the boundary during 
background field removal. This did not affect the performance of the numerical 
simulations or the phantom experiments. However, in the volunteer scans, in regions, 
where muscle tissue and fat intersected the boundary, errors occurred, which lead to 
localized water fat swaps at the edge of the masked region. These could simply be 
excluded by manually adjusting the tissue mask after water fat separation.  
Subsequently, the background field was removed from the corrected field map using 
the Laplacian Boundary Value algorithm (176). Finally, dipole field inversion was 
performed using the Morphology Enabled Dipole Inversion (MEDI) algorithm 
(260,281,286,287). A regularization parameter of 𝜆 = 1000 was chosen in the 
volunteer cohort, since this provided a good trade-off between streaking minimization 
and only a limited amount of over-smoothing. In the phantom scans and numerical 
simulations, a stronger regularization was applied (𝜆 = 10) as there were only water, 
air and fat present in the scanned region. 
For comparison and analysis, the algorithm was performed without T2* IDEAL 
correction in the phantom experiments, the simulations, and a single volunteer case. 
Here, the background field from the uncorrected Δ𝐵 (258–260) was simply removed 
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using the Laplacian Boundary Algorithm and the susceptibility map was estimated 
using MEDI. 
The acquired images in the phantom experiments suffered from several artifacts, in 
particular variations in signal intensity which were assumed to be due to flow induced 
by gradient vibrations. Furthermore, it was impossible to remove all air bubbles from 
the water tank and there was a small air inclusion at the top of the table tennis ball, 
which were difficult to process and caused artifacts. This may lead to incomplete 
removal of streaking artifacts using MEDI, which relies on the magnitude images for 
estimation of susceptibility maps. Since it was known that there would be only three 
materials present (air, water, fat), the fat fraction map, which simplified the 
segmentation of the fat phantom, in combination with the magnitude images were used 
in order to create an artificial magnitude image for the MEDI calculation. The MEDI 
algorithm was repeated using this magnitude image to improve streaking artifact 
correction. As explained in chapter 3, MEDI removes all streaking artifacts that 
correspond to edges not present on the magnitude image. Therefore, if the magnitude 
images only depict the table tennis ball and the air inclusion in water, most of the 
residual streaking artifact should be removed.  
For each experiment, the outputs of the T2* IDEAL algorithm, fat fraction, and 
Δ𝐵𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑, were compared to the magnitude images and Δ𝐵𝑢𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑. The 
susceptibility maps generated with Δ𝐵𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 and Δ𝐵𝑢𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 were compared. 
While the majority of susceptibility differences within the neck were small and the 
vessel wall is very thin in volunteers, the region of fat close to the carotid arteries was 
used in order to evaluate the quality of the susceptibility maps. Regions of fat and 
muscle tissue were outlined to measure the mean susceptibility values within each. 
These values were compared to values found in literature and the susceptibility noise 
level was measured in a way similar to (286). The noise estimate was defined as the 
standard deviation of the susceptibility within a water/muscle tissue region of interest. 
Data processing and analysis were performed using MATLAB (R2017b, MathWorks, 
Natick, Mass). The code for the uncorrected Δ𝐵-estimation, phase unwrapping, 




In numerical simulations and the phantom experiments, T2* IDEAL correctly identified 
regions containing fat. Figure 5-2 shows magnitude images (a-c) and fat fraction 
images (d-f) for the simulation (a, d), phantom experiment (b, e), and a volunteer scan 
(c, f). The regions containing fat exhibited a greater fat-fraction than the other areas. 
Within the sphere that was simulated to contain fat, the table-tennis ball fat phantom, 
and the fat in the volunteers, a high fat fraction was measured (FFsim = 99.38±0.32%, 
FFexperiment = 94.61±1.5%, FFvolunteers = 77.3%±6.75 (the latter values were the median 
and interquartile range calculated over all volunteers)).  
 
Figure 5-2: Magnitude images (a-c) and fat fraction maps (d-f) for the numerical simulation (a, d), 
phantom experiment (b, e), and volunteer scan (c, f) 
Figure 5-3 compares the field maps 𝛥𝐵𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 to 𝛥𝐵𝑢𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑, estimated with and 
without T2* IDEAL correction respectively. It can be seen that the frequency value 
determined by scaling 𝛥𝐵𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 estimated with T2
* IDEAL was changed as expected 
(the difference between Δ𝐵𝑢𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 − Δ𝐵𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 scaled to be given in Hz: Δ𝑓𝑠𝑖𝑚=-
220.00±0.00 Hz, Δ𝑓𝑝ℎ𝑎𝑛𝑡𝑜𝑚=-221.61±0.12 Hz, Δ𝑓𝑣𝑜𝑙𝑠=-217.84±1.97 Hz (the latter 




Figure 5-3: Uncorrected (a-c) and T2* IDEAL-corrected (d-f) field inhomogeneity maps (scaled to be 
given in radians) in the numerical simulation (a, d), phantom experiment (b,e), and volunteer scan (c, f) 
Figure 5-4 shows the magnitude images (a-c), as well as the susceptibility maps 
generated with (d-f) and without T2* IDEAL correction (g-i). The first column shows the 
results from the numerical simulation, the second column shows the results from the 
phantom experiment, and the third column shows the results from the phantom 
experiment with a modified magnitude image. On the susceptibility maps calculated 
with T2* IDEAL correction, the difference in mean susceptibility between fat and water 
and the standard deviation inside the fat phantom were measured to be 0.61±0.00 
ppm in the simulations (Figure 5-4 d) which is in agreement with the ground truth value. 
For the phantom experiments the mean difference and standard deviation were 
0.53±0.03 ppm (Figure 5-4 e), a relatively small deviation from the literature value of 
0.61 ppm. The results were improved when the synthetic magnitude image was used 
as an input for the MEDI calculation, with a measured susceptibility difference of 
0.56±0.02 ppm Figure 5-4 f. The improved quality of this susceptibility map was 
expected since flow related artifacts were removed on the synthetic magnitude 
images. The flow artifacts introduced edges on the original magnitude images, that 
were in reality not present within the water so that the removal of streaking artifacts by 
the MEDI algorithm was incomplete. The noise level as calculated by the standard 
deviation within water was relatively small, for the simulation 𝜎𝑠𝑖𝑚 = 0.0012 𝑝𝑝𝑚, the 
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phantom experiments 𝜎𝑝ℎ𝑎𝑛𝑡𝑜𝑚 = 0.05 𝑝𝑝𝑚, and the phantom experiments with the 
synthetic magnitude images 𝜎𝑝ℎ𝑎𝑛𝑡𝑜𝑚_𝑠𝑦𝑛𝑡ℎ = 0.05 𝑝𝑝𝑚. Without T2
* IDEAL correction 
applied (Figure 5-4 g-i), the susceptibility differences differed greatly in both numerical 
simulations and phantom experiments from the expected values (Numerical 
Simulations: 𝜒𝑓𝑎𝑡=-3.91±0.75 ppm; Phantom Experiments: 𝜒𝑓𝑎𝑡=-3.88±1.49 ppm, 
Phantom experiments with modified magnitude image 𝜒𝑓𝑎𝑡=-3.76±0.63). In addition, 
this large deviation from the ground truth worsened the image quality due to strong 
streaking artifacts. This means that, the noise level within water which was calculated 
as the standard deviation, is much larger (𝜎𝑠𝑖𝑚 = 0.83 𝑝𝑝𝑚; 𝜎𝑝ℎ𝑎𝑛𝑡𝑜𝑚 = 0.96 𝑝𝑝𝑚; 
𝜎𝑝ℎ𝑎𝑛𝑡𝑜𝑚_𝑠𝑦𝑛𝑡ℎ = 0.97 𝑝𝑝𝑚). 
 
Figure 5-4: Magnitude images (a-c), susceptibility maps generated with the T2* IDEAL-corrected field 
inhomogeneity maps (d-f) and susceptibility maps generated with uncorrected field inhomogeneity 
maps (g-i) for the numerical simulation (a, d, g), phantom experiment (b, e, h), and the phantom 
experiments with a corrected magnitude image. 
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In the volunteer study, high quality susceptibility maps could be produced after T2* 
IDEAL correction (Figure 5-5). The median of the mean measured susceptibility values 
within regions of fat relative to muscle tissue, 0.64±0.13 ppm, in the volunteer scans 
corresponded to literature values (0.61-0.64 ppm). The vessel wall was identified as 
slightly more diamagnetic than blood and muscle tissue. While noisier than the 
magnitude images (𝜎𝑣𝑜𝑙𝑢𝑛𝑡𝑒𝑒𝑟𝑠 = 0.09 ± 0.04 𝑝𝑝𝑚), the vessel wall and lumen could be 
identified. Without T2* IDEAL correction, in the volunteer scans, a similar effect could 
be observed to the simulations and phantom experiments. Without T2* IDEAL 
correction, the mean susceptibility value inside the fat relative to muscle tissue 
(1.9±0.67ppm) differed greatly from the expected literature values (0.61-0.64 ppm) 
and the susceptibility map suffered from streaking artifacts that obscured the entire 
region of interest (𝜎𝑠𝑖𝑚 = 0.15 𝑝𝑝𝑚). This made it very difficult to interpret. The 
susceptibility maps of the remaining volunteers are given in Appendix A. 
 
Figure 5-5: This figure displays the magnitude image (a) for anatomical reference and the susceptibility 
map calculated where 𝛥𝐵 was T2* IDEAL corrected (b,c). The entire slice is shown in b), while c) shows 
the area surrounding the carotid artery only for magnification purposes. The susceptibility map 
calculated from 𝛥𝐵, where no correction was applied is shown in (d). 
5.4 Discussion 
This work shows the ability of the T2* IDEAL algorithm to correctly and independently 
identify regions containing a large fat fraction and correct the Δ𝐵 estimate accordingly. 
This results in high quality susceptibility maps which were able to quantify the 
susceptibility of fat in the neck and identify the diamagnetic vessel wall. Without T2* 
IDEAL correction, the fat introduced offset errors into the Δ𝐵 maps, which propagated 
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onto the susceptibility maps. This not only led to erroneous susceptibility estimates for 
fatty tissue but also severe streaking artifacts.  
Due to the convolution operation that describes the relationship between the magnetic 
field and the susceptibility map, localized errors on Δ𝐵 lead to nonlocal errors on the 
susceptibility map—voxels where Δ𝐵 has been wrongly estimated, for example due to 
chemical shift artifacts or insufficient SNR, lead to nonlocal errors, for example 
streaking artifacts, on the resulting susceptibility map (284,285).  
The reduction of streaking artifacts is important to correctly analyse the underlying 
anatomy. Without application of T2* IDEAL a severe decrease in image quality could 
be observed. Streaking artifacts obscured the entire image and the carotid arteries 
and render either a qualitative or a quantitative analysis impossible.  
It is acknowledged here that the chemical shift of fat in the neck may not be exactly 
220 Hz and the susceptibility may not exactly be 0.61 ppm. The resulting inaccuracies 
in Δ𝐵 estimation may subsequently propagate onto the susceptibility maps. Despite 
this, the combination of T2* IDEAL and QSM produced high quality susceptibility maps 
with these assumptions that were able to correctly estimate susceptibility in selected 
regions of interest and depict the anatomy of the neck. In order to further increase the 
accuracy, a more accurate estimation of the fat-spectrum within the fat could be 
achieved using MR spectroscopic imaging. However, when assessing carotid artery 
plaques, the exact susceptibility value of fat outside the carotid artery plaque is 
irrelevant and the streaking artifacts in the proposed methodology were not obscuring 
the carotid artery. An improved modelling of the fat spectrum therefore may or may 
not improve the image quality. Another effect of the frequency shift of lipids is chemical 
shift induced misregistration. During frequency encoding, the spatial information from 
which the image is reconstructed relies on the spatial variation of frequency. The 
chemical shift makes the signal from fat appear to be generated at a different location 
in the frequency encode direction. This results in band artifacts at water/fat interfaces 
(121). It was assumed that the chemical shift-induced misregistration was negligible, 
which was justified by the large bandwidth and low field strength.  
Other methods attempting to perform QSM in the neck and of carotid arteries and 
carotid artery plaques have ignored chemical shift artifacts (310,312) or acquired the 
signal in-phase (313). It has even been acknowledged that neglecting these effects 
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leads to artifacts on the susceptibility maps (310). An alternative to minimize the 
chemical shift related artifacts would be to choose in-phase echoes only. This however 
limits the choice of echo times and therefore increases the echo spacing, which in turn 
decreases the SNR at later echoes. By using QSM in conjunction with T2* IDEAL 
instead, it was possible to acquire echoes at arbitrary echo times. i.e. with a shorter 
echo spacing than would be required for in-phase imaging, with a conventional multi-
echo gradient echo imaging sequence. This may be advantageous in patient scans at 
1.5T imaging, particularly if the SNR and image quality is poor due to patient anatomy 
or patient movement. 
5.5 Conclusion 
The feasibility of acquiring susceptibility maps of the necks and carotid arteries of a 
volunteer cohort using a combination of QSM and T2* IDEAL water fat separation has 
been demonstrated. In the next chapter this will be applied in a cohort of patients 
diagnosed with carotid artery disease. Carotid artery plaques frequently contain 
sources of high susceptibility differences relative to healthy muscle tissue – 
intraplaque haemorrhage and calcification – and plaques also contain a lipid core 
which may be identified using water-fat separation. Furthermore, QSM may offer a 
method of quantification and positive contrast in imaging paramagnetic contrast 
agents such as Ultrasmall Superparamagnetic Iron Oxide (USPIO) nanoparticles. 
Since the image quality is typically poorer in patients compared to volunteer studies, 
a further reduction in echo spacing will be achieved using bipolar readout gradients. A 
reduction in echo spacing leads to shorter echo times, which are of a higher SNR, and 




Chapter 6 Simultaneous MRI Water-Fat 
Separation and Quantitative 
Susceptibility Mapping of Carotid 
Artery Plaque Pre- and Post-USPIO 
Aspects of this work are published in the article Ruetten PPR, et al. “Simultaneous 
MRI water‐fat separation and quantitative susceptibility mapping of carotid artery 
plaque pre‐ and post‐ultrasmall superparamagnetic iron oxide‐uptake.”, Magn Reson 
Med. 2020;84(2):686–697. doi: 10.1002/mrm.28151 (305). Other parts of this work 
have been presented at various conferences (Ruetten PPR, et al. “Quantitative 
Susceptibility Mapping of the Carotid Artery Wall using IDEAL”, Proc. 34th Ann. Sci. 
Meeting ESMRMB, 2017:20 (306); Ruetten PPR, et al. “Quantitative Susceptibility 
Mapping of the Carotid Artery Walls”, Proc. MRC Symposium, 2017 (307); Ruetten 
PPR, et al. “Phase Corrected Bipolar Acquisition for Simultaneous Water-Fat 
Separation and Quantitative Susceptibility Mapping of the Carotid Artery Wall”, Proc. 
26th Ann. Meeting of ISMRM. ; 2018:2194 (308); Ruetten PPR, et al. “Simultaneous 
Water-Fat Separation and Quantitative Susceptibility Mapping of the Carotid Artery 
Wall: Sequence and Processing Considerations”, Proc. 30th Ann. Int. Conf. SMRA, 
2018:A52 (309); Ruetten PPR, et al. “Calcification and USPIO detection in Carotid 
Artery Plaque using QSM and SWI”, Proc. 27th Ann. Meeting of ISMRM 2019:2090 
(292); Ruetten PPR, et al. “Plaque feature analysis using a joint method of QSM and 
water-fat separation”, Proc. 27th Ann. Meeting of ISMRM 2019:2091 (311); Ruetten 
PPR, et al. “Identification of USPIO-uptake in calcified Atherosclerotic Plaques”, Proc. 
36th Ann. Sci. Meeting ESMRMB 2019:20 (315)) 
 
6.1 Introduction 
As demonstrated in chapter 4, susceptibility effects play an important role in imaging 
carotid artery plaques. It has been demonstrated in particular that Susceptibility 
Weighted Imaging (SWI) may be used to identify large changes in tissue susceptibility 
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caused by plaque calcification and that SWI may be used in the detection of Ultrasmall 
Superparamagnetic Iron Oxide (USPIO) contrast agent uptake by macrophages in 
carotid plaques.  
As previously described, USPIO nanoparticles are injected intravenously and can 
enter plaques from the lumen through a leaky endothelium, where they are taken up 
by macrophages, thus serving as a marker for plaque inflammation (126,137,138). In 
the past, USPIO-uptake has been detected by comparing two MRI scans, acquired 
before and after administration of the contrast agent. In regions containing the contrast 
agent, the signal intensity will decrease on T2*w gradient echo imaging and increase 
on R2*-maps (137,138,141–143). However, a pixel-wise comparison of images 
acquired before and after contrast agent administration requires complex co-
registration so that the plaque is often divided into segments, which can be compared 
more easily (137,138,141,142). As an alternative, the use of positive contrast 
techniques to image USPIO uptake has been proposed to render pre-contrast scans 
obsolete and simplify USPIO-detection even in calcified plaques (144,148,151,152).  
Many positive contrast techniques such as IRON (148) or GRASP (151) use the fact 
that USPIO-uptake leads to a severe increase in tissue susceptibility, thus creating 
field inhomogeneities. While the positive contrast techniques rely on dedicated 
sequences in order to image only the signal originating from regions containing certain 
field inhomogeneities, it was shown in chapter 4 that conventional (multi-echo) 
gradient echo phase images are linearly related to these field inhomogeneities. SWI 
and filtered phase images were used to distinguish between the fields from 
diamagnetic and paramagnetic materials, which are quite different. This allowed for a 
clear distinction between paramagnetic and diamagnetic materials in lightly calcified 
plaques. However, in chapter 3, it was shown that the fields are highly orientation and 
geometry dependent. By depicting the underlying susceptibility distribution instead, 
Quantitative Susceptibility Mapping (QSM) offers a more direct way to visualize the 
contrast agent uptake and distinguish it from calcification: The susceptibility 
distribution does not suffer from non-local effects, and also is not orientation 
dependent. These improvements that QSM offers over SWI have been discussed in 
previous studies in the brain, where QSM has improved the distinction between 
paramagnetic haemorrhage and diamagnetic calcification in comparison with 
SWI/filtered phase images (171).  
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Chapter 5 demonstrated the feasibility of imaging the carotid artery wall in a group of 
healthy volunteers using QSM in combination with water fat separation. The potential 
for QSM in imaging carotid atherosclerosis has been demonstrated in previous studies 
(292,308,310–313), but these studies either did not evaluate the errors caused by the 
presence of fat or required the acquisition at in-phase echo times (313) and also did 
not evaluate its potential for providing positive contrast in imaging USPIO contrast 
agent uptake in carotid atherosclerosis (310,312,313). In chapter 5 it was shown that 
the chemical shift from fat caused severe errors in the field map estimation, that 
propagated onto the susceptibility maps of the neck and the carotid arteries and 
obscured the region surrounding the carotid arteries. These errors were corrected 
through the inclusion of T2* IDEAL water-fat separation in QSM processing. In addition 
to removing artifacts and improving the image quality of the resulting susceptibility 
maps, this may also offer a novel method of identifying the lipid rich necrotic core 
(LRNC), another feature of atherosclerotic plaques. A previous study has discussed 
the use of Dixon-based water-fat separation techniques in carotid artery plaques (not 
in combination with QSM) to identify the LRNC (316).  
In chapter 5, it was shown feasible to generate susceptibility maps of the necks and 
carotid arteries of volunteers by performing QSM in combination with T2*-IDEAL water-
fat separation, using a conventional multi-echo gradient echo MRI sequence 
(Susceptibility Weighted Angiography, SWAN). However, in patient studies, the signal-
to-noise ratio (SNR) and image quality are often much lower than in volunteer scans 




Figure 6-1: The observed image quality is better in volunteer scans (a) in comparison to patient scans 
(b) 
This may be due to issues with coil positioning or patient movement. Within this study, 
it was therefore proposed to use bipolar readout gradients in order to shorten echo-
spacing. This acquisition technique has shown in previous studies to improve SNR, 
acquisition efficiency and to reduce the number of phases wraps and to widen the 
spectral bandwidth in which water and fat can be separated (317,318). However, due 
to gradient delays and eddy currents, gradient-polarity-specific phase offsets are 
added onto the signal at each echo time. This means that phase discrepancies 
between even and odd numbered bipolar echoes are introduced, which require 
correction (317,318).  
The hypothesis of this chapter is that using bipolar readout gradients would render T2* 
IDEAL water-fat separation and QSM in the neck and of carotid arteries more robust 
and could be used in a patient cohort. Within the patient cohort T2* IDEAL was 
evaluated as a means to identify the LRNC, and QSM served to identify and distinguish 




6.2.1 Signal Processing: 
Phase Correction: 
In order to perform Δ𝐵 mapping of the bipolar multi-echo gradient echo dataset, it is 
necessary to remove the gradient-polarity-specific phase offsets, which are caused by 
gradient delays and eddy currents (317,318). Since unipolar echoes all have the same 
gradient polarity, as shown in Figure 6-2 a), the added phase-offset is constant and 
can be ignored. In bipolar echoes, the gradient polarity in even numbered echoes is 
reversed from the polarity in odd echoes (Figure 6-2 b).  
 
Figure 6-2: Sequence Diagram of a gradient echo sequence using Unipolar (a) and Bipolar Readout 
Gradients (b) 
Therefore, even numbered echoes are offset in phase by Δθ from odd numbered 
echoes. Assuming a constant echo spacing, in voxels with a negligible fat-fraction, Δθ 
can be estimated from the phase of the first, second, and third echo: 
∠((𝑆2 ∙ 𝑆1
∗) ∙ (𝑆2 ∙ 𝑆3
∗)) = 2Δθ. Here, S1, S2, and S3 are the complex signals acquired at 
the first, second, and third echo time respectively. In previously presented methods 
(317–319) to correct for this type of phase offset, the variation of Δθ with position was 
assumed to be linear—predominantly in the readout direction, but there have also 
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been cases where it was modelled in two or three dimensions (317,318). In this 
research the dataset was inspected and Δθ was assumed to vary linearly in 2D. A 
linear function was fit to the estimated Δθ. Areas of insufficient SNR and areas of fat 
were excluded from the fitting process. The complex data were then corrected by 
removing the linearly modelled Δθ from the even echoes. 
Fat/Water Separation: 
As described previously in chapter 5, QSM in the neck requires correction of the 
chemical shift of fat. The T2* IDEAL (241,261,262) algorithm was used in order to 
estimate the fat-fraction within each voxel and correct Δ𝐵 accordingly. In chapter 5, 
where unipolar readout gradients were used, the background field estimated with the 
Laplacian Boundary Value algorithm (176) was used as an initial Δ𝐵 estimate. In the 
current chapter, bipolar readout gradients were used to reduce the echo spacing and 
therefore a rougher initial estimate for the external field 𝐵𝑒𝑥𝑡 could be used. This was 
achieved by estimating Δ𝐵 generated from the odd echoes only without any T2* IDEAL 
correction applied (258–260); they were approximately at in-phase echo times, and 
therefore chemical shift artifacts that could potentially propagate onto T2* IDEAL were 
minimized. To this Δ𝐵 estimate a low-pass filter was applied to extract its background 
field. If necessary, the background field estimate was then unwrapped using a graph-
cut-based spatial phase unwrapping algorithm (263). Subsequently, the unwrapped 
background field served as an input to the T2*-IDEAL algorithm when estimating the 
corrected Δ𝐵 estimate. This 𝛥𝐵 estimate calculated with the T2*-IDEAL algorithm 
typically did not require additional phase unwrapping. Using a low-pass filter instead 
of the Laplacian Boundary Value algorithm (176) to estimate the background field has 
the advantage that there are fewer artifacts at the boundary of the ROI; these may 
lead to water fat swaps, which require the ROI to be adjusted after water-fat separation 
as described in chapter 5.  
In order to illustrate the benefit of the bipolar echoes, the field maps in the volunteers 
were also estimated using an additional acquisition with unipolar readout gradients 
that was also analysed in chapter 5. The background field was estimated by low-pass 
filtering an initial Δ𝐵 estimate, which was calculated from the unipolar echo dataset 
without any T2* IDEAL correction. This was used as an input for the T2* IDEAL 
algorithm. The resulting fat-fraction maps and field maps were compared. 
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Quantitative Susceptibility Mapping: 
From the T2*-IDEAL-corrected Δ𝐵-estimate of the bipolar readout gradient dataset, the 
background field was removed using the Laplacian Boundary Value algorithm (176). 
The internal field was then inverted using Morphologically Enabled Dipole Inversion 
(MEDI) (260,281,286,287). The 3D tissue mask for both background field removal and 
dipole field inversion was manually drawn slice-by-slice on magnitude images and Δ𝐵 
maps by me. As described previously in Chapter 5 the mask was carefully drawn. This 
involved excluding voxels of insufficient SNR to avoid artifacts. Furthermore, the 
boundary of the mask was drawn through regions of relatively uniform susceptibility 
such as muscle tissue in order to minimize the presence of susceptibility variations 
within the boundary, which are the cause of artifacts during background field removal. 
The boundary was also placed as far away as possible from the carotid arteries in 
order to reduce the effect of errors that are caused by background field removal near 
the boundary of the tissue mask on the carotid artery wall.  
6.2.2 Data Acquisition: 
From 31/10/2017 to 10/01/2019, 15 participants were imaged after giving written 
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Table 6-1: Sequence Parameters * the slice thickness is interpolated from the acquired 2 mm to 1 mm 
using zero-filling. 
The ten healthy participants (3 women and 7 men aged 30.7±10.7 years, range 23-55 
years) were scanned as described in chapter 5. In addition to the axial flow-
compensated 3D multi-echo gradient-echo acquisition with unipolar readout gradients 
which was also analysed in chapter 5, an axial flow-compensated 3D multi-echo 
gradient-echo acquisition with bipolar readout gradients was also acquired at 1.5T 
(MR450w, GE Healthcare, Waukesha, WI) for QSM in the same scanning session. 
The repetition times (TR) of both sequences were chosen to be of equal length, so 
that they could be compared easily. This served to illustrate the benefit of the bipolar 
readout gradients in comparison to the unipolar readout gradients. The imaging 
parameters for the healthy volunteer study are given in Table 6-1.  
The patient population consisted of five patients (1 woman and 4 men, mean age 
71±7.5 years, range 63–81 years) with moderate to severe carotid artery disease (i.e. 
50-99% luminal stenosis on carotid duplex imaging). Datasets from four out of the five 
patients were also analysed in chapter 4 for SWI analysis. The patient recruitment was 
done by Dr Ammara Usman. Prior to the study patients were screened to minimize 
potential contraindications of Ferumoxytol contrast agents. This included a review of 
their medical history, while screening and cross-checking at the time of recruitment 
and consent. The following exclusion criteria were used: History of atopy, asthma or 
allergic reaction to contrast media, iron or dextran or a known documented history of 
haemochromatosis. Furthermore, patients with immune inflammatory conditions, e.g. 
systemic lupus erythematosus, rheumatoid arthritis were excluded. All of the 
participants gave informed consent and the study, also presented in chapter 4, had 
ethical approval from the East of England – Cambridge Central Research Ethics 
Committee. The patients were scanned on the same MRI system as the volunteers. 
Two scans were performed, one was performed before and the other one 48 hours 
after 5 mg/kg USPIO-injection (Ferumoxytol, AMAG Pharmaceuticals, Lexington MA). 
The injection was performed under the supervision of Dr Usman by trained staff. For 
QSM, the axial 3D multi-echo gradient echo acquisition with bipolar gradients was 
used due to the benefits established in the volunteer study—which will be described 
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in the ‘Results’ and ‘Discussion’ sections of this chapter. The raw MRI data were 
reconstructed using ASSET, as in chapter 4 and 5. The 𝑇2
∗w images for each individual 
echo were generated using the GE scanner reconstruction. These magnitude images 
were also used for and 𝑅2
∗ mapping. An additional multi-contrast protocol was acquired 
during the same MRI exams in order to validate the QSM results. This included T2*w 
images and R2*-maps calculated from the same dataset, 3D time-of-flight MRA, and 
black-blood (DANTE) and fat-suppressed T1w 3D fast-spin-echo (CUBE). R2*-
mapping was performed with in-house-developed Matlab code provided by Dr Jianmin 
Yuan on a voxel-by-voxel basis. The black blood preparation CUBE was implemented 
by Dr Jianmin Yuan. He also provided the multi-echo gradient echo sequence, where 
minor changes to the GE product sequence were made such as a modifiable number 
of echoes. Through assessment of the multi-contrast protocol alone, plaque 
morphology could be evaluated. Plaque calcification appeared as hypointense on all 
sequences of the protocol and hyperintense on R2*-maps. Through comparison of the 
pre- and post-contrast images, USPIO-uptake could be identified. As described in the 
introduction, elevated concentrations of iron oxide nanoparticles lead to a decrease in 
signal intensity (SI) on T2*w images and an increase in R2*. Furthermore, at low 
concentrations, the contrast agent appeared hyperintense on T1w imaging. As 
previously described, this stems from USPIOs also having a T1 shortening effect (127). 
All of the imaging parameters for the patient study are given in Table 6-1.  
In two patients, histology and in two patients computed tomography (CT) data were 
available. The CT scans were acquired on a Siemens Somatom Definition Flash 
system (100kV, 0.5×0.5×1 and 0.6×0.6×1 mm3 resolution). The process of the 
histological analysis is described later. 
6.2.3 Data Analysis: 
Healthy Volunteer Scans: 
To assess feasibility and benefits of bipolar acquisitions for generating susceptibility 
maps of the carotid arteries, the field maps and fat-fraction maps (generated with T2* 
IDEAL) of bipolar and unipolar acquisitions were compared. On the magnitude images,  
I subsequently manually outlined fat and muscle tissue  using ITK-SNAP (version 
3.6.0; http://www.itksnap.org) (320). The mean values within these ROIs on the 
susceptibility maps, generated from the bipolar acquisition, were measured for all 
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volunteers to calculate the susceptibility differences and CNR. Noise was defined as 
the standard deviation within muscle tissue, which was of relatively uniform 
susceptibility similar to Liu et al. (286). Furthermore, the T2* IDEAL corrected 
susceptibility map was compared to a susceptibility map calculated from an 
uncorrected Δ𝐵 estimate that was calculated by fitting the function 𝑆(𝑡) ∝ 𝑒−𝑖∙𝛾∙Δ𝐵∙𝑇𝐸 to 
the acquired data (258–260). 
Patient Scans: 
In order to evaluate the patient population, plaque features were identified on 
susceptibility maps. These findings were confirmed in comparison with the multi-
contrast images. Therefore, all images acquired before and after contrast agent 
administration were centred on the bifurcation, so that slices could be compared. The 
susceptibility maps were referenced to the mean susceptibility within the 
sternocleidomastoid muscle, similar to the technique proposed in (242), where muscle 
tissue was used as a reference for QSM in the prostate. As susceptibility maps have 
an unknown offset, there has been a need to find suitable reference tissues that make 
susceptibility maps comparable across subjects (253,254,321). It is important that 
there is little variability in the susceptibility measured in these regions between 
patients. In the brain, cerebrospinal fluid and various white matter regions have been 
proposed as such reference regions (253,254,321). In other areas of the body urine 
and muscle tissue have been used (242). Regions of calcification were identified on 
both pre- and post-contrast susceptibility maps by their strong diamagnetism, i.e. 
negative susceptibility. USPIO-uptake was identified by its paramagnetic appearance, 
i.e. positive susceptibility, on the post-contrast susceptibility maps only. Furthermore, 
regions of “normal” plaque tissue were identified, where the susceptibility was close to 
zero. All of these regions were outlined on QSM and subsequently compared visually 
with the corresponding slices of the multi-contrast protocol. The presence of 
calcification was indicated by elevated R2*-values and Hounsfield units (CT) and 
appeared hypointense on all other images. USPIO-uptake was detected on the post-
contrast images by identifying an increase in R2* and a decrease in T2*w signal 
intensity in comparison with the pre-contrast images and also by an increase in signal 
intensity on some T1w images, if the USPIO concentration was low. 
Subsequently, the values measured within regions outlined to be normal plaque, 
calcification, and USPIO-uptake on QSM were compared quantitatively. QSM, R2*-
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maps and T2*w gradient-echo magnitude images all stemmed from the same dataset 
and were therefore naturally co-registered. Susceptibility values and R2*-values are of 
a quantitative nature. However, a direct comparison of T2*w signal intensity in between 
patients and of pre-and post-contrast images is not very meaningful. This is primarily 
due to the non-quantitative nature of T2*w images and the inhomogeneous coil 
sensitivity of the carotid coil that was used. As the patient position changes between 
scans and the patients have differently shaped necks, the coil sensitivity around the 
carotid artery plaques will vary. Therefore, all of the signal intensities were relative 
signal intensities (rSI) to the sternocleidomastoid muscle. Voxels with insufficient SNR 
to calculate R2* were excluded from the analysis by inspection of the R2*-maps and the 
T2*w magnitude images. After calculating the mean value within each region, the 
median and interquartile range over all patients were subsequently presented in box-
plot form.  
Subsequently, calcification volumes were outlined on 3D TOF and CT, so that their 
volumes could be calculated. These volumes were compared to the volumes of the 
calcified regions as outlined on QSM. Pearson’s correlation coefficient was used to 
describe the relationship between the calcification regions measured on 3D TOF and 
QSM. 
Furthermore, a lipid rich necrotic core was identified by an elevated value on the fat-
fraction map generated using T2* IDEAL from one pre-contrast scan, where histological 
validation was available. For comparison, a plaque region with a low fat fraction, 
unlikely to contain lipid core and a region of the sternocleidomastoid muscle were 
outlined. The fat fraction values measured within these ROIs were presented in box-
plot form. Subsequently, the presence of the lipid core was confirmed through 
histology, as described below.  
Data processing and analysis were performed using MATLAB (R2017b, MathWorks, 
Natick, Mass). The code for the uncorrected Δ𝐵-estimation, phase unwrapping, 
background field removal and dipole field inversion were taken from the MEDI toolbox. 
Histological Analysis: 
Two cases were available for histological analysis. These were already presented in 
chapter 4 for comparison with SWI. The specimens were decalcified and sliced at 3mm 
intervals. The tissue was embedded in paraffin wax; thin sections were cut at 3 µm 
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thickness and then stained with Haematoxylin and Eosin, Perl’s Prussian Blue (for 
iron) and Elastic Van Gieson (elastic fibre stain). The histopathological analysis was 
performed by the tissue bank team and Dr Alison Cluroe, the consultant 
histopathologist. Slices of histology and MRI were approximately matched in location. 
This was presented as a method to validate the presence of plaque features such as 
USPIO uptake, calcification, and/or lipid core. However, it needs to be acknowledged 
that due to the differences in resolution and slice thickness between the two 
techniques, this comparison was limited by the resolution in the slice thickness.  
6.3 Results: 
The field maps and water-fat fraction images calculated from the bipolar readout 
acquisitions were visually similar to the results achieved with the unipolar readout as 
shown in Figure 6-3. In the border regions, the bipolar water-fat separation 
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outperformed the results achieved with the unipolar gradients, where there were more 
frequent water-fat swaps and Δ𝐵 also appeared noisier. 
The T2* IDEAL-corrected 𝛥𝐵 subsequently produced high-quality susceptibility maps. 
Figure 6-4 shows an axial slice of the neck of a healthy volunteer. Figure 6-4 a and b 
show the magnitude images for anatomical reference. The susceptibility map on 
Figure 6-4 c demonstrates high susceptibility differences between tissue and fat. The 
median of the mean susceptibility difference between fat and muscle tissue measured 
in all volunteers (median ± interquartile range (IQR) 0.56 ppm ± 0.12 ppm) agrees with 
previously published values for the susceptibility of fat (0.61-0.64 ppm) 
(241,314,322,323). The CNR calculated between fat and muscle was 6.95, with the 
Figure 6-3: 𝛥𝐵 (a,c) and Fat-Fraction maps (b,d) estimated with T2* IDEAL bipolar (a,b) and unipolar 
readout gradient datasets (c,d) (I also presented the results in  (305)) 
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noise level estimated to be 0.08 ppm. The susceptibility maps of the remaining 
volunteers are given in Appendix B. 
 
Figure 6-4: The un-zoomed (a) and zoomed (b) magnitude images of a healthy volunteer scans are 
given as an anatomical reference for an T2* IDEAL-corrected susceptibility map from a healthy volunteer 
(c) in comparison with an uncorrected susceptibility map from the same volunteer (d). On the T2* IDEAL-
corrected susceptibility map the ROI containing fat is outlined in red, and the muscle tissue in green. (I 
also presented these results in the publication (305)) 
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In order to highlight the improvements achieved with this technique, the acquired 
susceptibility maps were again compared to a susceptibility map without T2* IDEAL 
correction, which exhibited severe streaking artifacts and errors inside the regions 
containing fat (Figure 6-4 d). Therefore, the techniques could also be applied to the 
patient cohort. This way, it was possible to acquire high quality susceptibility maps in 
the patient study. 
On all patient exams plaque calcification appeared much more diamagnetic on both 
pre-contrast (median ± IQR of -0.86±0.22 ppm) and post-contrast QSM (-1.27±0.71 
ppm), than “normal plaque tissue” which had a susceptibility close to zero and did not 
seem to contain any calcification or USPIO-uptake (pre-contrast QSM: -0.1±0.04 ppm; 
post-contrast QSM: -0.16±0.07 ppm). USPIO uptake appeared as paramagnetic on 
the post-contrast QSM (1.32±0.61 ppm). Figure 6-5 & Figure 6-6 illustrate this in two 




In both cases plaque calcification could again be easily identified by its strong 
diamagnetism on pre- and post-contrast susceptibility maps (yellow arrow). It could be 
distinguished from “normal plaque tissue”, and the strongly paramagnetic plaque 
regions, where USPIO contrast agents have been taken up, as indicated by the blue 
arrow. A comparison with the multi-contrast protocol, confirmed these results: regions 
of QSM-identified plaque calcification appeared as hypointense on 3D TOF, T1w 
DANTE CUBE, and on T2*w gradient echo magnitude images. On R2*-maps, QSM-
identified calcifications appeared hyperintense. This was the case for both pre- and 
 Figure 6-5: A 70-year-old man was scanned before (a-f) and after (g-l) contrast agent administration. 
Calcified regions are indicated by a yellow arrow. They appear hypointense on QSM (a, g), T2*w GRE 
(c, i), 3D TOF MRA (e, k) and T1w FSE (f, l). They appear hyperintense on filtered phase images (b, 
h) and R2*-maps (d, j). USPIO uptake is indicated by the blue arrows on the post-contrast images. 
USPIO-uptake appears hyperintense on QSM (g), R2*-maps (j), and T1w FSE (l). It appears 




post-contrast images. On Figure 6-6 g) the presence of calcification was furthermore 






Figure 6-6: A 65-year-old man was scanned before (a-f) and after (h-m) contrast agent administration. 
Calcified regions are indicated by a yellow arrow. They appear hypointense on QSM (a, h), T2*w GRE 
(c, j), 3D TOF MRA (e, l) and T1w FSE (f, m). They appear hyperintense on filtered phase images (b, 
i), R2*-maps (d, k), and CT (g). USPIO uptake is indicated by the blue arrows on the post-contrast 
images. USPIO-uptake appears hyperintense on QSM (h), R2*-maps (k), and T1w FSE (m). It appears 




The presence of QSM-identified USPIO-uptake was confirmed by comparing the pre-
and post-contrast images. Within these regions, a decrease in rSI on the T2*w gradient 
echo magnitude images (0.48 rSI units) and increase in R2*-values (75.8 s-1) could be 
observed in comparison to the normal plaque tissue on the pre-contrast scans. While 
there was an overall decrease in T2* rSI and increase in R2* on the post-contrast 
images, the changes within regions of QSM-identified USPIO uptake were much 
stronger than within regions of QSM-identified calcification (0.14 rSI units / 43.4 s-1) or 
normal plaque tissue (0.19 rSI units / 37.1 s-1). In some cases, USPIO-uptake also 
coincided with an increase in T1w SI. 
 
Figure 6-7: To confirm the presence of calcification and USPIO uptake, the respective ROIs were 
outlined on QSM and the mean susceptibility values (a), R2*-values (b), and T2*w rSI values (c) were 
measured within each region. The box plots combine the mean ROI values measured in all volunteers. 
(I also presented these results in the publication (305)) 
These results were confirmed in box-plot form. Figure 6-7 shows the box-plots of the 
mean susceptibility values (Figure 6-7 a), R2* values (Figure 6-7 b), and T2*w rSI values 
(Figure 6-7 c) measured within regions of calcification, USPIO-uptake and normal 
plaque tissue as outlined on QSM for all patients. QSM allowed for a clear distinction 
between calcification, USPIO-uptake, and normal plaque tissue, which had a strongly 
negative, positive and close to zero susceptibility value respectively (Figure 6-7 a). 
There is a slight difference in distribution between the susceptibility of calcified tissue 
on pre- and post-contrast scans. From inspection of the images, this may be due to 
the increase of streaking artifacts on the post-contrast dataset, which may lead to more 
extreme values within calcified regions, or it may be due to partial volume effects. 
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On both R2* maps and T2*w images, USPIO-uptake and calcification caused high 
R2*/low T2* values (Figure 6-7 b, c). This means that they confirm the results shown in 
QSM, i.e. increased de-phasing in regions of strong susceptibility sources but were 
unable to distinguish diamagnetic from paramagnetic materials. In contrast to the QSM 
dataset, the overall de-phasing increased on the T2* rSI or R2* datasets, which can be 
seen by an overall increase in R2*/decrease in T2* rSI within normal plaque regions 
post-contrast. This highlights that it might be problematic to quantify the concentration 
of USPIO uptake from changes in R2* alone due to the non-local field effects caused 
by the presence of USPIO contrast agents. The MRI results from the remaining patient 
cases are shown in Appendix C. 
When assessing the volumes of calcification measured on QSM in comparison to 3D 
TOF, the measured volumes were of similar size and location and showed a high 
correlation (Pearson’s Correlation Coefficient = 0.995). The QSM-identified volumes 
of calcification also agreed with CT validation, as shown in Figure 6-6, which was only 
available in a limited number of, i.e. two, cases.  
6.3.1 Histology: 
Histology was available in the same patients that were described in chapter 4 section 
4.3.1. The first case is of a lightly calcified plaque (Figure 6-8), which was also 
described in Figure 6-5 and will also be analysed later in Figure 6-9. In chapter 4, this 
plaque was analysed in Figure 4-2 & Figure 4-10. Much like SWI, QSM was able to 
detect calcification and USPIO uptake within this plaque, which was initially confirmed 
by the multi-contrast protocol. When comparing the MRI results to the histological 
analysis, these results were confirmed. Perl’s Prussian Blue stained the iron particles, 
i.e. the USPIO-nanoparticles blue. Due to decalcification, plaque calcification 
appeared as pale areas on both Perl’s Prussian Blue and Haematoxylin and Eosin 
staining. There is a small area of blue staining next to the plaque calcification, which 
may be due to USPIO particles but could also stem from haemorrhage, hemosiderin 





Figure 6-8: This is a case of a 70-year-old man in which USPIO uptake and calcification were identified 
on pre- (a) and post-contrast (b) QSM, which was confirmed by histology (c). On this histology slide (c), 
which is decalcified and uses a Perl’s Prussian Blue Stain, the calcification appears as a pale island 
and the iron particles are stained blue. Calcification can be seen in the yellow box (*) (e) and the iron 
particles, stained blue, are in the blue box (d). These results confirm the presence of the QSM-detected 
juxtaluminal USPIO-uptake on the post-contrast susceptibility map (b) (blue arrow). Calcification can 
be seen at the border of the plaque on both pre- and post-contrast QSM (yellow arrow, a, b). The tissue 
section was slightly ripped, which commonly occurs during carotid endarterectomy surgery or during 
sectioning. (I also presented these results in the publication (305)) 
Analysis of the fat-fraction map of the same plaque showed an elevated fat-fraction, 
indicating the presence of a lipid rich necrotic core (Figure 6-9). The analysis used 
was similar to Koppal et al. (316), who used an elevated fat-fraction on Dixon-based 
water fat separation, but not T2* IDEAL, to identify the lipid core. Figure 6-9 shows that 
the fat-fraction was heightened in the region identified as the lipid core when compared 
to “normal” plaque region and the sternocleidomastoid muscle. This was confirmed 
when considering the Elastic Van Gieson histochemical stain, on which the LRNC 
could be identified by a yellow/pink colouring and the presence of cholesterol crystals. 
This is in contrast to the purple staining which is due to the elastic fibres. 
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Figure 6-9: This case shows the plaque of a 70-year-old man. The fat-fraction map (a, b) with (b) and 
without (a) the ROIs outlined is positioned next to a gradient-echo magnitude image (TE = 4.4 ms) for 
anatomical reference (c). The carotid artery plaque is inside the green box. On the fat fraction map, the 
lipid rich necrotic core is identifiable by hyperintensity (b, outlined in red), while the plaque area 
containing low to no lipid content is outlined in green. A region of sternocleidomastoid muscle tissue 
was outlined in yellow for reference. The fat fractions measured within all regions of interest are 
presented in boxplot form (f). The histological analysis with the Elastic Van Gieson histochemical stain, 
depicted the presence of the lipid core clearly. This was made visible due to the yellow/pink colouring 
(d, e) and the presence of cholesterol crystals (e). (I also presented these results in the publication 
(305)) 
The second plaque that underwent histological analysis was more heavily calcified 
(Figure 6-10). This plaque was also analysed in chapter 4, and is shown in Figure 4-3 
and Figure 4-11. On pre-contrast QSM, it appeared strongly hypointense. On the post-
contrast QSM, the overall signal intensity changed to hyperintense. This suggests that 
there was UPSIO uptake within the plaque and USPIO-particles were interspersed 
with calcification. The histological analysis confirmed these results. The calcification 
was located beneath the lining of the vessel. Iron particles stained in blue on the Perl’s 
Prussian Blue stain were located within the overlying fibrotic tissue and widely 
dispersed in the space between large areas/nodules of macrocalcification, which 























































































































































































































































































































































































































































































































































































































































































































































































































































Within this chapter the feasibility and benefit of performing simultaneous QSM and T2* 
IDEAL water fat-separation in the neck and of carotid arteries using bipolar readout 
gradients was demonstrated. In chapter 5, it was shown that an accurate estimate of 
the fat-fraction and correction of the Δ𝐵 map improved image quality of the 
susceptibility maps of the neck and carotid arteries by reducing streaking artifacts and 
also corrects the susceptibility value measured inside regions of fat. In this chapter, 
bipolar instead of unipolar readout gradients were used. This improves the SNR of the 
echoes following the first echo, which is important for Δ𝐵 estimation. Furthermore, 
minimum spaced echoes improved water-fat separation. This improvement can be 
explained by considering the cost-function of the T2* IDEAL algorithm. The algorithm 
searches for the value of ΔB which minimizes the difference between the signal model 
and the measured signal. A larger echo spacing leads to a smaller frequency range 
(bandwidth) within which the signal can be correctly determined. The initial Δ𝐵-
estimate is required to be within this frequency range and therefore needs to be 
sufficiently accurate. If it is outside the frequency range, the algorithm may converge 
to a different solution, producing water-fat swaps and errors in Δ𝐵. The reduced 
minimum echo spacing achieved by the bipolar echoes therefore maximized SNR and 
simultaneously widened the bandwidth within which water and fat could be 
unambiguously determined. The effect of echo spacing on the convergence of the 
IDEAL algorithm has been demonstrated in previous studies (324–326). 
After evaluating the feasibility and performance of this technique for generating 
susceptibility maps of the neck and the carotid artery wall in a volunteer study, this 
technique was subsequently applied within a patient cohort. QSM was able to assess 
atherosclerotic plaques in vivo, to detect features such as calcification and also 
provide a novel method for positive contrast of USPIO-uptake, a marker for carotid 
plaque inflammation. In addition to this, QSM may also be able to identify intra-plaque 
haemorrhage (IPH). IPH was not detected in our patient cohort, but other research 
studies have shown the ability of QSM to detect it due to its high paramagnetism 
(310,327). In the brain, haemorrhage has been one of the features that has been 
widely detected and distinguished from calcification using QSM (171). This allows for 
the hypothesis that although not present in our study, IPH could be detected using this 
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methodology. Furthermore, T2* IDEAL water-fat separation detected a LRNC in one 
patient, where its presence was confirmed using histology. While this is only a single 
case, it was believed to be worth inclusion in our results as another study employed 
another Dixon-based water fat separation technique in a larger patient cohort in 
comparison with histology (316). All of this was achieved within a single sequence, 
which can be used as part of a conventional multi-contrast protocol that already 
involves R2*-mapping, and therefore does not require any additional scanning time.  
Particular interest is granted to QSM’s ability to detect USPIO-uptake. In previous 
research, USPIO-uptake is commonly detected by a decrease in signal intensity on 
T2*w imaging and increase in R2*-value on R2* mapping, when comparing post-contrast 
images to images acquired before contrast agent administration. The comparison with 
the set of pre-contrast images is required since the USPIO-uptake regions are 
indistinguishable from other strong sources of susceptibility such as calcification. In 
previously published techniques pre- and post-contrast images were matched on the 
carotid bifurcation and the plaque was divided into segments (quadrants 
(126,141,143) or octants (137)). Subsequently, the mean R2* value or T2* signal 
intensity relative to the sternocleidomastoid muscle within each segment could be 
compared. A large change in signal then indicated that there was USPIO-uptake 
(137,138,141–143). Therefore, USPIO-uptake is only detected with a coarse 
resolution (e.g. four plaque regions if quadrant analysis is used (126,141,143) or eight 
if octant analysis is used (137)) and USPIO-uptake may be underestimated or missed 
due to partial volume effects. Furthermore, background field effects increase the 
overall de-phasing on post-contrast images, which may lead to errors in estimating the 
amount of contrast agent uptake. In chapter 4 SWI has been proposed as a potential 
technique that improves on some of these issues. While the images provided 
meaningful and improved results, SWI suffered from non-local effects, which played 
an especially serious role in heavily calcified plaques.  
Within this study, QSM has shown the potential to identify USPIO-uptake qualitatively 
within a single post-contrast scan with positive contrast, which can potentially eliminate 
the need for a pre-contrast scan (144,148,151,152), typically performed two or three 
days before the post-contrast scan (137,138,141–143). This is particularly evident in 
lightly calcified plaques, where regions of USPIO-uptake and calcification do not 
overlap. QSM distinguished between regions of paramagnetism and diamagnetism on 
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the post-contrast images, rendering the pre-contrast acquisition superfluous (Figure 
6-5 & Figure 6-6). In heavily calcified plaques (e.g. Figure 6-10), partial volume effects 
lead to a hyperintense appearance of the USPIO-uptake post-contrast even when it is 
interspersed with calcified nodules. Although partial volume effects decreased the 
signal intensity in those regions, USPIO-uptake dominated the contrast, rendering the 
plaques hyperintense rather than hypointense, as they had appeared on the pre-
contrast scan. The calcification may be identified by comparison of the multi-contrast 
protocol, for example on 3D TOF MRA or T1w sequences, where it appeared 
hypointense. Besides eliminating the need for an additional costly and time-consuming 
pre-contrast scan, QSM allows for an analysis of the USPIO-uptake regions in much 
higher detail. In contrast to quadrant analysis which simply evaluates the signal 
intensity within four segments, QSM allows for high resolution depiction of USPIO-
uptake.  
While this illustrates the benefit of QSM for qualitative analysis of USPIO-uptake, it 
also allows for improvements of the quantitative analysis of USPIO uptake. In the past, 
R2*-mapping and relative T2*w measurements have been used (137,138,141–143). As 
described above, this may require complex co-registration, which is why segment 
analysis is used. In addition to that insufficient SNR may lead to failing of R2* mapping 
in individual voxels. Also R2* may overestimate USPIO-uptake due to background field 
and non-local USPIO-field effects increasing the overall R2* value on post-contrast 
scans (137,143,144). Furthermore, both T2*w imaging and R2*-mapping suffer from 
non-local artifacts which lead to an overestimation of the volumes containing USPIO-
uptake. By contrast, QSM displays the underlying susceptibility distribution, which 
minimizes non-local artifacts and background field effects due to the QSM processing. 
In addition, the relationship between UPSIO-content and susceptibility has been 
demonstrated to be linear (295). For Ferumoxytol a scaling factor of 59.6 ppm ml/mg 
at 1.5T (295) has been previously established, so that it can be estimated that the 
plaques scanned within this study contain a concentration of 22±10 µg/ml of 
Ferumoxytol. This is calculated by dividing the median of the mean susceptibility 
values measured in regions of USPIO (1.32 ppm) by the scaling factor. For quantitative 
analysis, a pre-contrast scan may still be necessary to determine the change from the 
baseline susceptibility within regions of USPIO-uptake.  
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Due to these benefits, it is important to compare QSM to other positive contrast 
techniques. These are typically dedicated sequences such as IRON and GRASP. 
These techniques rely on detecting phase shifts caused by USPIO-contrast agents, 
not the underlying susceptibility distribution (148,151,152,293). As described in 
chapter 1, both IRON and GRASP use the effects of susceptibility induced fields 
generated by USPIO-contrast agents to selectively suppress signal from all other 
tissue. Therefore, these techniques image the field distribution rather than the 
underlying susceptibility. Furthermore, both IRON (148) and GRASP (151) are non-
quantitative and are dedicated sequences which require prior knowledge about the 
amount of dephasing due to USPIO-contrast agents (148,151,293). QSM therefore 
provides positive contrast and can simply be acquired with a conventional gradient 
echo sequence. It only requires consideration of how to minimize the chemical shift 
artifacts and maximize SNR. Furthermore, it provides a method to quantitatively 
assess USPIO uptake as described above and does not suffer from non-local effects. 
This study demonstrated that simultaneous T2* IDEAL water fat separation and QSM 
using bipolar readout gradients could be applied in the neck in 10 healthy volunteers 
and 5 patients (10 scans) and produced high quality susceptibility maps. Here the 
benefits of QSM in imaging carotid plaques over previously established techniques 
were made clear. However, the study was limited by the relatively small sample size. 
There was an even smaller subset of patients who underwent surgery and on which 
histological analysis could be performed. Since the patients did not undergo a 
dedicated CT scan, the CT validation was also limited. However, the QSM results were 
confirmed by a previously established multi-contrast MRI protocol and, where 
available, QSM agreed with histology and also with CT. There was no IPH identified 
in any of these patients. However, QSM was able to detect paramagnetic substances, 
i.e. USPIO-uptake, and previous studies in the brain have shown that it can detect 
haemorrhage and distinguish it from calcification. A pilot study that used QSM in the 
carotid arteries detected calcification and intraplaque haemorrhage, thus confirming 
our hypothesis (310). When imaging USPIO-contrast agents in the presence of 
intraplaque haemorrhage, a dedicated pre-contrast scan may be necessary. 
Alternatively, an additional sequence to selectively image IPH such as MR Direct 
Thrombus Imaging (which can be used to image fresh thrombus) (MR DTI) could be 
used to distinguish USPIO-uptake from IPH on QSM (125). As low concentrations of 
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USPIO-uptake also have a T1 shortening effect, future studies could investigate 
whether a combination of QSM and MR DTI could be used to distinguish IPH from 
USPIO-uptake. 
Another limitation of QSM of the carotid artery plaque was a reduced image quality 
due to streaking artifacts, noise, and artifacts, which may originate from imperfect 
background field removal. For anatomical imaging of the carotid plaques, QSM should 
be combined with an additional sequence for anatomical imaging such as 3D TOF or 
black blood FSE. Furthermore, the proposed algorithm ignored chemical-shift-induced 
misregistration errors associated with bipolar readout gradients, which were assumed 
to be negligible due to the large bandwidth, relatively large pixel size and low magnetic 
field strengths. At smaller pixel sizes or at stronger field strengths, this may become 
an issue and may be addressed using different methods. For instance Lu et al. 
generated water and fat images by addressing the chemical shift induced 
misregistration issues in k-space (319). However, this study only solves the issue for 
water and fat images and may require further work for a solution for the field map. 
6.5 Conclusion 
In conclusion, the work in this chapter demonstrated that QSM in combination with T2* 
IDEAL water-fat separation was able to identify the lipid rich necrotic core, calcification, 
and USPIO uptake within a single sequence. This is complementary to the 
conventional protocol and provides a novel positive contrast methodology for the 
identification and quantification of USPIO-uptake in carotid plaques, which simplifies 
and improves the detection of USPIO-contrast agent uptake even in calcified plaques. 
Therefore, it may be used in the future to assess carotid plaque inflammation in vivo 




Chapter 7 Summary and Future 
Developments 
In this work it was hypothesized that susceptibility effects can help in characterizing 
carotid artery plaques and provide a positive contrast mechanism for imaging 
inflammation using USPIO contrast agents. Susceptibility Weighted Imaging showed 
promising results and was further improved upon using Quantitative Susceptibility 
Mapping in combination with T2* IDEAL water-fat separation. 
T2*w imaging and R2*-mapping have frequently been used to image paramagnetic 
haemorrhage and diamagnetic calcification (294), which are features of 
atherosclerotic plaques. However, both features shorten T2* relaxation time and 
therefore they can typically only be identified in post-acquisition analysis of the multi-
contrast images. Both techniques have also been used to image USPIO-uptake by 
macrophages in inflamed atherosclerotic plaques (137,138,141–143). The highly 
paramagnetic USPIO nanoparticles cause an increase in R2*. In order to differentiate 
this change, from diamagnetic calcification, it is necessary to measure the changes in 
R2* or T2*w SI between two MRI examinations acquired before and after USPIO 
contrast-agent administration. Therefore, it has been suggested that positive contrast 
imaging techniques could be used to identify susceptibility changes induced by uptake 
of the USPIO to depict the presence of the contrast agent as signal hyperintensities 
(144,148,151,152). SWI and QSM have been shown to reflect changes in local field 
inhomogeneity and susceptibility respectively which are unique to paramagnetic and 
diamagnetic substances. This can simplify and improve the post-contrast acquisition 
analysis. The applications where this has been demonstrated were reviewed 
extensively in chapter 2 section 2.2.5. 
The results in chapter 4 show that SWI and filtered phase images were able to identify 
calcification and distinguish it from USPIO-uptake within a single scan under certain 
conditions: The acquired information was complementary to R2* mapping and T2*w 
GRE and simplified the post-acquisition analysis. This allowed for unambiguous 
identification of calcification on pre-contrast images and also for a distinction between 
paramagnetic USPIO-particles and diamagnetic materials on the post-contrast scan 
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alone, if their locations did not overlap. In previous studies which employed R2*-
mapping and/or T2*w imaging, a distinction between the two substances always 
required the comparison of pre- and post-contrast scans, due to their identical 
appearance in terms of signal intensity within these techniques. However, in heavily 
calcified plaques the unambiguous identification of USPIO-nanoparticles and 
calcification was difficult as this technique suffered from non-local effects, i.e., the 
geometry, sequence-, and orientation dependence associated with SWI. This 
limitation was addressed in the following chapters by more extensively processing the 
GRE data to produce susceptibility maps. In chapters 5 and 6 QSM was performed in 
numerical simulations, phantom scans, a volunteer cohort and a patient study to both 
identify atherosclerotic plaque calcification and USPIO contrast agent uptake. The 
susceptibility maps could be generated from a conventional T2*w multi-echo gradient 
echo sequence as is used for R2*-mapping. In addition to the conventionally applied 
post-processing steps used for QSM in the brain, a water-fat separation method was 
used in order to account for the presence of fat in the neck near the location of the 
carotid artery bifurcation. In this study T2* IDEAL water-fat separation was 
implemented to correct for the chemical shift artifacts stemming from fat present in the 
neck that lead to severe streaking artifacts which obscured the carotid arteries and 
erroneous susceptibility values on the susceptibility maps. In other studies that have 
attempted to perform QSM to image the carotid artery wall and/or carotid artery 
plaques these artifacts have been acknowledged however they have always been 
neglected (310,312) or the data were required to be acquired at an in-phase echo time 
(313).  
In T2* IDEAL water-fat separation a shorter echo spacing is beneficial and it is not 
necessary to acquire echoes at specific echo times, for example in or out of phase. In 
this study minimally spaced echoes were essential due to the reduced image quality 
in patient scans and at a relatively low field strength of 1.5T. Using bipolar echoes 
reduces the echo spacing in comparison to conventionally used unipolar readout multi-
echo gradient echo acquisitions used in QSM. Multi-shot multi-echo gradient echo 
could be used to further reduce echo spacing, but at the proposed resolution this would 
have led to unnecessarily long and not clinically feasible imaging times. The proposed 
method manages to reduce echo spacing while not at the same scale as the multi-
shot techniques in a clinically feasible acquisition time. 
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QSM was able to identify USPIO-uptake in heavily and lightly calcified plaques and 
carotid plaque calcification, allowing for a quantitative analysis of carotid artery 
plaques in a patient cohort. Due to its quantitative nature, it may also be used to 
evaluate the concentration of USPIO nanoparticles taken up in the plaques. QSM 
required more complex post-acquisition processing. However, it was able to address 
the shortcomings of SWI. QSM and T2* IDEAL water-fat separation can be performed 
with the complex data from a conventional multi-echo gradient echo MRI sequence 
using a minimum echo spacing, that maximizes signal to noise ratio and is acquired 
for conventional R2*-mapping. In addition, water-fat separation also served to identify 
a lipid rich necrotic core, which agreed with results from another previous study (316), 
that used a Dixon-based water-fat separation method to detect the lipid core. Overall 
this is a very important additional advantage since it means that QSM in combination 
with T2* IDEAL water fat separation can serve to identify plaque features such lipid rich 
necrotic core and calcification within a single sequence as well as providing a positive 
contrast mechanism for imaging USPIO-uptake. Furthermore, other studies have 
demonstrated the ability of QSM to identify intraplaque haemorrhage (310,327). 
There are several limitations to this study. First of all, the sample size was limited. For 
a statistical comparison of this methodology to other methods a larger sample size 
would be required. It should be noted that Ferumoxytol is no longer commercially 
available in the UK (328) and must be obtained via a specialist unlicensed medicines 
importer (Mawdsleys, Salford, UK) . This had the consequence of having a small study 
population. No intraplaque haemorrhage and only one lipid core could be 
unambiguously detected. As discussed in chapter 6, it is important to assess if and 
how USPIO-uptake can be detected in a single scan using QSM in plaques containing 
haemorrhage. In future implementations, it is therefore necessary to include additional 
sequences into the MRI protocol: The current study was designed to detect 
calcification and USPIO-uptake with the multi-contrast protocol, which could therefore 
be used as a confirmation of the results from QSM. A dedicated sequence to image 
intraplaque haemorrhage, such as MR direct thrombus imaging (125) could serve as 
a comparative measure with QSM to confirm the presence of intraplaque 
haemorrhage. The feasibility of detecting intraplaque haemorrhage and calcification 
has been shown in a pilot study applying QSM to a patient cohort in the neck (310). 
Similarly, the presence of a lipid rich necrotic core as identified with water-fat 
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separation should be confirmed with dedicated sequences, such as diffusion weighted 
imaging (329) or using contrast enhanced MRI (330). These would be the additions 
necessary if the study was designed again today.  
An additional reason why the study population for QSM was limited, was due to the 
fact that the study was initially designed to detect USPIO-uptake using R2*-mapping 
and T2*w imaging using a fat-suppressed, black-blood multi-echo gradient echo 
dataset. As was shown in chapter 4, it is possible to perform SWI on this dataset, but 
the benefits of improved vessel wall detection in volunteers do not always translate to 
the detection of carotid artery plaques, which may be hypointense, for example in the 
presence of calcification. When considering the phase images for performing QSM of 
the carotid artery wall, the suppression of signal from blood and fat is also 
counterproductive, as this will leave the regions of fat and the lumen to contain phase 
noise only. Therefore, the resulting susceptibility maps would contain strong artifacts. 
If the study was redesigned today, it would therefore not only include the relevant 
sequence to image a lipid core and intraplaque haemorrhage, but also would only 
contain a bright blood, multi-echo gradient echo sequence in all patient scans. 
This study has also shown the capability of QSM to identify calcification. Typically, this 
has been detected by using the multi-contrast protocol and was identified by 
hypointensities on all contrast-weightings. In our research group, zero-echo time (ZTE) 
imaging has demonstrated the ability to detect carotid artery calcification (331). On 
PDw ZTE images, calcification appear as hypointensities or after intensity correction 
on inverse log-scale ZTE images as hyperintensities (331,332). Due to the short 
acquisition time, it would be a useful sequence to add to the imaging protocol and 
compare its performance against that of QSM. Furthermore, it would be interesting to 
evaluate how QSM may detect smaller calcifications, or regions of microcalcification, 
that are below a certain resolution. Since microcalcifications in carotid arteries have 
been shown to be a feature of plaque vulnerability and are associated with plaque 
inflammation (75), it would be interesting to investigate the limits of detection of QSM 
for certain small calcifications. This could be done, for example, in a phantom by 
imaging different concentrations of hydroxyapatite. 
Improvements can also be made to the post-processing methodology: The current 
implementation of the water-fat separation to correct for chemical shift artifacts 
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assumes that there is a fixed chemical shift of -220 Hz at 1.5T for all types of fat. 
However, it is acknowledged that the chemical shift of fat in the neck and the lipid core 
are different. More accurate modelling of the fat spectrum within the fat in the neck 
close to the carotid arteries would potentially allow for improved correction of the Δ𝐵 
estimate and a further reduction in artifacts. A multi-peak modelling of the fat spectrum 
can be included in the T2* IDEAL algorithm, as has been demonstrated by Yu et al. 
(333). More accurate modelling of the fat spectrum within the lipid core would possibly 
allow for the improved detection of elevated fat fraction within the lipid core. The 
currently proposed technique, like the one proposed by Koppal et al. (316), shows only 
a slight elevation in the region, where a lipid rich necrotic core was identified. Validation 
of this method would require a spectroscopic analysis of the fat in the neck and the 
lipid rich necrotic core. The fat in the neck close to the carotid arteries could be 
analysed in volunteer scans, while the lipid core could be analysed in ex-vivo scans.  
In addition, several assumptions were made when modelling the effects of bipolar 
gradient echo readouts. A more accurate modelling of phase and amplitude 
modulation of bipolar echoes may improve the accuracy of the technique (334). An 
additional assumption was that the chemical shift induced misregistration between 
echoes was negligible due to the high bandwidth and the relatively low scanner field 
strength. This may be included in future algorithmic implementations, particularly when 
using higher field strengths. 
I have shown consistently that QSM was able to provide high quality susceptibility 
maps of the carotid artery wall in healthy volunteers and patients with carotid artery 
atherosclerosis. Therefore, it is suited for larger scale studies to detect the presence 
of macrophages in plaques with high levels of USPIO-uptake. QSM is more specific 
than R2*-mapping or T2* weighted imaging in the identification of regions of USPIO-
uptake and therefore allows regions of USPIO-uptake to be manually outlined. In 
contrast, R2*-mapping or T2* weighted images are unable to differentiate between 
diamagnetic and paramagnetic substances and frequently required the use of 
segment/quadrant analysis to compare pre- and post-contrast administration scans to 
identify and analyse regions of USPIO-uptake in previous studies (126,137,141,143). 
QSM-identified USPIO-uptake may be analysed like any other feature identified with 
high-resolution MRI, so that for example, the more detailed volume measurements of 
USPIO-uptake could be analysed as well as the morphology of USPIO-uptake regions. 
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While R2*-mapping displays a quantifiable increase with USPIO-contrast agent 
concentration, it is hampered by background field effects and it is difficult to make a 
direct estimation of USPIO contrast agent concentration from R2*-values alone. The 
susceptibility measured with QSM has a direct linear relationship with USPIO-
concentration. All these novel features can be evaluated in terms of their correlation 
with different stages of disease, monitoring disease progression or assessing plaque 
vulnerability. QSM may also allow the identification of USPIO-uptake within a single 
scan, eliminating the need for a pre-contrast acquisition. This simplifies study design, 
eliminates the need for image co-registration, reduces cost due to the additional MRI 
examinations, and improves patient acceptance.  
Therefore, QSM of carotid atherosclerosis offers a wide variety of applications in 
assessing plaque features and also improves the analysis of carotid artery plaque 
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The remaining susceptibility maps from the volunteer scans presented in chapter 5. 
 
Figure 1: Susceptibility map of a healthy volunteer 
 




Figure 3: Susceptibility map of a healthy volunteer 
 




Figure 5: Susceptibility map of a healthy volunteer 
 




Figure 7: Susceptibility map of a healthy volunteer 
 










The remaining susceptibility maps from the volunteer scans presented in chapter 6 
using bipolar readouts. 
 
Figure 1: Susceptibility map of a healthy volunteer 
 




Figure 3: Susceptibility map of a healthy volunteer 
 




Figure 5: Susceptibility map of a healthy volunteer 
 




Figure 7: Susceptibility map of a healthy volunteer 
 
















Figure 1: Pre- and post-contrast QSM of a patient with a carotid artery plaque (calcification is indicated 








Figure 2: Pre- and post-contrast QSM of a patient with a carotid artery plaque (calcification is indicated 











Figure 3: Pre- and post-contrast QSM of a patient with a carotid artery plaque (calcification is indicated 
by the yellow arrow, USPIO-uptake by the blue arrow) 
 
